[
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0001",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 24
    },
    "stem": "下列有關血壓測量的敘述，何者錯誤?",
    "options": [
      {
        "key": "A",
        "text": "小腿與上臂的血壓差增加常見於重度主動脈閉鎖不 全 (aortic regur郾tation) 或嚴重下肢周邊血管疾病"
      },
      {
        "key": "B",
        "text": "小腿的收縮壓通常比上臂的收縮壓高 20 m1nHg"
      },
      {
        "key": "C",
        "text": "血壓袖帶的長度和寬度應分別為手臂圓周的 80% 和 40% 。 使用不合適的小袖帶，會導致對 實際血塵值明顯低估"
      },
      {
        "key": "D",
        "text": "兩側上臂的收縮血壓差距，正常應在 !OnunHg 以內"
      }
    ],
    "answer": "C",
    "explanation": "若袖帶過小，通常會使所測得的血壓高估（因為需要更高壓\n力才能完全壓迫動脈），而非低估 。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0002",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 25
    },
    "stem": "下列有關糖尿病與高血壓的敘述，何者錯誤？",
    "options": [
      {
        "key": "A",
        "text": "糖尿病病人的高血壓盛行率較沒有糖尿病者高"
      },
      {
        "key": "B",
        "text": "糖尿病病人罹患高血壓的首選控制血壓藥物為 angiotensin-converting enzyme inh心tors 或是an giotensin receptor blockers"
      },
      {
        "key": "C",
        "text": "糖尿病病人的血壓控制目標通常建議比沒有糖 尿病的患者來得寬鬆"
      },
      {
        "key": "D",
        "text": "高血糜會促進糖尿病的大血管與小血管病變的 發生及惡化"
      }
    ],
    "answer": "C",
    "explanation": "糖尿病患者的血壓控制目標通常較一般人嚴格 ，以減少大血\n管和微血管併發症的風險。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0003",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 25
    },
    "stem": "下列針對主動脈縮窄 (coarctation of the aorta) 的敘述，何者錯誤？",
    "options": [
      {
        "key": "A",
        "text": "狹窄處最常見於左鎖骨下動脈後方、動脈導管 (ductus arteriosus) 開口對側"
      },
      {
        "key": "B",
        "text": "年幼嬰兒可表現為心衰竭或 shock，常合併 PDA"
      },
      {
        "key": "C",
        "text": "可造成上肢高血壓、下肢血壓較低與股動脈搏動減弱"
      },
      {
        "key": "D",
        "text": "典型胸部 X 光可見 rib notching 與 figure of 3 sign"
      }
    ],
    "answer": "A",
    "explanation": "主動脈縮窄典型狹窄位於左鎖骨下動脈分支處附近，常在動\n脈導管附著區域；題目 A 的描述位置不恰當。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0004",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 26
    },
    "stem": "下列對於高血壓急症 (hypertensive emergency) 的敘述，何者正確？",
    "options": [
      {
        "key": "A",
        "text": "只要血壓大於 180/120 mmHg 即可診斷，不需終末器官傷害"
      },
      {
        "key": "B",
        "text": "應在數分鐘內將血壓降至正常，以避免腦出血"
      },
      {
        "key": "C",
        "text": "需要合併急性終末器官傷害，通常需靜脈降壓並監測"
      },
      {
        "key": "D",
        "text": "可使用舌下短效 nifedipine 作為常規急救用藥"
      }
    ],
    "answer": "C",
    "explanation": "高血壓急症重點在於「急性終末器官傷害」(如腦、心、腎、\n主動脈剝離等)；需靜脈降壓並監測，避免過快降壓與避免短效\nnifedipine。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0005",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 27
    },
    "stem": "下列何者不是原發性醛固酮增多症 (primary aldosteronism) 常見特徵？",
    "options": [
      {
        "key": "A",
        "text": "高血壓合併低血鉀"
      },
      {
        "key": "B",
        "text": "代謝性鹼中毒"
      },
      {
        "key": "C",
        "text": "血漿腎素活性上升"
      },
      {
        "key": "D",
        "text": "可對 MRA（如 spironolactone）反應良好"
      }
    ],
    "answer": "C",
    "explanation": "原發性醛固酮增多症常見：高血壓、低血鉀、代謝性鹼中毒、\n腎素被抑制（低），且對 MRA 有效。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0006",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 28
    },
    "stem": "關於 24 小時動態血壓監測 (ABPM) 的敘述，下列何者正確？",
    "options": [
      {
        "key": "A",
        "text": "ABPM 無法評估夜間血壓"
      },
      {
        "key": "B",
        "text": "夜間血壓下降 10-20% 稱為 dipper，屬正常生理"
      },
      {
        "key": "C",
        "text": "non-dipper 代表較低的心血管風險"
      },
      {
        "key": "D",
        "text": "ABPM 僅能用於已確診高血壓者，不適用於白袍高血壓評估"
      }
    ],
    "answer": "B",
    "explanation": "ABPM 可監測夜間血壓與節律；正常人夜間血壓下降 10-20%\n（dipper）。non-dipper 反而與較高心血管併發症風險相關；\nABPM 也可用於白袍/隱匿性高血壓評估。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0007",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 29
    },
    "stem": "下列何者為妊娠期高血壓治療中應避免使用的藥物？",
    "options": [
      {
        "key": "A",
        "text": "Methyldopa"
      },
      {
        "key": "B",
        "text": "Labetalol"
      },
      {
        "key": "C",
        "text": "ACE inhibitor / ARB"
      },
      {
        "key": "D",
        "text": "Hydralazine"
      }
    ],
    "answer": "C",
    "explanation": "妊娠期高血壓常用 methyldopa/labetalol/hydralazine；ACEi/ARB\n（以及 DRI）為妊娠禁忌（胎兒腎毒性/畸胎風險）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0008",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 30
    },
    "stem": "下列關於 resistant hypertension 的敘述，何者最恰當？",
    "options": [
      {
        "key": "A",
        "text": "定義為使用 1 種降壓藥仍無法達標"
      },
      {
        "key": "B",
        "text": "常與鹽皮質激素（醛固酮）機轉相關，加用 MRA 可能有效"
      },
      {
        "key": "C",
        "text": "與生活型態無關"
      },
      {
        "key": "D",
        "text": "不需評估繼發性高血壓原因"
      }
    ],
    "answer": "B",
    "explanation": "頑固型高血壓需考慮服藥依從性、白袍效應、生活型態與繼發性\n原因；不少患者與醛固酮相關，MRA（如 spironolactone）常有效。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0009",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 31
    },
    "stem": "下列何者最符合高血壓治療中 thiazide 類利尿劑的特性？",
    "options": [
      {
        "key": "A",
        "text": "常造成高血鉀"
      },
      {
        "key": "B",
        "text": "可增加尿酸，可能誘發痛風"
      },
      {
        "key": "C",
        "text": "主要用於急性肺水腫第一線"
      },
      {
        "key": "D",
        "text": "對骨質沒有影響"
      }
    ],
    "answer": "B",
    "explanation": "Thiazide 可能造成低血鉀、低鈉、增加尿酸（痛風風險）、高血糖等；\n在高血壓為常用第一線之一。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0010",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 32
    },
    "stem": "下列何者最符合 ACE inhibitor 可能造成的不良反應？",
    "options": [
      {
        "key": "A",
        "text": "乾咳與血管性水腫"
      },
      {
        "key": "B",
        "text": "嚴重低血鈣"
      },
      {
        "key": "C",
        "text": "甲狀腺機能亢進"
      },
      {
        "key": "D",
        "text": "嚴重中性球增多"
      }
    ],
    "answer": "A",
    "explanation": "ACEi 常見副作用：乾咳、血管性水腫、高血鉀、腎功能惡化（特別是雙側腎動脈狹窄）。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0011",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 33
    },
    "stem": "關於 dihydropyridine (DHP) 類 CCB，下列何者較正確？",
    "options": [
      {
        "key": "A",
        "text": "以抑制房室結傳導為主"
      },
      {
        "key": "B",
        "text": "較常造成周邊水腫與反射性心搏過速"
      },
      {
        "key": "C",
        "text": "可用於控制心房顫動心室率為首選"
      },
      {
        "key": "D",
        "text": "對血管平滑肌作用很弱"
      }
    ],
    "answer": "B",
    "explanation": "DHP 類以血管擴張為主，常見副作用包括周邊水腫、潮紅、頭痛，\n短效製劑更容易引起反射性心搏過速。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0012",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 34
    },
    "stem": "下列何者最適合描述 non-DHP 類 CCB（verapamil/diltiazem）的作用？",
    "options": [
      {
        "key": "A",
        "text": "主要增加心肌收縮力"
      },
      {
        "key": "B",
        "text": "主要降低心率並抑制房室結傳導"
      },
      {
        "key": "C",
        "text": "主要用於治療低血壓"
      },
      {
        "key": "D",
        "text": "與心臟傳導無關"
      }
    ],
    "answer": "B",
    "explanation": "Non-DHP 類 CCB 主要影響心臟傳導系統（尤其 AV node），可降心率、\n抑制傳導，並具有負性變力作用。"
  },

  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0013",
    "source_type": "original",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "page": 35
    },
    "stem": "下列何者最符合 β 阻斷劑具有 ISA (intrinsic sympathomimetic activity) 的意義？",
    "options": [
      {
        "key": "A",
        "text": "具有部分致效作用，靜息心率下降較少"
      },
      {
        "key": "B",
        "text": "完全沒有心臟相關副作用"
      },
      {
        "key": "C",
        "text": "更適合心肌梗塞後長期預後改善"
      },
      {
        "key": "D",
        "text": "可作為急性肺水腫首選"
      }
    ],
    "answer": "A",
    "explanation": "ISA 代表部分致效活性，因此靜息時心率下降較少；在需強力交感抑制（如 MI 後）通常偏好無 ISA 的 β 阻斷劑。"
  },

  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0001",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "關於 24 小時動態血壓監測（ABPM）之夜間血壓節律（dipping），下列何者最正確？",
    "options": [
      {
        "key": "A",
        "text": "正常人夜間血壓通常上升 10–20%（dipper）"
      },
      {
        "key": "B",
        "text": "夜間血壓下降 10–20% 稱為 dipper，與較低心血管風險相關"
      },
      {
        "key": "C",
        "text": "non-dipper（夜間未下降）通常代表較低心血管風險"
      },
      {
        "key": "D",
        "text": "ABPM 無法評估夜間血壓"
      }
    ],
    "answer": "B",
    "explanation": "ABPM 可監測夜間血壓；正常生理為夜間相對日間下降約 10–20%（dipper）。若夜間未下降（non-dipper）代表節律異常，與較高心血管併發症風險相關。",
    "tags": [
      "hypertension",
      "ABPM"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0002",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "量測血壓時袖帶（cuff）尺寸的原則，下列何者正確？",
    "options": [
      {
        "key": "A",
        "text": "袖帶寬度約為上臂圓周的 10%，長度約為 20%"
      },
      {
        "key": "B",
        "text": "袖帶寬度與長度分別約為上臂圓周的 40% 與 80%"
      },
      {
        "key": "C",
        "text": "袖帶過小會使量到的血壓偏低估"
      },
      {
        "key": "D",
        "text": "袖帶過大會使量到的血壓偏高估"
      }
    ],
    "answer": "B",
    "explanation": "正確袖帶尺寸：寬度約為上臂圓周 40%，長度約為 80%。袖帶過小通常會高估血壓（需要更高壓力才能壓迫動脈），過大則可能低估。",
    "tags": [
      "hypertension",
      "blood pressure measurement"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0003",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "妊娠高血壓/子癲前症需要降壓治療時，下列何者較符合常用且相對安全的降壓藥選擇？",
    "options": [
      {
        "key": "A",
        "text": "ACE inhibitor"
      },
      {
        "key": "B",
        "text": "ARB"
      },
      {
        "key": "C",
        "text": "Methyldopa"
      },
      {
        "key": "D",
        "text": "Direct renin inhibitor (aliskiren)"
      }
    ],
    "answer": "C",
    "explanation": "妊娠相關高血壓常用 methyldopa、labetalol、hydralazine。ACEi/ARB/DRI 具胎兒腎毒性與畸胎風險，為妊娠禁忌。",
    "tags": [
      "hypertension",
      "pregnancy",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0004",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "下列哪一項最符合 ACE inhibitor 在心血管系統的臨床益處（除降壓外）？",
    "options": [
      {
        "key": "A",
        "text": "促進心室重塑（remodeling）"
      },
      {
        "key": "B",
        "text": "降低前負荷與後負荷、減少心肌梗塞後不良重塑"
      },
      {
        "key": "C",
        "text": "增加交感活性以維持心輸出量"
      },
      {
        "key": "D",
        "text": "主要作用為增加血小板聚集"
      }
    ],
    "answer": "B",
    "explanation": "ACEi 可減少 preload/afterload，並在 MI 後減少不良心室重塑、保留左心室功能、延緩心衰進展，故常作為具適應症患者的重要藥物。",
    "tags": [
      "hypertension",
      "ACEi",
      "heart failure",
      "post-MI"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0005",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "對於『頑固型高血壓（resistant hypertension）』或懷疑原發性醛固酮增多症患者，加用下列何種藥物最有證據支持？",
    "options": [
      {
        "key": "A",
        "text": "Spironolactone"
      },
      {
        "key": "B",
        "text": "Digoxin"
      },
      {
        "key": "C",
        "text": "Short-acting nifedipine"
      },
      {
        "key": "D",
        "text": "Isosorbide dinitrate"
      }
    ],
    "answer": "A",
    "explanation": "Resistant HTN 常與醛固酮相關機轉有關；MRA（如 spironolactone）在頑固型高血壓與原發性醛固酮增多症常有效。",
    "tags": [
      "hypertension",
      "resistant hypertension",
      "MRA"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0006",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "下列何者屬於 dihydropyridine（DHP）類鈣離子阻斷劑（CCB），且相對較偏血管擴張作用？",
    "options": [
      {
        "key": "A",
        "text": "Verapamil"
      },
      {
        "key": "B",
        "text": "Diltiazem"
      },
      {
        "key": "C",
        "text": "Amlodipine"
      },
      {
        "key": "D",
        "text": "Ivabradine"
      }
    ],
    "answer": "C",
    "explanation": "DHP 類（如 amlodipine、felodipine、nifedipine）以血管擴張為主；verapamil、diltiazem 為 non-DHP，較偏抑制心傳導/降心率。",
    "tags": [
      "hypertension",
      "CCB",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0007",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "非二氫吡啶（non-DHP）類 CCB 的共同特徵，下列何者正確？",
    "options": [
      {
        "key": "A",
        "text": "主要降低心率與房室結傳導"
      },
      {
        "key": "B",
        "text": "完全沒有負性變力作用"
      },
      {
        "key": "C",
        "text": "主要用於急性主動脈剝離第一線"
      },
      {
        "key": "D",
        "text": "常造成反射性心搏過速為主要副作用"
      }
    ],
    "answer": "A",
    "explanation": "Non-DHP（verapamil、diltiazem）可降低心率並抑制 AV node 傳導，具有負性變力作用；反射性心搏過速更常見於 DHP 類。",
    "tags": [
      "CCB",
      "arrhythmia",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0008",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "關於 β 阻斷劑的 intrinsic sympathomimetic activity（ISA），下列敘述何者正確？",
    "options": [
      {
        "key": "A",
        "text": "有 ISA 的 β 阻斷劑通常更適合心肌梗塞後二級預防"
      },
      {
        "key": "B",
        "text": "ISA 代表藥物同時具有部分致效劑活性，較不會造成靜息心率過低"
      },
      {
        "key": "C",
        "text": "所有 β1 選擇性阻斷劑都具有 ISA"
      },
      {
        "key": "D",
        "text": "ISA 會增加死亡率因此臨床完全禁用"
      }
    ],
    "answer": "B",
    "explanation": "ISA 表示部分致效活性，靜息心率下降較少；在需強力抑制交感（如 MI 後）通常偏好無 ISA 的 β 阻斷劑。",
    "tags": [
      "beta blocker",
      "pharmacology"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0009",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "關於『兩側上臂收縮壓差（inter-arm difference）』的臨床意義，下列何者較恰當？",
    "options": [
      {
        "key": "A",
        "text": "差距越大越代表量測正常"
      },
      {
        "key": "B",
        "text": "一般而言差距若明顯增大，需考慮周邊動脈疾病或主動脈弓分支病變"
      },
      {
        "key": "C",
        "text": "只要舒張壓相同就不需理會"
      },
      {
        "key": "D",
        "text": "只與情緒緊張有關，無臨床意義"
      }
    ],
    "answer": "B",
    "explanation": "兩側上臂血壓差若明顯（常以 >10–15 mmHg 作為警訊），需考慮血管狹窄/周邊動脈疾病等。臨床上會以較高的一側作後續追蹤基準。",
    "tags": [
      "blood pressure measurement",
      "vascular disease"
    ]
  },
  {
    "id": "MED_03_CARD_PULM_DER_HTN_Q0010",
    "source_type": "derived",
    "book": {
      "code": "MED_03_CARD_PULM",
      "title": "三(1) 心內、胸內"
    },
    "location": {
      "section": "HTN",
      "note": "derived from text"
    },
    "stem": "急性主動脈剝離（aortic dissection）初始藥物處置的核心原則為何？",
    "options": [
      {
        "key": "A",
        "text": "先給血管擴張劑降低血壓，β 阻斷劑可延後"
      },
      {
        "key": "B",
        "text": "先控制心率/收縮力（β 阻斷）以降低 dP/dt，再視需要加血管擴張劑"
      },
      {
        "key": "C",
        "text": "以利尿劑為第一線降低後負荷"
      },
      {
        "key": "D",
        "text": "以短效 nifedipine 舌下含服快速降壓"
      }
    ],
    "answer": "B",
    "explanation": "主動脈剝離急性期重點是降低剪力（shear stress）：先用 β 阻斷劑降低心率與 dP/dt，再視血壓加硝普鈉等血管擴張劑；避免單獨先給擴張劑造成反射性心搏過速。",
    "tags": [
      "aortic disease",
      "emergency",
      "hypertension"
    ]
  },
  
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0014",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 26 },
    "stem": "下列何者不是寬的脈搏壓（wide pulse pressure）要考慮的鑑別診斷？",
    "options": [
      { "key": "A", "text": "主動脈瓣狹窄 (aortic stenosis)" },
      { "key": "B", "text": "甲狀腺毒症 (thyrotoxicosis)" },
      { "key": "C", "text": "感染發燒" },
      { "key": "D", "text": "開放性動脈導管 (patent ductus arteriosus)" }
    ],
    "answer": "A",
    "explanation": "主動脈瓣狹窄通常造成『窄』脈搏壓，因射出受限使收縮壓不易上升。相反地，甲亢、發燒、PDA 等高心輸出/低周邊阻力或增加收縮壓情境較常見 wide pulse pressure。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0015",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 26 },
    "stem": "一位 26 歲女性患高血壓半年，近 3 個月出現心悸、頭痛、流汗。若欲給藥治療其高血壓，下列何者最適當？（疑嗜鉻細胞瘤）",
    "options": [
      { "key": "A", "text": "僅使用 α 阻斷劑 (alpha-adrenergic blocker)" },
      { "key": "B", "text": "僅使用 β 阻斷劑 (beta-adrenergic blocker)" },
      { "key": "C", "text": "鈣離子阻斷劑" },
      { "key": "D", "text": "先 α 阻斷，再加 β 阻斷" }
    ],
    "answer": "B",
    "explanation": "嗜鉻細胞瘤若單獨先給 β 阻斷劑，會造成未被抑制的 α 作用『相對占優勢』而使血壓更劇烈上升。正確原則是先 α 阻斷後必要時再加 β 阻斷。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0016",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 27 },
    "stem": "一位 27 歲女性長期追蹤高血壓，為育齡/可能懷孕族群。下列何者最不適合？",
    "options": [
      { "key": "A", "text": "methyldopa" },
      { "key": "B", "text": "長效型 calcium channel blocker" },
      { "key": "C", "text": "labetalol" },
      { "key": "D", "text": "ACE inhibitor" }
    ],
    "answer": "D",
    "explanation": "ACEI/ARB 具胎兒腎毒性與致畸胎風險，育齡女性/妊娠應避免；methyldopa、labetalol、部分 CCB（如 nifedipine）較常作為妊娠期可用選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0017",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 27 },
    "stem": "25 歲男性疑嗜鉻細胞瘤即將接受手術治療，下列處置何者最正確？",
    "options": [
      { "key": "A", "text": "立刻安排緊急手術切除" },
      { "key": "B", "text": "儘快安排 CT 導引腎上腺腫瘤切片" },
      { "key": "C", "text": "手術前 7–10 天先給予適量 α 阻斷劑並補充水分" },
      { "key": "D", "text": "立即給予體抑素類似物 (somatostatin analogue)" }
    ],
    "answer": "C",
    "explanation": "嗜鉻細胞瘤手術前需充分準備：先以 α 阻斷劑控制血壓並擴充血容量（補液），必要時再加 β 阻斷以控制心搏過速；避免穿刺活檢誘發兒茶酚胺危象。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0018",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 28 },
    "stem": "下列何種狀況不是使用 ACE inhibitor 的禁忌？",
    "options": [
      { "key": "A", "text": "腎功能持續惡化" },
      { "key": "B", "text": "低血鉀" },
      { "key": "C", "text": "懷孕" },
      { "key": "D", "text": "雙側腎動脈狹窄" }
    ],
    "answer": "B",
    "explanation": "ACEI 常見問題是『高血鉀』而不是低血鉀；懷孕、雙側腎動脈狹窄、腎功能惡化等需避免或慎用。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0019",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 28 },
    "stem": "當高血壓病人合併下列狀況時，何者較不支持次發性高血壓？",
    "options": [
      { "key": "A", "text": "抽血發現低血鉀" },
      { "key": "B", "text": "頭痛、心悸、盜汗" },
      { "key": "C", "text": "睡覺打鼾且白天嗜睡" },
      { "key": "D", "text": "高血脂症" }
    ],
    "answer": "D",
    "explanation": "低血鉀（考慮原發性醛固酮增多症）、三聯症狀（考慮嗜鉻細胞瘤）、打鼾嗜睡（考慮 OSA）都支持次發性高血壓；高血脂並非典型次發性線索。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0020",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 29 },
    "stem": "26 歲患者 BMI 20，健檢發現高血壓、低血鉀。評估次發性高血壓的檢查何者最適當？",
    "options": [
      { "key": "A", "text": "aldosterone 與 plasma renin activity" },
      { "key": "B", "text": "ACTH 與 cortisol" },
      { "key": "C", "text": "24 小時尿 VMA 與 catecholamines" },
      { "key": "D", "text": "free T4 與 TSH" }
    ],
    "answer": "A",
    "explanation": "高血壓合併低血鉀優先考慮原發性醛固酮增多症；初步檢查為 aldosterone/renin（比值）評估。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0021",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 29 },
    "stem": "測量血壓時由近心端往周邊逐次測量，下列敘述何者正確？",
    "options": [
      { "key": "A", "text": "收縮壓上升、舒張壓下降" },
      { "key": "B", "text": "收縮壓上升、舒張壓上升" },
      { "key": "C", "text": "收縮壓不變、舒張壓下降" },
      { "key": "D", "text": "收縮壓上升、舒張壓不變" }
    ],
    "answer": "A",
    "explanation": "越往周邊血管阻力與反射波影響增加，收縮壓通常較高；舒張壓受大血管回彈影響，往周邊相對較低。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0022",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 29 },
    "stem": "40 歲糖尿病患者，eGFR 59 mL/min/1.73m² 且尿蛋白 1.5 g/day，血壓 138/86 mmHg。下列處置何者最恰當？",
    "options": [
      { "key": "A", "text": "輔以低劑量長效型胰島素" },
      { "key": "B", "text": "使用紅血球生成素以減緩腎功能惡化" },
      { "key": "C", "text": "加用 ACEi/ARB（RAS blockade）" },
      { "key": "D", "text": "低蛋白飲食合併胺基酸補充品" }
    ],
    "answer": "C",
    "explanation": "糖尿病合併蛋白尿/CKD 者，優先使用 RAS blockade（ACEi 或 ARB）以降低蛋白尿並延緩腎功能惡化，血壓目標常較嚴格（依指南與個案）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0023",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 30 },
    "stem": "65 歲男性換藥後出現腹脹與便秘，最可能使用下列何種降壓藥？",
    "options": [
      { "key": "A", "text": "Valsartan" },
      { "key": "B", "text": "Renitec (enalapril)" },
      { "key": "C", "text": "Labetalol" },
      { "key": "D", "text": "Amlodipine" }
    ],
    "answer": "D",
    "explanation": "鈣離子阻斷劑常見副作用包括便秘、周邊水腫等；臨床題幹以 amlodipine 作為選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0024",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 30 },
    "stem": "55 歲女性高血壓與糖尿病，近 3 個月乾咳，無呼吸道警訊，胸部 X 光正常。下列何者最重要？",
    "options": [
      { "key": "A", "text": "肺功能檢查" },
      { "key": "B", "text": "鼻竇 X 光檢查" },
      { "key": "C", "text": "詢問/確認是否使用 ACE inhibitor 等降壓藥" }
    ],
    "answer": "C",
    "explanation": "ACE inhibitor 典型副作用為乾咳；在排除警訊與影像正常時，需優先回顧用藥史。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0025",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 32 },
    "stem": "60 歲女性血壓 170/100 mmHg、BMI 27.1，平日睡前紅酒 30 mL。下列何者屬建議的生活型態改變？",
    "options": [
      { "key": "A", "text": "減輕體重" },
      { "key": "B", "text": "每日鈉攝取量控制（例如減鹽）" },
      { "key": "C", "text": "降低酒精攝取量" },
      { "key": "D", "text": "生活型態對血壓無實證支持" }
    ],
    "answer": "A",
    "explanation": "生活型態（體重、飲食鈉、酒精、運動）均與血壓有實證關聯；選項中以減重作為最佳單選答案（其餘亦屬可建議）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0026",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "55 歲糖尿病男性，血壓 160/100 mmHg，尿蛋白 (+)，creatinine 1.0 mg/dL。起始降壓藥物何者較適當？",
    "options": [
      { "key": "A", "text": "利尿劑" },
      { "key": "B", "text": "ACEi/ARB" },
      { "key": "C", "text": "β 阻斷劑" },
      { "key": "D", "text": "methyldopa" }
    ],
    "answer": "B",
    "explanation": "糖尿病合併蛋白尿者，ACEi/ARB 可降低蛋白尿並提供腎保護效益，常作為優先選擇。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0027",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "下列何者是次發性高血壓最常見原因？",
    "options": [
      { "key": "A", "text": "腎實質疾病 (renal parenchymal disease)" },
      { "key": "B", "text": "原發性醛固酮增多症" },
      { "key": "C", "text": "嗜鉻細胞瘤" },
      { "key": "D", "text": "庫欣氏症候群" }
    ],
    "answer": "A",
    "explanation": "次發性高血壓最常見原因為腎實質疾病；其他如腎血管性、原發性醛固酮增多症、OSA 等亦常見但相對次之。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0028",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "58 歲男性無糖尿病/CKD，血壓 172/102 mmHg。血壓控制目標何者較適當？",
    "options": [
      { "key": "A", "text": "160/90 mmHg" },
      { "key": "B", "text": "140/90 mmHg" },
      { "key": "C", "text": "130/80 mmHg" },
      { "key": "D", "text": "120/80 mmHg" }
    ],
    "answer": "B",
    "explanation": "依題目所用教材/考題版本（台灣常見教法），無 DM/CKD 且未滿 60 歲之一般族群，目標多以 <140/90 mmHg 為基準（不同指南年份可能略有差異）。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0029",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 34 },
    "stem": "下列關於次發性高血壓的敘述，何者正確？",
    "options": [
      { "key": "A", "text": "原發性醛固酮增多症常合併高血鉀" },
      { "key": "B", "text": "最常見的次發性高血壓為腎實質病變" },
      { "key": "C", "text": "嗜鉻細胞瘤亦可發生於腎上腺外組織" },
      { "key": "D", "text": "睡眠呼吸障礙亦為次發性高血壓原因之一" }
    ],
    "answer": "A",
    "explanation": "原發性醛固酮增多症典型是低血鉀而非高血鉀；其餘敘述（腎實質病變最常見、嗜鉻細胞瘤可腎上腺外、OSA 相關）皆為正確概念，因此本題以 A 為錯誤選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0030",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 35 },
    "stem": "高血壓婦女懷孕時，下列哪項降壓藥不適合使用？",
    "options": [
      { "key": "A", "text": "α-methyldopa" },
      { "key": "B", "text": "labetalol" },
      { "key": "C", "text": "captopril" },
      { "key": "D", "text": "nifedipine" }
    ],
    "answer": "C",
    "explanation": "ACE inhibitor（如 captopril）為妊娠禁忌；methyldopa、labetalol、nifedipine 常作為妊娠期可用選項。"
  },
  {
    "id": "MED_03_CARD_PULM_ORIG_HTN_Q0031",
    "source_type": "original",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "page": 35 },
    "stem": "24 歲女性早發且難控制高血壓，合併低血鉀。下列何者最可能？",
    "options": [
      { "key": "A", "text": "嗜鉻細胞瘤" },
      { "key": "B", "text": "庫欣氏症候群" },
      { "key": "C", "text": "先天性腎上腺增生" },
      { "key": "D", "text": "康氏症候群（Conn syndrome，原發性醛固酮增多症）" }
    ],
    "answer": "D",
    "explanation": "早發高血壓合併低血鉀應優先考慮原發性醛固酮增多症。庫欣/CAH 常伴雄性素或皮質醇相關表現；嗜鉻細胞瘤則以陣發性頭痛、心悸、盜汗較典型。"
  },

  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "關於腹主動脈瘤（AAA）篩檢，下列何者最符合常見建議？",
    "options": [
      { "key": "A", "text": "所有 40 歲以上成人每年超音波篩檢" },
      { "key": "B", "text": "65–75 歲曾吸菸男性可考慮一次性腹部超音波篩檢" },
      { "key": "C", "text": "僅女性需要篩檢，男性不需" },
      { "key": "D", "text": "AAA 篩檢首選檢查是胸部 X 光" }
    ],
    "answer": "B",
    "explanation": "AAA 篩檢常見建議為：65–75 歲曾吸菸男性接受一次性腹部超音波（不同指南對女性/家族史族群有延伸建議）。超音波是首選篩檢工具。",
    "tags": ["aorta", "AAA", "screening"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "急性主動脈剝離的降壓治療策略，下列何者正確？",
    "options": [
      { "key": "A", "text": "先用血管擴張劑降壓，再視需要加 β 阻斷劑" },
      { "key": "B", "text": "優先 β 阻斷劑降低心率與 dP/dt，再視血壓加血管擴張劑" },
      { "key": "C", "text": "優先利尿劑降低後負荷" },
      { "key": "D", "text": "以短效 nifedipine 舌下含服作為標準處置" }
    ],
    "answer": "B",
    "explanation": "剝離急性期核心是降低剪力：先 β 阻斷降低心率與 dP/dt，再用血管擴張劑輔助降壓；避免單獨先給擴張劑造成反射性心搏過速。",
    "tags": ["aortic dissection", "emergency", "blood pressure"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0003",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "胸主動脈瘤（TAA）或 AAA 的破裂風險因子，下列何者最直接相關？",
    "options": [
      { "key": "A", "text": "瘤體直徑越大" },
      { "key": "B", "text": "血鈣越低" },
      { "key": "C", "text": "TSH 越高" },
      { "key": "D", "text": "血小板越多" }
    ],
    "answer": "A",
    "explanation": "主動脈瘤破裂風險最重要的臨床指標之一是直徑（以及成長速度）；直徑越大，破裂風險越高。",
    "tags": ["aneurysm", "risk"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0004",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "主動脈剝離 Stanford 分型的描述，下列何者正確？",
    "options": [
      { "key": "A", "text": "Type A：不涉及升主動脈；Type B：涉及升主動脈" },
      { "key": "B", "text": "Type A：涉及升主動脈；Type B：不涉及升主動脈" },
      { "key": "C", "text": "Type A/B 只以是否合併高血壓區分" },
      { "key": "D", "text": "Type A/B 與 DeBakey 分型完全無關" }
    ],
    "answer": "B",
    "explanation": "Stanford Type A 只要涉及升主動脈即屬 Type A；Type B 為不涉及升主動脈的剝離（通常自左鎖骨下動脈遠端開始）。",
    "tags": ["aortic dissection", "classification"]
  },
  {
    "id": "MED_03_CARD_PULM_DER_AORTA_Q0005",
    "source_type": "derived",
    "book": { "code": "MED_03_CARD_PULM", "title": "三(1) 心內、胸內" },
    "location": { "section": "Aortic disease", "note": "derived from text" },
    "stem": "急性主動脈剝離時常見的『影像/臨床線索』，下列何者較典型？",
    "options": [
      { "key": "A", "text": "撕裂樣胸背痛、兩側血壓差、縱隔增寬" },
      { "key": "B", "text": "黃疸合併茶色尿" },
      { "key": "C", "text": "慢性乾咳持續 3 個月" },
      { "key": "D", "text": "侷限性右下腹痛合併反跳痛" }
    ],
    "answer": "A",
    "explanation": "典型線索包括突發撕裂樣胸背痛、脈搏/血壓不對稱、胸部 X 光縱隔增寬；確診多依 CTA/TEE/MRI 視情況選用。",
    "tags": ["aortic dissection", "clinical"]
  },

  
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0001",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜胸部X光判讀" },
    "stem": "要診斷肺尖 (lung apices) 上的病灶，下列何種 X 光片的照法最為適當？",
    "options": [
      { "key": "A", "text": "PA view" },
      { "key": "B", "text": "lateral view" },
      { "key": "C", "text": "lateral decubitus view" },
      { "key": "D", "text": "lordotic view" }
    ],
    "answer": "D",
    "explanation": "Lordotic view 可減少鎖骨與第一、二肋骨對肺尖的遮蔽，提升肺尖病灶辨識度，因此最適合用來看肺尖病灶。 [oai_citation:4‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0002",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜胸部X光判讀" },
    "stem": "50 歲男性主訴胸痛和咳嗽，胸部影像如圖（題本），最可能的診斷為下列何者？",
    "options": [
      { "key": "A", "text": "肺癌" },
      { "key": "B", "text": "侷限性肋膜積液" },
      { "key": "C", "text": "葉間積液 (interlobar effusion)" },
      { "key": "D", "text": "肺動脈栓塞 (pulmonary embolism)" }
    ],
    "answer": "A",
    "explanation": "題本詳解指出：可見 mass lesion 壓迫支氣管造成不規則狹窄；積液較不會造成此型態；肺栓塞梗塞較常呈外側 wedge-shaped 影像表現，因此選肺癌。 [oai_citation:5‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_DER_PULM_BASIC_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜症狀學鑑別" },
    "stem": "胸痛病患的初步鑑別診斷，下列哪一組屬於本書強調需優先排除的『四大急症』？",
    "options": [
      { "key": "A", "text": "心肌梗塞、主動脈剝離、高張性氣胸、心包膜填塞" },
      { "key": "B", "text": "肺癌、胃食道逆流、肋軟骨炎、帶狀皰疹" },
      { "key": "C", "text": "肺結核、COPD、氣喘、支氣管擴張" },
      { "key": "D", "text": "肺炎、肋膜積液、肺水腫、肺栓塞" }
    ],
    "answer": "A",
    "explanation": "本書在胸痛鑑別中明確提到需先排除四大急症：心肌梗塞、主動脈剝離、高張性氣胸、心包膜填塞。 [oai_citation:6‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["chest pain", "emergency", "differential"]
  },
  {
    "id": "MED3_V1_DER_PFT_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜肺功能" },
    "stem": "下列何者為本書對 COPD 的肺功能診斷門檻？",
    "options": [
      { "key": "A", "text": "FEV1/FVC < 70%" },
      { "key": "B", "text": "FEV1/FVC < 90%" },
      { "key": "C", "text": "TLC < 70% predicted" },
      { "key": "D", "text": "DLCO > 120% predicted" }
    ],
    "answer": "A",
    "explanation": "書中在肺量計段落寫明：阻塞性氣道阻塞與 COPD 的定義可用 FEV1/FVC < 70% 作為門檻。 [oai_citation:7‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["spirometry", "COPD", "diagnosis"]
  },
  {
    "id": "MED3_V1_DER_DLCO_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜肺功能" },
    "stem": "依本書：DLCO 下降較常見於下列哪一組情況？",
    "options": [
      { "key": "A", "text": "肺氣腫、間質性肺病、肺血管栓塞" },
      { "key": "B", "text": "肥胖、肺出血、心衰竭早期、氣喘" },
      { "key": "C", "text": "單純焦慮過度換氣" },
      { "key": "D", "text": "上呼吸道感染（鼻炎）" }
    ],
    "answer": "A",
    "explanation": "書中列舉：DLCO 在肺氣腫、間質性肺病、肺血管栓塞時會下降；在肥胖、肺出血、心衰竭早期、氣喘等血流量增加情境可上升。 [oai_citation:8‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["DLCO", "PFT", "differential"]
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜肺功能" },
    "stem": "支氣管擴張劑可逆性試驗（bronchodilator reversibility test）陽性，依本書最符合的條件是？",
    "options": [
      { "key": "A", "text": "FEV1 增加 > 12% 且 > 200 mL" },
      { "key": "B", "text": "FEV1 增加 > 5% 且 > 50 mL" },
      { "key": "C", "text": "FEV1/FVC < 70% 即可視為陽性" },
      { "key": "D", "text": "DLCO 增加 > 10% 即可視為陽性" }
    ],
    "answer": "A",
    "explanation": "書中氣喘診斷段落：支氣管擴張劑可逆性試驗陽性為 FEV1 增加 >12% 且 >200 mL；若 >15% 且 >400 mL 更能確認診斷。 [oai_citation:9‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["asthma", "spirometry", "reversibility"]
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0007",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜題目" },
    "stem": "對於急性氣喘發作，下列何者藥物不是第一線的治療選項？",
    "options": [
      { "key": "A", "text": "β2 adrenergic agents" },
      { "key": "B", "text": "Anticholinergics" },
      { "key": "C", "text": "Corticosteroids" },
      { "key": "D", "text": "Theophylline" }
    ],
    "answer": "D",
    "explanation": "題本將急性發作第一線放在吸入型支氣管擴張劑（SABA）、抗膽鹼藥（視嚴重度加用）與全身性類固醇；theophylline 因治療窗窄、副作用與交互作用較多，通常不作急性發作第一線。題幹出處同題組。 [oai_citation:10‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0008",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜題目" },
    "stem": "下列關於氣喘 (bronchial asthma) 疾病的敘述，何者錯誤？",
    "options": [
      { "key": "A", "text": "呼吸道慢性發炎反應 (chronic inflammation)" },
      { "key": "B", "text": "呼吸道過度反應 (hyperresponsiveness)" },
      { "key": "C", "text": "多屬不可逆性的氣道阻塞 (irreversible airway obstruction)" },
      { "key": "D", "text": "屬異質性 (heterogeneous) 疾病，常是基因與環境因素交互作用所致" }
    ],
    "answer": "C",
    "explanation": "氣喘典型特徵是可變且多數可逆的氣流受限（尤其在早期/適當治療下），並非『多屬不可逆』；A、B、D 符合氣喘核心特徵（慢性發炎、氣道高反應、異質性與基因×環境交互）。 [oai_citation:11‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0009",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜題目" },
    "stem": "評估支氣管哮喘病患急性發作時，下列何種理學檢查結果不能作為哮喘嚴重度指標？",
    "options": [
      { "key": "A", "text": "使用輔助肌吸氣 (accessory muscle use)" },
      { "key": "B", "text": "使用噘嘴呼吸 (pursed-lip breathing)" },
      { "key": "C", "text": "胸腔過度充氣 (hyperinflation)" },
      { "key": "D", "text": "有奇異脈 (paradoxical pulse)" }
    ],
    "answer": "B",
    "explanation": "題本詳解：噘嘴呼吸屬於氣喘/COPD 的呼吸訓練技巧，並非急性惡化的嚴重度表徵；其餘如輔助肌使用、過度充氣、奇異脈可見於嚴重發作評估情境。 [oai_citation:12‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)"
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜病史詢問" },
    "stem": "下列哪一項病史特徵『較不像』典型氣喘？",
    "options": [
      { "key": "A", "text": "症狀在半夜或清晨惡化" },
      { "key": "B", "text": "症狀隨時間變化，且可被病毒感染/運動/過敏原誘發" },
      { "key": "C", "text": "只有咳嗽、沒有其他呼吸道症狀" },
      { "key": "D", "text": "咳、喘、胸悶、喘鳴多種症狀並存" }
    ],
    "answer": "C",
    "explanation": "書中指出：只有咳嗽而無其他呼吸道症狀時，需優先考慮 post-nasal drip 或 GERD；其餘選項皆是偏向氣喘的典型病史特徵。 [oai_citation:13‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["asthma", "history", "differential"]
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜病史詢問" },
    "stem": "慢性痰多（chronic sputum production）合併呼吸道症狀時，依本書較應優先考慮哪一組診斷？",
    "options": [
      { "key": "A", "text": "COPD 或支氣管擴張" },
      { "key": "B", "text": "單純氣喘" },
      { "key": "C", "text": "心因性過度換氣" },
      { "key": "D", "text": "急性肺栓塞" }
    ],
    "answer": "A",
    "explanation": "書中在『較不像氣喘』的病史列出：慢性痰多需考慮 COPD 或支氣管擴張。 [oai_citation:14‡三(1)：心內、胸內.pdf](sediment://file_00000000ec107206b1b91d397c0efbac)",
    "tags": ["sputum", "COPD", "bronchiectasis"]
  },

  
  {
    "id": "MED3_V1_DER_COPD_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜診斷" },
    "stem": "COPD 的肺功能診斷最核心的條件為何？",
    "options": [
      { "key": "A", "text": "FEV1/FVC < 0.70（支氣管擴張劑後）" },
      { "key": "B", "text": "DLCO > 120% predicted" },
      { "key": "C", "text": "TLC < 80% predicted" },
      { "key": "D", "text": "FEV1 > 80% predicted 即可確診" }
    ],
    "answer": "A",
    "explanation": "COPD 的關鍵是『持續性氣流受限』，以支氣管擴張劑後 FEV1/FVC < 0.70 作為典型診斷門檻。TLC 下降偏限制型；DLCO 上升非 COPD 典型。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜病理生理" },
    "stem": "下列何者最符合肺氣腫（emphysema）造成氣流受限的主要機轉？",
    "options": [
      { "key": "A", "text": "肺泡壁破壞導致彈性回縮力下降與小氣道塌陷" },
      { "key": "B", "text": "支氣管平滑肌痙攣為主，完全可逆" },
      { "key": "C", "text": "肺泡毛細血管充血使 DLCO 上升" },
      { "key": "D", "text": "胸水增加導致 FEV1/FVC 上升" }
    ],
    "answer": "A",
    "explanation": "肺氣腫的核心是肺泡結構破壞 → 彈性回縮力下降 → 呼氣期小氣道易塌陷與 air trapping，造成不可完全逆轉的氣流受限。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜鑑別" },
    "stem": "下列何者較支持『COPD』而非『氣喘』？",
    "options": [
      { "key": "A", "text": "中老年、長期吸菸史、症狀持續且可逆性較差" },
      { "key": "B", "text": "症狀明顯日夜變動、清晨/半夜加劇、可逆性高度陽性" },
      { "key": "C", "text": "FEV1 增加 >12% 且 >200 mL（支擴後）是典型 COPD" },
      { "key": "D", "text": "DLCO 一定上升" }
    ],
    "answer": "A",
    "explanation": "COPD 常見於中老年且與吸菸高度相關，症狀較持續且支擴後可逆性較差；氣喘常見症狀變動、夜間/清晨加劇，且可逆性試驗陽性更支持氣喘。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "COPD 急性惡化（AECOPD）第一線『支氣管擴張』用藥組合最典型為何？",
    "options": [
      { "key": "A", "text": "吸入 SABA（如 albuterol）± 吸入 SAMA（如 ipratropium）" },
      { "key": "B", "text": "theophylline 單方" },
      { "key": "C", "text": "吸入 ICS 單方" },
      { "key": "D", "text": "長效 β2 刺激劑（LABA）起始即可取代所有短效藥" }
    ],
    "answer": "A",
    "explanation": "AECOPD 急性期以短效支氣管擴張劑為主：SABA ± SAMA；theophylline 治療窗窄不作首選；ICS 單方不適合急性期立即救急。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "AECOPD 使用全身性類固醇的典型建議劑量/療程為何？",
    "options": [
      { "key": "A", "text": "Prednisone 40 mg/day 約 5 天（或等效劑量）" },
      { "key": "B", "text": "Prednisone 5 mg/day 連續 6 個月" },
      { "key": "C", "text": "僅在同時有蕁麻疹時才使用" },
      { "key": "D", "text": "必須靜脈高劑量 methylprednisolone 500 mg/day 連續 14 天" }
    ],
    "answer": "A",
    "explanation": "AECOPD 給予短療程全身性類固醇可改善肺功能與症狀、降低治療失敗；常用 prednisone 40 mg/day 5 天（或等效）。長期低劑量或高劑量長療程副作用大且不必要。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "AECOPD 何時較需要考慮抗生素治療？",
    "options": [
      { "key": "A", "text": "痰量增加、痰變膿、呼吸困難加劇（Anthonisen 三症狀）或需機械通氣" },
      { "key": "B", "text": "只要有咳嗽就一定要抗生素" },
      { "key": "C", "text": "只要胸部 X 光正常就一定不需要抗生素" },
      { "key": "D", "text": "僅在白血球 > 20,000 才需要" }
    ],
    "answer": "A",
    "explanation": "AECOPD 抗生素通常在細菌感染可能性高時使用：三大症狀（呼吸困難、痰量增加、痰膿性）或需要（非侵襲/侵襲）通氣支持者。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜氧氣與通氣" },
    "stem": "AECOPD 給氧治療的目標血氧飽和度（SpO2）最常建議為何？",
    "options": [
      { "key": "A", "text": "88–92%" },
      { "key": "B", "text": "100% 以避免缺氧" },
      { "key": "C", "text": "70–75% 以避免 CO2 retention" },
      { "key": "D", "text": "不需監測，給越多越好" }
    ],
    "answer": "A",
    "explanation": "COPD 可能有慢性高碳酸血症；急性惡化給氧目標通常 88–92% 以兼顧氧合與避免過度給氧導致 CO2 retention/酸中毒風險。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜氧氣與通氣" },
    "stem": "AECOPD 何者最符合啟動非侵襲性正壓通氣（NIV）的典型指徵？",
    "options": [
      { "key": "A", "text": "呼吸性酸中毒（如 pH < 7.35）且 PaCO2 升高" },
      { "key": "B", "text": "單純鼻塞" },
      { "key": "C", "text": "單純發燒但呼吸正常" },
      { "key": "D", "text": "pH 7.50（呼吸性鹼中毒）且 PaCO2 下降" }
    ],
    "answer": "A",
    "explanation": "NIV 對 AECOPD 合併高碳酸血症與呼吸性酸中毒最有實證效益，可降低插管率與死亡率。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜長期治療" },
    "stem": "長期氧療（LTOT）在穩定 COPD 的典型適應症為何？",
    "options": [
      { "key": "A", "text": "PaO2 ≤ 55 mmHg 或 SaO2 ≤ 88%（穩定狀態），或 PaO2 56–59 合併肺高壓/右心衰/紅血球增多" },
      { "key": "B", "text": "只要有喘就應該 24 小時給氧" },
      { "key": "C", "text": "只要 DLCO 下降就必須 LTOT" },
      { "key": "D", "text": "只要 FEV1 < 80% 就必須 LTOT" }
    ],
    "answer": "A",
    "explanation": "LTOT 的死亡率獲益主要在嚴重慢性低氧血症族群；條件通常以 PaO2/SaO2 門檻（及合併右心衰/肺高壓/紅血球增多等）判定。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜特殊病因" },
    "stem": "年輕（<45 歲）或下葉為主之肺氣腫、非典型吸菸史者，應考慮哪個可檢驗的特殊病因？",
    "options": [
      { "key": "A", "text": "α1-antitrypsin deficiency" },
      { "key": "B", "text": "G6PD deficiency" },
      { "key": "C", "text": "sickle cell disease" },
      { "key": "D", "text": "Gilbert syndrome" }
    ],
    "answer": "A",
    "explanation": "α1-antitrypsin deficiency 會造成較早發的肺氣腫（常為 panacinar，偏下葉），遇到年輕或不符吸菸量的病人要想到並檢驗。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜藥物策略" },
    "stem": "下列哪一項最符合 roflumilast 的典型使用情境？",
    "options": [
      { "key": "A", "text": "慢性支氣管炎表現、重度氣流受限且反覆急性惡化者（作為降低惡化策略之一）" },
      { "key": "B", "text": "急性發作第一線立即救急用藥" },
      { "key": "C", "text": "所有 COPD 病人都必須使用" },
      { "key": "D", "text": "只用於肺炎的抗生素替代品" }
    ],
    "answer": "A",
    "explanation": "Roflumilast（PDE-4 inhibitor）主要用在部分高風險 COPD（特別慢性支氣管炎表型、重度、反覆惡化）以降低惡化頻率；不是急性救急藥。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜ICS 適應症概念" },
    "stem": "COPD 長期治療中，何者較支持加用吸入型類固醇（ICS）（通常以 ICS/LABA 或 triple therapy）？",
    "options": [
      { "key": "A", "text": "反覆惡化且嗜酸性球偏高／或有明顯氣喘重疊特徵" },
      { "key": "B", "text": "只有單次輕微咳嗽" },
      { "key": "C", "text": "沒有惡化史且症狀很輕" },
      { "key": "D", "text": "只因為 DLCO 下降" }
    ],
    "answer": "A",
    "explanation": "ICS 在 COPD 的主要角色是降低部分病人的惡化風險，特別是反覆惡化且血嗜酸性球較高、或有氣喘重疊者；單純輕症或無惡化史不一定需要，且 ICS 會增加肺炎風險。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜非藥物治療" },
    "stem": "下列何者是 COPD 具有最大長期預後效益、且所有吸菸者都應積極執行的介入？",
    "options": [
      { "key": "A", "text": "戒菸（含行為治療與藥物輔助）" },
      { "key": "B", "text": "每日預防性口服類固醇" },
      { "key": "C", "text": "每週靜脈抗生素" },
      { "key": "D", "text": "長期使用短效 β2 刺激劑單方" }
    ],
    "answer": "A",
    "explanation": "戒菸是 COPD 最關鍵的疾病修正介入，可降低肺功能下降速度並改善長期預後；其他選項不是標準或風險遠大於獲益。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0014",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜併發症" },
    "stem": "COPD 併發肺高壓/右心衰（cor pulmonale）時，較可能出現下列哪個臨床表現？",
    "options": [
      { "key": "A", "text": "下肢水腫、頸靜脈怒張、肝腫大" },
      { "key": "B", "text": "侷限性右下腹反跳痛" },
      { "key": "C", "text": "黃疸合併灰白便" },
      { "key": "D", "text": "腦膜刺激徵" }
    ],
    "answer": "A",
    "explanation": "慢性缺氧導致肺血管收縮與重塑可形成肺高壓，進而造成右心負荷增加與右心衰，典型表現為 JVD、周邊水腫、肝腫大等。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0015",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜鑑別與影像" },
    "stem": "下列哪一項胸部影像/生理特徵較符合肺氣腫（emphysema）而非慢性支氣管炎（chronic bronchitis）？",
    "options": [
      { "key": "A", "text": "過度充氣、橫膈變平、DLCO 下降較明顯" },
      { "key": "B", "text": "長期咳痰為主，DLCO 多正常" },
      { "key": "C", "text": "一定合併大量胸水" },
      { "key": "D", "text": "一定合併雙側肺門淋巴結腫大" }
    ],
    "answer": "A",
    "explanation": "肺氣腫常見 air trapping/過度充氣與橫膈變平，且因肺泡-毛細血管床破壞導致 DLCO 下降；慢性支氣管炎則以咳痰為主、DLCO 常較保留。"
  },

  
  {
    "id": "MED3_V1_DER_ILD_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病（ILD）｜總論" },
    "stem": "典型 ILD 的肺功能型態最常見為何？",
    "options": [
      { "key": "A", "text": "限制型：TLC 下降、FVC 下降，FEV1/FVC 正常或上升" },
      { "key": "B", "text": "阻塞型：FEV1/FVC 下降為主" },
      { "key": "C", "text": "完全正常肺功能" },
      { "key": "D", "text": "只會造成 DLCO 上升" }
    ],
    "answer": "A",
    "explanation": "ILD 以肺實質/間質受損為主，典型呈限制型通氣障礙（TLC、FVC 下降），FEV1/FVC 常正常或相對上升；DLCO 多下降而非上升。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜氣體交換" },
    "stem": "下列何者最常見於多數 ILD 的氣體交換異常？",
    "options": [
      { "key": "A", "text": "DLCO 下降" },
      { "key": "B", "text": "DLCO 上升" },
      { "key": "C", "text": "A–a gradient 一定正常" },
      { "key": "D", "text": "只會造成 PaCO2 上升、PaO2 正常" }
    ],
    "answer": "A",
    "explanation": "ILD 造成肺泡-微血管膜受損與肺血管床減少，最典型是 DLCO 下降，且常見運動時低氧與 A–a gradient 增加。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜身體檢查" },
    "stem": "下列哪一組身體檢查較符合纖維化型 ILD（例如 IPF）？",
    "options": [
      { "key": "A", "text": "吸氣末乾囉音（Velcro crackles）± 杵狀指" },
      { "key": "B", "text": "單側胸膜摩擦音合併高熱" },
      { "key": "C", "text": "典型哮鳴音為主且完全可逆" },
      { "key": "D", "text": "只有鼻塞與流鼻水" }
    ],
    "answer": "A",
    "explanation": "纖維化型 ILD 常見雙側吸氣末細碎乾囉音（Velcro-like crackles），部分患者可見杵狀指；哮鳴音更像氣喘/COPD。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜影像學" },
    "stem": "ILD 評估中，最能用來辨識纖維化型態（如 UIP pattern）的影像檢查為何？",
    "options": [
      { "key": "A", "text": "高解析度胸部電腦斷層（HRCT）" },
      { "key": "B", "text": "單純 PA chest X-ray 即可確診分型" },
      { "key": "C", "text": "腹部超音波" },
      { "key": "D", "text": "心電圖" }
    ],
    "answer": "A",
    "explanation": "HRCT 是 ILD 分型與判斷纖維化樣態（UIP、NSIP、HP 等）的核心工具；CXR 常不足以分型。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜UIP/IPF" },
    "stem": "典型 UIP（usual interstitial pneumonia）在 HRCT 的最代表性特徵組合為何？",
    "options": [
      { "key": "A", "text": "周邊/胸膜下為主、基底部優勢的網狀影（reticulation）＋蜂窩肺（honeycombing）± traction bronchiectasis" },
      { "key": "B", "text": "中央型為主的肺門淋巴結腫大" },
      { "key": "C", "text": "瀰漫性樹芽徵（tree-in-bud）為主" },
      { "key": "D", "text": "大量胸水為主" }
    ],
    "answer": "A",
    "explanation": "UIP 的典型影像是胸膜下/周邊、基底部優勢的纖維化表現（reticulation、traction bronchiectasis）並常見 honeycombing。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜IPF 治療" },
    "stem": "下列何者屬於 IPF（idiopathic pulmonary fibrosis）具疾病修正效果、常用的抗纖維化藥物？",
    "options": [
      { "key": "A", "text": "Nintedanib 或 Pirfenidone" },
      { "key": "B", "text": "吸入 SABA（albuterol）單用" },
      { "key": "C", "text": "長期高劑量全身性類固醇作為標準治療" },
      { "key": "D", "text": "Warfarin 作為標準抗纖維化治療" }
    ],
    "answer": "A",
    "explanation": "IPF 的疾病修正治療以抗纖維化藥物（nintedanib、pirfenidone）為主，可減緩肺功能下降；常規長期高劑量類固醇不作為 IPF 標準治療。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜急性惡化" },
    "stem": "已知 IPF 病人突然在數天到數週內呼吸快速惡化、影像出現新發廣泛磨玻璃陰影（ground-glass opacities），最符合下列何者？",
    "options": [
      { "key": "A", "text": "IPF 急性惡化（acute exacerbation）" },
      { "key": "B", "text": "單純慢性穩定期變化" },
      { "key": "C", "text": "一定是肺癌轉移" },
      { "key": "D", "text": "一定是氣胸" }
    ],
    "answer": "A",
    "explanation": "IPF 急性惡化典型是短期內呼吸惡化，HRCT 可見在既有纖維化背景上新發的雙側磨玻璃/實變，需積極排除感染、心衰、肺栓塞等。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜NSIP vs UIP 概念" },
    "stem": "下列何者較偏向 NSIP（nonspecific interstitial pneumonia）而非典型 UIP？",
    "options": [
      { "key": "A", "text": "相對較均勻的磨玻璃陰影與纖維化、蜂窩肺較少見" },
      { "key": "B", "text": "明顯胸膜下基底部蜂窩肺為主" },
      { "key": "C", "text": "樹芽徵為主" },
      { "key": "D", "text": "大量胸水為主" }
    ],
    "answer": "A",
    "explanation": "NSIP 常呈較均勻的炎症/纖維化分布，ground-glass 相對多、honeycombing 較少；UIP 則常見胸膜下基底部為主的 honeycombing。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜過敏性肺炎（HP）" },
    "stem": "過敏性肺炎（hypersensitivity pneumonitis）最關鍵的病史線索為何？",
    "options": [
      { "key": "A", "text": "反覆接觸特定抗原（如鳥類、黴菌、農業/加濕器）後出現呼吸症狀" },
      { "key": "B", "text": "長期抽菸且咳痰為主" },
      { "key": "C", "text": "單次暴露粉塵後立即大量咳血" },
      { "key": "D", "text": "只有夜間喘鳴、完全可逆" }
    ],
    "answer": "A",
    "explanation": "HP 是免疫反應導致的間質性肺病，診斷核心是『明確的抗原暴露史』與其時間相關性；處置重點之一也包含避免暴露。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜結節病（Sarcoidosis）" },
    "stem": "下列哪個組合較典型支持結節病（sarcoidosis）？",
    "options": [
      { "key": "A", "text": "雙側肺門淋巴結腫大（BHL）± 非乾酪性肉芽腫" },
      { "key": "B", "text": "胸膜下基底部蜂窩肺為主" },
      { "key": "C", "text": "大量膿痰合併 lobar consolidation" },
      { "key": "D", "text": "只要 DLCO 下降就可診斷 sarcoidosis" }
    ],
    "answer": "A",
    "explanation": "Sarcoidosis 常見影像為雙側肺門淋巴結腫大，病理為非乾酪性肉芽腫；診斷需臨床＋影像＋（必要時）組織學與排除其他肉芽腫疾病。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜藥物性肺損傷" },
    "stem": "下列哪一組藥物與 ILD/間質性肺炎風險的關聯最典型？",
    "options": [
      { "key": "A", "text": "Amiodarone、Bleomycin、Nitrofurantoin" },
      { "key": "B", "text": "Metformin、Aspirin、Acetaminophen" },
      { "key": "C", "text": "Omeprazole、Famotidine、Aluminum hydroxide" },
      { "key": "D", "text": "Loratadine、Cetirizine、Fexofenadine" }
    ],
    "answer": "A",
    "explanation": "Amiodarone、bleomycin、nitrofurantoin 等是常被考的藥物性肺損傷/間質性肺炎原因；遇到 ILD 病人務必回顧用藥史。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜職業暴露" },
    "stem": "下列哪一項職業/環境暴露與特定 ILD（塵肺症）配對最合理？",
    "options": [
      { "key": "A", "text": "石綿（asbestos）→ 胸膜斑塊/石綿肺（asbestosis）" },
      { "key": "B", "text": "花粉暴露 → 矽肺（silicosis）" },
      { "key": "C", "text": "冷空氣 → 石綿肺" },
      { "key": "D", "text": "咖啡因 → 煤工塵肺（CWP）" }
    ],
    "answer": "A",
    "explanation": "石綿暴露與 asbestosis、胸膜斑塊、（並增加惡性間皮瘤/肺癌風險）是經典考點；矽肺多見於採礦/砂石噴砂等矽粉塵暴露。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜自體免疫關聯" },
    "stem": "下列哪一項最符合『結締組織疾病相關 ILD（CTD-ILD）』的臨床情境？",
    "options": [
      { "key": "A", "text": "ILD 合併 Raynaud 現象、關節痛/皮疹或特定自體抗體" },
      { "key": "B", "text": "單純反覆上呼吸道感染" },
      { "key": "C", "text": "只有偶發咳嗽，無其他系統症狀" },
      { "key": "D", "text": "只有胸痛，無呼吸道症狀" }
    ],
    "answer": "A",
    "explanation": "CTD-ILD 常見於 RA、systemic sclerosis、myositis、SLE 等背景；辨識點是 ILD 合併系統性自體免疫線索與血清學支持。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0014",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜鑑別陷阱" },
    "stem": "下列哪一項更像『心因性/循環性』而非 ILD 主要表現？",
    "options": [
      { "key": "A", "text": "運動喘合併雙下肢水腫與端坐呼吸" },
      { "key": "B", "text": "進行性運動喘合併吸氣末乾囉音" },
      { "key": "C", "text": "DLCO 下降與限制型肺功能" },
      { "key": "D", "text": "HRCT 出現周邊基底部纖維化" }
    ],
    "answer": "A",
    "explanation": "端坐呼吸與周邊水腫更支持心衰/循環系統問題；ILD 則偏向限制型肺功能、DLCO 下降、乾囉音與 HRCT 纖維化所見。"
  },
  {
    "id": "MED3_V1_DER_ILD_Q0015",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 ILD｜處置原則" },
    "stem": "對多數疑似 ILD 病人，下列哪一項是最通用且重要的第一步策略？",
    "options": [
      { "key": "A", "text": "系統性釐清暴露史（職業/環境/藥物）＋安排 HRCT 與肺功能（含 DLCO）" },
      { "key": "B", "text": "直接長期高劑量類固醇，不需診斷分型" },
      { "key": "C", "text": "只做 CXR 即可，不需 HRCT" },
      { "key": "D", "text": "只要咳嗽就先開抗生素 4 週" }
    ],
    "answer": "A",
    "explanation": "ILD 的關鍵在『分類與找原因』：暴露史（藥物/職業/抗原）常直接決定診斷與治療；HRCT 與 PFT（含 DLCO）是基礎評估工具，必要時再進一步做血清學、BAL 或肺活檢。"
  },

  
  {
    "id": "MED3_V1_DER_PE_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜（下一節）肺栓塞／肺高壓｜PE 總論" },
    "stem": "疑似肺栓塞（PE）病人最常見、最典型的臨床表現組合為何？",
    "options": [
      { "key": "A", "text": "突發呼吸困難、胸痛（多為胸膜性）、心搏過速" },
      { "key": "B", "text": "長期咳痰、晨起喘鳴、可逆性高度陽性" },
      { "key": "C", "text": "大量黃疸、茶色尿、灰白便" },
      { "key": "D", "text": "局部右下腹反跳痛" }
    ],
    "answer": "A",
    "explanation": "PE 常見突發呼吸困難、胸痛（可為胸膜性）、心搏過速；亦可合併咳血、暈厥、低血壓（大塊 PE）。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜PE 診斷策略" },
    "stem": "疑似 PE 的檢查策略，下列何者最符合通用流程？",
    "options": [
      { "key": "A", "text": "先估計臨床前測機率（Wells/改良 Geneva），低/中風險可用 D-dimer 排除，高風險直接做影像" },
      { "key": "B", "text": "所有人先做 CTPA，不需分層" },
      { "key": "C", "text": "D-dimer 只要偏高就可直接確診 PE" },
      { "key": "D", "text": "胸部 X 光正常即可排除 PE" }
    ],
    "answer": "A",
    "explanation": "PE 診斷核心是「前測機率＋檢驗」。低/中機率可用（年齡調整）D-dimer 排除；高機率者應直接做 CTPA（或相當影像）確認。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜D-dimer" },
    "stem": "關於 D-dimer 的敘述，下列何者正確？",
    "options": [
      { "key": "A", "text": "高 D-dimer 具有高特異性，可直接確診 PE" },
      { "key": "B", "text": "在低/中前測機率時，陰性 D-dimer 有助排除 PE" },
      { "key": "C", "text": "D-dimer 在任何族群都不會受到年齡影響" },
      { "key": "D", "text": "D-dimer 只在肺炎才會上升" }
    ],
    "answer": "B",
    "explanation": "D-dimer 特徵是敏感度高、特異度低；在低/中機率族群，陰性有助排除 PE。年齡、感染、手術、癌症、妊娠等都會使 D-dimer 上升。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜影像學" },
    "stem": "在血流動力學穩定、腎功能許可的疑似 PE 病人，最常用來確認診斷的影像檢查為何？",
    "options": [
      { "key": "A", "text": "CT pulmonary angiography（CTPA）" },
      { "key": "B", "text": "腹部超音波" },
      { "key": "C", "text": "單純胸部 X 光" },
      { "key": "D", "text": "腦部 MRI" }
    ],
    "answer": "A",
    "explanation": "CTPA 是臨床最常用的 PE 確診影像（在腎功能可接受且無明顯禁忌時）。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜影像學" },
    "stem": "下列哪一種情境較適合考慮 V/Q scan（通氣灌流掃描）而非 CTPA？",
    "options": [
      { "key": "A", "text": "嚴重碘劑過敏或腎功能不佳且胸部 X 光相對乾淨" },
      { "key": "B", "text": "所有 PE 都應優先 V/Q scan" },
      { "key": "C", "text": "D-dimer 陰性" },
      { "key": "D", "text": "已明確高風險且休克" }
    ],
    "answer": "A",
    "explanation": "在 CTPA 不適合（造影禁忌）且胸部基礎影像相對乾淨時，V/Q scan 可用於 PE 評估。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜危險因子" },
    "stem": "下列何者屬於典型 PE 危險因子？",
    "options": [
      { "key": "A", "text": "近期手術或長期臥床、惡性腫瘤、口服避孕藥/妊娠、既往 VTE" },
      { "key": "B", "text": "單純高血脂" },
      { "key": "C", "text": "過敏性鼻炎" },
      { "key": "D", "text": "偏頭痛" }
    ],
    "answer": "A",
    "explanation": "PE 多來自下肢/骨盆深層靜脈血栓（DVT），危險因子包括手術/臥床、癌症、雌激素相關、既往 VTE、血栓體質等。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜心電圖" },
    "stem": "PE 的心電圖表現，下列何者最典型（但並非必然）？",
    "options": [
      { "key": "A", "text": "竇性心搏過速" },
      { "key": "B", "text": "ST elevation 只在 V1–V4" },
      { "key": "C", "text": "PR 下降" },
      { "key": "D", "text": "必然出現完全性房室傳導阻滯" }
    ],
    "answer": "A",
    "explanation": "PE 最常見 ECG 是竇性心搏過速；S1Q3T3、右軸偏移、右束支傳導阻滯等可見但敏感度不高。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜治療" },
    "stem": "血流動力學穩定的確診 PE 病人，最核心的初始治療為何？",
    "options": [
      { "key": "A", "text": "抗凝治療（如 DOAC 或 heparin 起始，視個案調整）" },
      { "key": "B", "text": "立即溶栓作為常規" },
      { "key": "C", "text": "只給氧，不需抗凝" },
      { "key": "D", "text": "長期口服類固醇" }
    ],
    "answer": "A",
    "explanation": "大多數穩定 PE 的基礎治療是抗凝，降低血栓延伸與復發。溶栓多保留給高風險（massive）或特定次高風險情境。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜高風險 PE" },
    "stem": "下列何者最符合『高風險（massive）PE』的定義？",
    "options": [
      { "key": "A", "text": "持續性低血壓／休克（hemodynamic instability）" },
      { "key": "B", "text": "只有輕微胸痛" },
      { "key": "C", "text": "D-dimer 很高" },
      { "key": "D", "text": "胸部 X 光正常" }
    ],
    "answer": "A",
    "explanation": "高風險（massive）PE 的核心是血流動力學不穩定（休克或持續低血壓）。這群病人需考慮更積極再灌流策略（溶栓/導管/手術）。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜溶栓" },
    "stem": "下列哪一項最符合 PE 溶栓治療的典型適應症？",
    "options": [
      { "key": "A", "text": "高風險（massive）PE 合併休克/低血壓，且無重大出血禁忌" },
      { "key": "B", "text": "所有確診 PE 都必須溶栓" },
      { "key": "C", "text": "只有 D-dimer 升高" },
      { "key": "D", "text": "單純輕症且可以門診追蹤" }
    ],
    "answer": "A",
    "explanation": "溶栓主要用於 hemodynamic instability 的高風險 PE；穩定 PE 通常以抗凝為主。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜下肢血栓" },
    "stem": "疑似 PE 病人若同時有下肢腫痛，最合理的下一步檢查（可協助支持 VTE）為何？",
    "options": [
      { "key": "A", "text": "下肢靜脈超音波（compression ultrasonography）" },
      { "key": "B", "text": "胃鏡" },
      { "key": "C", "text": "腦波" },
      { "key": "D", "text": "甲狀腺超音波" }
    ],
    "answer": "A",
    "explanation": "PE 常源自下肢 DVT。下肢靜脈超音波可找 DVT，對 VTE 診斷鏈非常有幫助（尤其當胸部影像不易/禁忌時）。"
  },
  {
    "id": "MED3_V1_DER_PH_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜PH 總論" },
    "stem": "肺高壓（PH）的確立診斷金標準檢查為何？",
    "options": [
      { "key": "A", "text": "右心導管檢查（right heart catheterization）" },
      { "key": "B", "text": "單純心臟超音波即可確診 PH 並分型" },
      { "key": "C", "text": "胸部 X 光" },
      { "key": "D", "text": "肺量計" }
    ],
    "answer": "A",
    "explanation": "心臟超音波可做初步篩檢與推估，但 PH 的確診與血流動力學分型需要右心導管。"
  },
  {
    "id": "MED3_V1_DER_PH_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜分型" },
    "stem": "下列哪一項最符合『慢性血栓栓塞性肺高壓（CTEPH）』的概念？",
    "options": [
      { "key": "A", "text": "急性 PE 後血栓未完全溶解，形成慢性阻塞/重塑導致 PH" },
      { "key": "B", "text": "單純氣喘造成可逆性氣流受限" },
      { "key": "C", "text": "上呼吸道感染造成鼻塞" },
      { "key": "D", "text": "只要有高血壓就會造成 PH" }
    ],
    "answer": "A",
    "explanation": "CTEPH 為 PE 後慢性血栓殘留/血管重塑造成的 PH，治療策略與一般 PAH 不同，需特別辨識（可考慮肺動脈內膜切除或介入）。"
  },
  {
    "id": "MED3_V1_DER_PH_Q0014",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜臨床" },
    "stem": "PH 病人常見症狀與徵象，下列何者較典型？",
    "options": [
      { "key": "A", "text": "漸進性運動喘、暈厥或胸悶、右心衰徵象（JVD/水腫）" },
      { "key": "B", "text": "侷限性右下腹劇痛" },
      { "key": "C", "text": "急性大量咳血且每天固定在清晨發作" },
      { "key": "D", "text": "只有鼻涕倒流" }
    ],
    "answer": "A",
    "explanation": "PH 典型為漸進性運動喘，嚴重時可暈厥或胸悶，晚期出現右心衰表現（JVD、下肢水腫、肝腫大等）。"
  },
  {
    "id": "MED3_V1_DER_PH_Q0015",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺栓塞／肺高壓｜篩檢" },
    "stem": "疑似 PH 的初步篩檢工具，下列何者最合適？",
    "options": [
      { "key": "A", "text": "心臟超音波估算肺動脈壓並評估右心結構功能" },
      { "key": "B", "text": "只做肺功能即可確診 PH" },
      { "key": "C", "text": "只做胸部 X 光即可排除 PH" },
      { "key": "D", "text": "只測 D-dimer" }
    ],
    "answer": "A",
    "explanation": "心臟超音波可做 PH 初步評估（估算肺動脈壓、右心室大小/功能、三尖瓣返流等），但確診仍需右心導管。"
  },
  
  {
    "id": "MED3_V1_DER_PNA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜CAP 定義" },
    "stem": "下列何者最符合社區型肺炎（CAP）的定義？",
    "options": [
      { "key": "A", "text": "入院 48 小時後才出現的新發肺炎" },
      { "key": "B", "text": "長照機構住民一律視為 VAP" },
      { "key": "C", "text": "在社區獲得、或入院早期（通常 <48 小時）即已存在的肺炎" },
      { "key": "D", "text": "所有免疫低下的肺炎都不算 CAP" }
    ],
    "answer": "C",
    "explanation": "CAP 指在醫療照護機構外獲得、或入院早期即已存在的肺炎；住院超過一段時間才新發者較符合 HAP/VAP 概念。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜HAP/VAP 定義" },
    "stem": "關於 HAP 與 VAP，下列何者正確？",
    "options": [
      { "key": "A", "text": "HAP：入院 48 小時後才發生；VAP：插管/呼吸器使用後才發生" },
      { "key": "B", "text": "HAP 只發生在門診" },
      { "key": "C", "text": "VAP 一定是病毒感染" },
      { "key": "D", "text": "HAP/VAP 都不需要考慮抗藥性菌" }
    ],
    "answer": "A",
    "explanation": "HAP（hospital-acquired pneumonia）多定義為入院 ≥48 小時後新發；VAP（ventilator-associated pneumonia）發生在插管通氣後（臨床多用插管 ≥48 小時後）且需高度考慮 MDR 風險。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜CAP 嚴重度" },
    "stem": "CAP 需要住院與否的嚴重度評估工具，下列何者最常用？",
    "options": [
      { "key": "A", "text": "CURB-65 或 PSI" },
      { "key": "B", "text": "CHADS2-VASc" },
      { "key": "C", "text": "Wells score（PE 用）" },
      { "key": "D", "text": "Glasgow coma scale 只能單獨決定是否住院" }
    ],
    "answer": "A",
    "explanation": "CAP 常用 CURB-65 或 PSI 進行風險分層，協助決定門診、住院或 ICU 評估；臨床仍需結合生命徵象與共病。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜CAP 門診治療" },
    "stem": "免疫正常、無重大共病、門診治療的 CAP，經驗性抗生素策略下列何者最合理？",
    "options": [
      { "key": "A", "text": "Amoxicillin（或相當 β-lactam）/Doxycycline，視地區抗藥性與個案調整" },
      { "key": "B", "text": "必須三合一：anti-pseudomonal β-lactam + vancomycin + azithromycin" },
      { "key": "C", "text": "只要咳嗽就給抗生素，無需影像證據" },
      { "key": "D", "text": "Warfarin 作為第一線抗感染治療" }
    ],
    "answer": "A",
    "explanation": "低風險 CAP 門診常以窄譜為主（如 amoxicillin 或 doxycycline；部分情境可用 macrolide 但需考量抗藥性）。高強度廣譜（含抗綠膿桿菌/抗 MRSA）並非常規。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜CAP 住院治療" },
    "stem": "一般病房住院 CAP（非 ICU）常見的經驗性治療組合何者最典型？",
    "options": [
      { "key": "A", "text": "β-lactam + macrolide，或 respiratory fluoroquinolone 單用（視個案）" },
      { "key": "B", "text": "只給吸入型 SABA" },
      { "key": "C", "text": "固定加 vancomycin（不論風險）" },
      { "key": "D", "text": "只要 CRP 低就不需要任何治療" }
    ],
    "answer": "A",
    "explanation": "住院 CAP（非 ICU）常見策略為 β-lactam（如 ceftriaxone/ampicillin-sulbactam）合併 macrolide，或使用 respiratory FQ 單用（依個案 QT/副作用/抗藥性與共病調整）。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜MRSA/綠膿桿菌風險" },
    "stem": "CAP 需要加 coverage for MRSA 或 Pseudomonas 的情境，較符合下列哪一項？",
    "options": [
      { "key": "A", "text": "既往有 MRSA/綠膿桿菌呼吸道分離史或近期住院且接受靜脈抗生素" },
      { "key": "B", "text": "單純過敏性鼻炎" },
      { "key": "C", "text": "年紀大於 30 歲" },
      { "key": "D", "text": "只要胸痛就一定要加 vancomycin + anti-pseudomonal" }
    ],
    "answer": "A",
    "explanation": "是否需要 MRSA/綠膿桿菌 coverage 以「具體風險因子」為主（如既往分離史、近期住院與 IV 抗生素等）；不建議無差別廣譜。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜Aspiration pneumonia" },
    "stem": "吸入性肺炎（aspiration pneumonia）的經驗性用藥思路，下列何者最正確？",
    "options": [
      { "key": "A", "text": "若是典型吸入性肺炎（非單純吸入性肺炎炎症），需涵蓋口腔厭氧菌的藥物（例如 ampicillin-sulbactam）" },
      { "key": "B", "text": "吸入事件後一定要加 vancomycin" },
      { "key": "C", "text": "只要吸到胃酸就等同細菌肺炎，永遠需抗生素" },
      { "key": "D", "text": "吸入性肺炎不會造成右下肺葉為主的浸潤" }
    ],
    "answer": "A",
    "explanation": "吸入可分 aspiration pneumonitis（化學性）與 aspiration pneumonia（細菌性）；後者常需涵蓋厭氧與口腔菌叢（視臨床情境）。浸潤分佈常與體位相關，右下肺葉常見。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜Atypical pneumonia" },
    "stem": "下列哪一項病原體最典型被歸類為『非典型肺炎（atypical pneumonia）』病因？",
    "options": [
      { "key": "A", "text": "Mycoplasma pneumoniae" },
      { "key": "B", "text": "Streptococcus pneumoniae" },
      { "key": "C", "text": "Klebsiella pneumoniae（典型大葉性/酒精、糖尿病等）" },
      { "key": "D", "text": "Staphylococcus aureus（多見於流感後或醫療相關）" }
    ],
    "answer": "A",
    "explanation": "非典型病原體常包含 Mycoplasma、Chlamydia pneumoniae、Legionella 等；典型大葉性肺炎常見為肺炎鏈球菌。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜Legionella" },
    "stem": "哪一組臨床線索較支持 Legionella 肺炎？",
    "options": [
      { "key": "A", "text": "肺炎合併腹瀉、低鈉血症、相對較少痰" },
      { "key": "B", "text": "肺炎合併大量膿痰與空洞" },
      { "key": "C", "text": "肺炎合併明顯嗜酸性球上升與蕁麻疹" },
      { "key": "D", "text": "肺炎合併典型支擴後可逆性陽性" }
    ],
    "answer": "A",
    "explanation": "Legionella 常考點包含腸胃症狀（腹瀉）、低鈉血症、肝酵素上升、相對乾咳或痰較少；治療需涵蓋 atypical（macrolide/respiratory FQ）。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜治療反應" },
    "stem": "CAP 接受抗生素治療後 48–72 小時仍未改善，下列哪一項是最合理的下一步思考方向？",
    "options": [
      { "key": "A", "text": "重新評估診斷與併發症：是否為非感染、是否有膿胸/脓肿、抗藥性或不典型病原、是否用藥不當" },
      { "key": "B", "text": "直接停掉所有治療，因為抗生素無效" },
      { "key": "C", "text": "永遠加上最高劑量類固醇即可" },
      { "key": "D", "text": "只要 CRP 下降就不需要管臨床狀況" }
    ],
    "answer": "A",
    "explanation": "治療反應不佳需系統性回頭檢查：診斷是否正確、是否併發膿胸/肺膿瘍、病原是否涵蓋、是否有抗藥性或非典型/病毒性、免疫狀態與用藥依從性等。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜HAP/VAP 抗生素" },
    "stem": "HAP/VAP 經驗性抗生素選擇的核心差異點為何？",
    "options": [
      { "key": "A", "text": "需評估 MDR 風險（含 MRSA、Pseudomonas）並依當地 antibiogram 調整" },
      { "key": "B", "text": "一律只用 penicillin G 即可" },
      { "key": "C", "text": "HAP/VAP 完全不需做培養" },
      { "key": "D", "text": "HAP/VAP 都不能使用 β-lactam" }
    ],
    "answer": "A",
    "explanation": "HAP/VAP 的重點是抗藥性菌風險更高，經驗治療需依 MDR 風險、病人狀態與醫院 antibiogram，並在培養結果出來後進行 de-escalation。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺部感染｜疫苗與預防" },
    "stem": "下列何者是降低高風險族群肺炎/侵襲性肺炎鏈球菌感染的重要預防策略？",
    "options": [
      { "key": "A", "text": "依適應症施打肺炎鏈球菌疫苗與流感疫苗" },
      { "key": "B", "text": "長期預防性口服抗生素（所有人）" },
      { "key": "C", "text": "每日口服類固醇（所有人）" },
      { "key": "D", "text": "完全避免運動" }
    ],
    "answer": "A",
    "explanation": "高風險族群（年長、慢性病、免疫低下等）疫苗接種（流感、肺炎鏈球菌）可降低肺炎與嚴重併發症風險；其他選項非標準預防策略。"
  }

,

  
  {
    "id": "MED3_V1_DER_TB_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺結核（TB）｜定義" },
    "stem": "下列何者最符合『活動性肺結核（active pulmonary TB）』？",
    "options": [
      { "key": "A", "text": "無症狀、影像正常、僅 TST/IGRA 陽性" },
      { "key": "B", "text": "有症狀與影像異常，且可檢出分枝桿菌（塗片/培養/NAAT）" },
      { "key": "C", "text": "僅有 BCG 接種史" },
      { "key": "D", "text": "單次咳嗽即確診" }
    ],
    "answer": "B",
    "explanation": "活動性 TB 需有臨床/影像證據，並以微生物學檢驗支持；僅 TST/IGRA 陽性而無臨床證據屬潛伏結核感染（LTBI）。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜潛伏感染" },
    "stem": "關於潛伏結核感染（LTBI），下列何者正確？",
    "options": [
      { "key": "A", "text": "一定具有傳染性" },
      { "key": "B", "text": "影像與症狀皆正常，但 TST/IGRA 陽性" },
      { "key": "C", "text": "一定需要 6 個月四合一治療" },
      { "key": "D", "text": "胸部 X 光必定有空洞" }
    ],
    "answer": "B",
    "explanation": "LTBI 為免疫學證據陽性但無臨床/影像活動性病灶，通常不具傳染性；治療策略與活動性 TB 不同。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜症狀" },
    "stem": "肺結核最典型的症狀組合為何？",
    "options": [
      { "key": "A", "text": "慢性咳嗽、夜間盜汗、體重減輕、發燒" },
      { "key": "B", "text": "突發胸痛、立即休克" },
      { "key": "C", "text": "急性高燒合併大量膿痰 24 小時內痊癒" },
      { "key": "D", "text": "只有鼻塞流鼻水" }
    ],
    "answer": "A",
    "explanation": "TB 為慢性消耗性疾病，常見慢性咳嗽、低度發燒、夜間盜汗與體重減輕。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜影像學" },
    "stem": "免疫正常成人的再活化型肺結核，最典型的影像分佈為何？",
    "options": [
      { "key": "A", "text": "上肺葉或肺尖為主，可能合併空洞" },
      { "key": "B", "text": "只在右下肺葉" },
      { "key": "C", "text": "僅中央肺門淋巴結腫大" },
      { "key": "D", "text": "一定有大量胸水" }
    ],
    "answer": "A",
    "explanation": "再活化 TB 偏好高氧分壓區域，典型位於上肺葉/肺尖，常可見空洞。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜兒童/免疫低下" },
    "stem": "下列何者較符合兒童或免疫低下者之肺結核表現？",
    "options": [
      { "key": "A", "text": "肺門/縱膈淋巴結腫大較常見" },
      { "key": "B", "text": "一定有上肺葉空洞" },
      { "key": "C", "text": "症狀一定很輕" },
      { "key": "D", "text": "不會發生粟粒型結核" }
    ],
    "answer": "A",
    "explanation": "兒童與免疫低下者常見肺門或縱膈淋巴結腫大，影像表現與成人再活化 TB 不同，亦可見粟粒型結核。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜檢驗" },
    "stem": "下列何者屬於結核感染的『免疫學檢驗』？",
    "options": [
      { "key": "A", "text": "痰抗酸菌塗片（AFB smear）" },
      { "key": "B", "text": "痰培養（culture）" },
      { "key": "C", "text": "IGRA 或 TST" },
      { "key": "D", "text": "NAAT（核酸放大）" }
    ],
    "answer": "C",
    "explanation": "IGRA/TST 為免疫學檢驗，反映是否曾感染結核；塗片、培養、NAAT 屬病原學檢驗。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜塗片與培養" },
    "stem": "關於痰抗酸菌塗片（AFB smear），下列何者正確？",
    "options": [
      { "key": "A", "text": "塗片陽性即可判定具傳染性風險" },
      { "key": "B", "text": "塗片陰性即可完全排除 TB" },
      { "key": "C", "text": "塗片比培養更敏感" },
      { "key": "D", "text": "塗片只能檢出死菌" }
    ],
    "answer": "A",
    "explanation": "AFB 塗片陽性代表菌量高、傳染性風險較高；但塗片陰性不能排除 TB，培養仍是金標準（但較慢）。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜NAAT" },
    "stem": "NAAT（核酸放大檢驗）在 TB 診斷中的優點為何？",
    "options": [
      { "key": "A", "text": "快速且可同時偵測結核菌與部分抗藥性" },
      { "key": "B", "text": "完全取代培養，不需後續檢驗" },
      { "key": "C", "text": "只適用於潛伏結核感染" },
      { "key": "D", "text": "一定比塗片慢" }
    ],
    "answer": "A",
    "explanation": "NAAT 可快速偵測 MTB，並可同時提供部分抗藥性資訊（如 rifampin），但仍需培養做完整藥敏。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜標準治療" },
    "stem": "藥物敏感性肺結核的標準初始治療為何？",
    "options": [
      { "key": "A", "text": "2 個月 HRZE + 4 個月 HR" },
      { "key": "B", "text": "2 週抗生素即可" },
      { "key": "C", "text": "單用 isoniazid 9 個月" },
      { "key": "D", "text": "終身治療" }
    ],
    "answer": "A",
    "explanation": "藥物敏感性 TB 標準治療為 2HRZE/4HR（共 6 個月），以降低復發與抗藥性。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜藥物副作用" },
    "stem": "下列哪一組藥物與其典型副作用配對最正確？",
    "options": [
      { "key": "A", "text": "Ethambutol → 視神經炎" },
      { "key": "B", "text": "Isoniazid → 聽力受損" },
      { "key": "C", "text": "Rifampin → 嚴重 QT 延長" },
      { "key": "D", "text": "Pyrazinamide → 視力模糊" }
    ],
    "answer": "A",
    "explanation": "Ethambutol 可能造成視神經炎；INH 相關為周邊神經病變（B6 缺乏）；Rifampin 會造成體液橘紅色；Pyrazinamide 常見高尿酸/關節痛。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜隔離" },
    "stem": "疑似活動性肺結核病人，最適當的感染管制措施為何？",
    "options": [
      { "key": "A", "text": "負壓隔離與空氣傳染防護" },
      { "key": "B", "text": "只需一般外科口罩" },
      { "key": "C", "text": "不需任何隔離" },
      { "key": "D", "text": "只要塗片陰性即可解除隔離" }
    ],
    "answer": "A",
    "explanation": "疑似或確診活動性肺結核需空氣傳染防護（負壓隔離）；解除隔離需依臨床與微生物學條件評估。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜抗藥性" },
    "stem": "MDR-TB 的定義為何？",
    "options": [
      { "key": "A", "text": "對 isoniazid 與 rifampin 皆具抗藥性" },
      { "key": "B", "text": "只對 ethambutol 抗藥" },
      { "key": "C", "text": "只要治療超過 6 個月即為 MDR-TB" },
      { "key": "D", "text": "只在 HIV 病人發生" }
    ],
    "answer": "A",
    "explanation": "MDR-TB 定義為至少對 INH 與 rifampin 抗藥，治療需使用第二線藥物並由專家管理。"
  },
  {
    "id": "MED3_V1_DER_TB_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜TB｜接觸者處置" },
    "stem": "活動性肺結核確診後，對密切接觸者的處置原則，下列何者正確？",
    "options": [
      { "key": "A", "text": "進行症狀評估與 TST/IGRA，必要時給予 LTBI 治療" },
      { "key": "B", "text": "完全不需評估" },
      { "key": "C", "text": "所有接觸者一律給四合一治療" },
      { "key": "D", "text": "只要無症狀即可忽略" }
    ],
    "answer": "A",
    "explanation": "密切接觸者需評估是否感染（TST/IGRA）與是否有活動性疾病，必要時給予 LTBI 治療以降低未來發病風險。"
  }

,
  
  {
    "id": "MED3_V1_DER_LCA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜分型" },
    "stem": "肺癌的兩大臨床分型為何？",
    "options": [
      { "key": "A", "text": "非小細胞肺癌（NSCLC）與小細胞肺癌（SCLC）" },
      { "key": "B", "text": "鱗狀細胞癌與腺癌（僅此兩型）" },
      { "key": "C", "text": "原位癌與轉移癌" },
      { "key": "D", "text": "良性與惡性" }
    ],
    "answer": "A",
    "explanation": "臨床決策上最重要的分類為 NSCLC 與 SCLC；NSCLC 再細分為腺癌、鱗狀細胞癌與大型細胞癌等。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜流行病學" },
    "stem": "下列何者最符合肺腺癌（adenocarcinoma）的典型特徵？",
    "options": [
      { "key": "A", "text": "最常見的肺癌型態，常位於周邊肺野，與非吸菸者亦相關" },
      { "key": "B", "text": "幾乎只發生在中央氣道" },
      { "key": "C", "text": "幾乎不會發生遠端轉移" },
      { "key": "D", "text": "只發生在重度吸菸男性" }
    ],
    "answer": "A",
    "explanation": "肺腺癌為最常見肺癌型態，常見周邊分布，與非吸菸者、女性及特定 driver mutation 相關。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜影像" },
    "stem": "肺癌影像評估與分期中，最核心的影像組合為何？",
    "options": [
      { "key": "A", "text": "胸部 CT（含對比）± PET-CT，必要時加腦部 MRI" },
      { "key": "B", "text": "單純胸部 X 光即可完整分期" },
      { "key": "C", "text": "腹部超音波即可取代所有檢查" },
      { "key": "D", "text": "心電圖" }
    ],
    "answer": "A",
    "explanation": "肺癌分期以 CT 為基礎，PET-CT 用於遠端轉移評估，疑似腦轉移需腦部 MRI。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜TNM 分期" },
    "stem": "肺癌 TNM 分期中，T 分期主要反映下列何者？",
    "options": [
      { "key": "A", "text": "腫瘤大小與局部侵犯程度" },
      { "key": "B", "text": "是否有遠端轉移" },
      { "key": "C", "text": "病人的體能狀態" },
      { "key": "D", "text": "是否接受過化療" }
    ],
    "answer": "A",
    "explanation": "TNM 中 T 代表腫瘤大小與局部侵犯，N 代表淋巴結，M 代表遠端轉移。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜SCLC" },
    "stem": "下列何者最符合小細胞肺癌（SCLC）的臨床特性？",
    "options": [
      { "key": "A", "text": "生長快速、早期轉移、對化療與放療敏感" },
      { "key": "B", "text": "多為周邊型、早期可手術治癒" },
      { "key": "C", "text": "幾乎不會產生副腫瘤症候群" },
      { "key": "D", "text": "通常不吸菸者為主" }
    ],
    "answer": "A",
    "explanation": "SCLC 具高度侵襲性、早期轉移，治療以化療/放療為主，手術角色有限，且常與吸菸相關。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜副腫瘤症候群" },
    "stem": "下列哪一組『肺癌型態—副腫瘤症候群』配對最正確？",
    "options": [
      { "key": "A", "text": "SCLC — SIADH / ectopic ACTH" },
      { "key": "B", "text": "腺癌 — Lambert-Eaton syndrome" },
      { "key": "C", "text": "鱗狀細胞癌 — SIADH" },
      { "key": "D", "text": "大型細胞癌 — 重症肌無力" }
    ],
    "answer": "A",
    "explanation": "SCLC 常見副腫瘤症候群包含 SIADH、ectopic ACTH；鱗狀細胞癌較常見 PTHrP 導致高血鈣。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜Driver mutations" },
    "stem": "NSCLC（特別是腺癌）常見、且會影響標靶治療選擇的 driver mutation 包含下列何者？",
    "options": [
      { "key": "A", "text": "EGFR、ALK、ROS1、BRAF" },
      { "key": "B", "text": "HLA-B27、APOE" },
      { "key": "C", "text": "BRCA1 只見於乳癌" },
      { "key": "D", "text": "沒有任何分子檢測價值" }
    ],
    "answer": "A",
    "explanation": "腺癌需評估多種 driver mutation（EGFR、ALK、ROS1、BRAF 等），以決定是否使用標靶治療。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜免疫治療" },
    "stem": "肺癌免疫治療常評估的腫瘤指標為何？",
    "options": [
      { "key": "A", "text": "PD-L1 表現量" },
      { "key": "B", "text": "HbA1c" },
      { "key": "C", "text": "D-dimer" },
      { "key": "D", "text": "TSH" }
    ],
    "answer": "A",
    "explanation": "PD-L1 表現量常用於評估免疫檢查點抑制劑（如 anti–PD-1/PD-L1）的適用性。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜治療策略" },
    "stem": "早期（I–II 期）NSCLC、病人可耐受手術時，最優先的治療策略為何？",
    "options": [
      { "key": "A", "text": "手術切除 ± 輔助治療" },
      { "key": "B", "text": "只給支持性治療" },
      { "key": "C", "text": "直接全身化療，不需手術" },
      { "key": "D", "text": "長期抗生素" }
    ],
    "answer": "A",
    "explanation": "早期 NSCLC 若可手術，手術切除為首選，依分期與病理考慮輔助化療/放療。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜鑑別" },
    "stem": "肺部結節的鑑別中，下列哪一項較支持惡性而非良性？",
    "options": [
      { "key": "A", "text": "邊緣不規則、spiculated、隨時間增大" },
      { "key": "B", "text": "長期大小不變、邊緣平滑" },
      { "key": "C", "text": "明顯鈣化呈中央爆米花樣" },
      { "key": "D", "text": "感染後迅速消退" }
    ],
    "answer": "A",
    "explanation": "不規則或 spiculated 邊緣、隨時間成長支持惡性；穩定、平滑或特徵性鈣化較偏良性。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜併發症" },
    "stem": "Pancoast tumor 最典型的臨床表現為何？",
    "options": [
      { "key": "A", "text": "肩痛、上肢疼痛/無力、Horner syndrome" },
      { "key": "B", "text": "大量腹瀉" },
      { "key": "C", "text": "急性腹痛" },
      { "key": "D", "text": "單純咳嗽無其他症狀" }
    ],
    "answer": "A",
    "explanation": "肺尖腫瘤（Pancoast）可侵犯臂叢神經與交感神經鏈，造成肩臂痛與 Horner syndrome。"
  },
  {
    "id": "MED3_V1_DER_LCA_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜肺癌｜篩檢" },
    "stem": "高風險族群肺癌篩檢的建議工具為何？",
    "options": [
      { "key": "A", "text": "低劑量胸部電腦斷層（LDCT）" },
      { "key": "B", "text": "每年胸部 X 光" },
      { "key": "C", "text": "腫瘤標記抽血" },
      { "key": "D", "text": "痰液細胞學即可" }
    ],
    "answer": "A",
    "explanation": "對高風險族群（年齡與吸菸史）建議以低劑量 CT 篩檢，可降低肺癌死亡率。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜胸部X光" },
    "stem": "要診斷肺尖（lung apex）病灶，下列何種 X 光照法最為適當？",
    "options": [
      { "key": "A", "text": "PA view" },
      { "key": "B", "text": "Lateral view" },
      { "key": "C", "text": "Lateral decubitus view" },
      { "key": "D", "text": "Lordotic view" }
    ],
    "answer": "D",
    "explanation": "Lordotic view 可減少鎖骨與前肋骨對肺尖的遮蔽，提升肺尖病灶（如 Pancoast tumor、TB）的可見度。"
  },
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜胸痛鑑別" },
    "stem": "胸痛病患需優先排除的『四大急症』不包含下列何者？",
    "options": [
      { "key": "A", "text": "急性心肌梗塞" },
      { "key": "B", "text": "主動脈剝離" },
      { "key": "C", "text": "高張性氣胸" },
      { "key": "D", "text": "肺炎" }
    ],
    "answer": "D",
    "explanation": "臨床急性胸痛需先排除心肌梗塞、主動脈剝離、高張性氣胸、心包膜填塞；肺炎雖可致胸痛，但非四大立即致命急症。"
  },
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜肺功能" },
    "stem": "下列何者最符合阻塞型肺病（obstructive lung disease）的肺功能表現？",
    "options": [
      { "key": "A", "text": "FEV1/FVC 下降" },
      { "key": "B", "text": "TLC 明顯下降" },
      { "key": "C", "text": "DLCO 一定上升" },
      { "key": "D", "text": "FVC 顯著下降且 FEV1/FVC 正常或上升" }
    ],
    "answer": "A",
    "explanation": "阻塞型肺病的核心為氣流受限，典型表現為 FEV1/FVC 下降；限制型則以 TLC/FVC 下降為主。"
  },
  {
    "id": "MED3_V1_ORIG_PULM_BASIC_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜甲 胸腔科基本知識｜DLCO" },
    "stem": "下列何種疾病最可能造成 DLCO 降低？",
    "options": [
      { "key": "A", "text": "肺氣腫" },
      { "key": "B", "text": "氣喘急性發作" },
      { "key": "C", "text": "肺出血" },
      { "key": "D", "text": "心衰竭早期" }
    ],
    "answer": "A",
    "explanation": "DLCO 下降常見於肺氣腫、間質性肺病與肺血管疾病；氣喘、肺出血與心衰竭早期可因血流增加而使 DLCO 上升。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜定義與病理" },
    "stem": "下列何者不是氣喘（bronchial asthma）的核心病理特徵？",
    "options": [
      { "key": "A", "text": "慢性氣道發炎" },
      { "key": "B", "text": "氣道過度反應" },
      { "key": "C", "text": "多數情況為可逆性氣流受限" },
      { "key": "D", "text": "永久且不可逆的氣道阻塞為主" }
    ],
    "answer": "D",
    "explanation": "氣喘的典型特徵為慢性發炎、氣道高反應與可變（多為可逆）的氣流受限；永久不可逆阻塞較符合 COPD。"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜診斷" },
    "stem": "下列哪一項最支持氣喘的診斷？",
    "options": [
      { "key": "A", "text": "FEV1/FVC < 70% 且完全不可逆" },
      { "key": "B", "text": "支氣管擴張劑後 FEV1 增加 >12% 且 >200 mL" },
      { "key": "C", "text": "DLCO 顯著下降" },
      { "key": "D", "text": "僅有慢性痰多" }
    ],
    "answer": "B",
    "explanation": "氣喘診斷重點在於可變、可逆的氣流受限；支氣管擴張劑後 FEV1 顯著改善（>12% 且 >200 mL）支持診斷。"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜誘發因子" },
    "stem": "下列何者最不常作為氣喘症狀惡化的誘發因子？",
    "options": [
      { "key": "A", "text": "病毒感染" },
      { "key": "B", "text": "運動" },
      { "key": "C", "text": "過敏原暴露" },
      { "key": "D", "text": "單純高血脂" }
    ],
    "answer": "D",
    "explanation": "氣喘常見誘發因子包括病毒感染、運動、過敏原、冷空氣等；高血脂並非典型誘因。"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜急性發作評估" },
    "stem": "評估氣喘急性發作嚴重度時，下列何者最能反映重症？",
    "options": [
      { "key": "A", "text": "使用輔助呼吸肌" },
      { "key": "B", "text": "能完整說一句話" },
      { "key": "C", "text": "PEF 接近個人最佳值" },
      { "key": "D", "text": "呼吸音清楚、無喘鳴" }
    ],
    "answer": "A",
    "explanation": "使用輔助呼吸肌、說話困難、PEF 明顯下降等皆支持嚴重急性發作；能完整說話與 PEF 接近最佳值則較輕。"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜急性治療" },
    "stem": "急性氣喘發作的第一線治療不包含下列何者？",
    "options": [
      { "key": "A", "text": "短效 β2 促效劑（SABA）" },
      { "key": "B", "text": "系統性類固醇" },
      { "key": "C", "text": "吸入型抗膽鹼藥（視嚴重度）" },
      { "key": "D", "text": "Theophylline 常規使用" }
    ],
    "answer": "D",
    "explanation": "急性發作以 SABA、系統性類固醇為主，重症可加抗膽鹼藥；theophylline 因治療窗窄與副作用，非急性第一線。"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜長期控制" },
    "stem": "下列何者為氣喘長期控制治療的基石？",
    "options": [
      { "key": "A", "text": "吸入型類固醇（ICS）" },
      { "key": "B", "text": "短效 β2 促效劑單獨長期使用" },
      { "key": "C", "text": "抗生素預防性使用" },
      { "key": "D", "text": "長期口服類固醇（所有病人）" }
    ],
    "answer": "A",
    "explanation": "ICS 為氣喘長期控制治療核心；SABA 不應單獨作為長期控制，口服類固醇僅限特定情境。"
  },
  {
    "id": "MED3_V1_ORIG_ASTHMA_Q0016",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜乙 氣喘｜鑑別" },
    "stem": "下列何者較不像氣喘，而應優先考慮其他診斷？",
    "options": [
      { "key": "A", "text": "只有慢性咳嗽、無喘鳴或呼吸困難" },
      { "key": "B", "text": "症狀夜間或清晨惡化" },
      { "key": "C", "text": "症狀隨時間變化" },
      { "key": "D", "text": "對支氣管擴張劑有反應" }
    ],
    "answer": "A",
    "explanation": "僅有慢性咳嗽需考慮 post-nasal drip、GERD 等；其餘皆為氣喘典型特徵。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_COPD_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜定義與診斷" },
    "stem": "下列何者為 COPD 診斷的關鍵肺功能標準？",
    "options": [
      { "key": "A", "text": "FEV1/FVC < 70%（支氣管擴張劑後）" },
      { "key": "B", "text": "TLC < 70% predicted" },
      { "key": "C", "text": "DLCO 一定下降" },
      { "key": "D", "text": "FEV1 一定 < 50% predicted" }
    ],
    "answer": "A",
    "explanation": "COPD 的核心為不可完全可逆的氣流受限；診斷以支氣管擴張劑後 FEV1/FVC < 70% 為準。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜危險因子" },
    "stem": "下列何者不是 COPD 的主要危險因子？",
    "options": [
      { "key": "A", "text": "長期吸菸" },
      { "key": "B", "text": "生質燃料或空氣污染暴露" },
      { "key": "C", "text": "α1-antitrypsin 缺乏" },
      { "key": "D", "text": "短期病毒感染一次" }
    ],
    "answer": "D",
    "explanation": "COPD 風險與長期暴露相關（吸菸、污染、遺傳）；單次短期感染不構成主要危險因子。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜臨床表型" },
    "stem": "下列何者最符合『pink puffer』的臨床特徵？",
    "options": [
      { "key": "A", "text": "呼吸困難明顯、體重偏低、氧合相對保留" },
      { "key": "B", "text": "明顯發紺、紅血球增多、周邊水腫" },
      { "key": "C", "text": "大量膿痰與反覆肺炎" },
      { "key": "D", "text": "主要表現為夜間咳嗽與喘鳴" }
    ],
    "answer": "A",
    "explanation": "Pink puffer 多對應肺氣腫表型：以呼吸困難為主、體重低、氧合相對保留；blue bloater 則偏慢性支氣管炎。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜臨床表型" },
    "stem": "下列何者較符合『blue bloater』的特徵？",
    "options": [
      { "key": "A", "text": "慢性咳痰、發紺、紅血球增多" },
      { "key": "B", "text": "體重過輕、嚴重呼吸困難、氧合正常" },
      { "key": "C", "text": "僅運動誘發喘鳴" },
      { "key": "D", "text": "急性起病、完全可逆" }
    ],
    "answer": "A",
    "explanation": "Blue bloater 多對應慢性支氣管炎表型：慢性咳痰、低氧血症、發紺與次發性紅血球增多。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化" },
    "stem": "COPD 急性惡化最常見的誘因為何？",
    "options": [
      { "key": "A", "text": "呼吸道感染" },
      { "key": "B", "text": "甲狀腺功能低下" },
      { "key": "C", "text": "腎結石" },
      { "key": "D", "text": "偏頭痛" }
    ],
    "answer": "A",
    "explanation": "COPD 急性惡化多由感染（病毒或細菌）誘發，其次為空氣污染等。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜急性惡化處置" },
    "stem": "COPD 急性惡化的第一線治療不包含下列何者？",
    "options": [
      { "key": "A", "text": "短效支氣管擴張劑（SABA ± SAMA）" },
      { "key": "B", "text": "系統性類固醇（短期）" },
      { "key": "C", "text": "氧氣治療（目標 SpO2 88–92%）" },
      { "key": "D", "text": "長期預防性抗生素立即啟動" }
    ],
    "answer": "D",
    "explanation": "急性惡化以支氣管擴張劑、短期類固醇與目標導向氧療為主；抗生素視細菌感染證據使用，非長期預防性。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0016",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜氧療" },
    "stem": "COPD 急性惡化給氧時，建議的血氧目標為何？",
    "options": [
      { "key": "A", "text": "SpO2 88–92%" },
      { "key": "B", "text": "SpO2 95–100%" },
      { "key": "C", "text": "PaO2 > 120 mmHg" },
      { "key": "D", "text": "不需監測" }
    ],
    "answer": "A",
    "explanation": "COPD 病人過度給氧可能導致 CO2 retention；建議目標 SpO2 88–92%。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0017",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜非侵襲性通氣" },
    "stem": "下列何者為 COPD 急性惡化使用非侵襲性正壓通氣（NIV）的適應症？",
    "options": [
      { "key": "A", "text": "呼吸性酸中毒（pH < 7.35 合併 PaCO2 上升）" },
      { "key": "B", "text": "僅有輕微喘" },
      { "key": "C", "text": "血壓穩定且無呼吸窘迫" },
      { "key": "D", "text": "單純低血糖" }
    ],
    "answer": "A",
    "explanation": "NIV 可改善通氣、降低插管率；適應症包含呼吸性酸中毒與顯著呼吸窘迫。"
  },
  {
    "id": "MED3_V1_ORIG_COPD_Q0018",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丙 COPD｜長期治療" },
    "stem": "下列何者為 COPD 長期藥物治療的核心？",
    "options": [
      { "key": "A", "text": "長效支氣管擴張劑（LABA/LAMA）" },
      { "key": "B", "text": "單獨長期口服類固醇" },
      { "key": "C", "text": "抗生素長期常規使用" },
      { "key": "D", "text": "只使用 SABA 即可" }
    ],
    "answer": "A",
    "explanation": "COPD 長期治療以長效支氣管擴張劑為基石；ICS 視急性惡化風險與嗜酸性球數量加用。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_ILD_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜總論" },
    "stem": "下列何者最符合間質性肺病（ILD）的典型臨床表現？",
    "options": [
      { "key": "A", "text": "漸進性呼吸困難、乾咳、運動耐受度下降" },
      { "key": "B", "text": "突發胸痛合併休克" },
      { "key": "C", "text": "大量膿痰、反覆高燒" },
      { "key": "D", "text": "間歇性喘鳴、完全可逆" }
    ],
    "answer": "A",
    "explanation": "ILD 多呈慢性、漸進性呼吸困難與乾咳；大量膿痰或完全可逆較不符合 ILD。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜理學檢查" },
    "stem": "ILD 病人最常見的理學檢查發現為何？",
    "options": [
      { "key": "A", "text": "雙側下肺野 fine crackles（Velcro rales）" },
      { "key": "B", "text": "單側濕囉音" },
      { "key": "C", "text": "明顯喘鳴為主" },
      { "key": "D", "text": "心包摩擦音" }
    ],
    "answer": "A",
    "explanation": "ILD 常見雙側下肺野細小爆裂音（Velcro rales），反映肺間質纖維化。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜肺功能" },
    "stem": "ILD 的典型肺功能表現為何？",
    "options": [
      { "key": "A", "text": "限制型通氣障礙（TLC、FVC 下降）" },
      { "key": "B", "text": "FEV1/FVC 顯著下降" },
      { "key": "C", "text": "僅有支氣管擴張劑可逆性" },
      { "key": "D", "text": "TLC 正常或上升" }
    ],
    "answer": "A",
    "explanation": "ILD 以限制型通氣障礙為主，FEV1/FVC 多正常或上升，與阻塞型疾病不同。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜DLCO" },
    "stem": "下列何者最符合 ILD 對 DLCO 的影響？",
    "options": [
      { "key": "A", "text": "DLCO 下降" },
      { "key": "B", "text": "DLCO 一定上升" },
      { "key": "C", "text": "DLCO 不受影響" },
      { "key": "D", "text": "僅在氣喘才改變" }
    ],
    "answer": "A",
    "explanation": "ILD 因肺泡—微血管膜受損，導致氣體交換效率下降，DLCO 常降低。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜影像" },
    "stem": "評估 ILD 最重要的影像檢查為何？",
    "options": [
      { "key": "A", "text": "高解析度胸部電腦斷層（HRCT）" },
      { "key": "B", "text": "單純胸部 X 光即可" },
      { "key": "C", "text": "腹部 CT" },
      { "key": "D", "text": "心臟超音波" }
    ],
    "answer": "A",
    "explanation": "HRCT 可清楚顯示網狀、蜂窩狀、ground-glass 等間質性病變，是 ILD 評估關鍵。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜IPF" },
    "stem": "特發性肺纖維化（IPF）最典型的 HRCT 表現為何？",
    "options": [
      { "key": "A", "text": "下肺野、周邊為主的蜂窩狀變化（honeycombing）" },
      { "key": "B", "text": "中央型支氣管擴張" },
      { "key": "C", "text": "單純肺門淋巴結腫大" },
      { "key": "D", "text": "廣泛實變伴氣支氣管徵" }
    ],
    "answer": "A",
    "explanation": "IPF 屬 UIP pattern，典型為下肺野、周邊為主的蜂窩狀與網狀變化。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0016",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜病因" },
    "stem": "下列何者不是 ILD 的常見病因或相關疾病？",
    "options": [
      { "key": "A", "text": "自體免疫疾病（如 RA、SSc）" },
      { "key": "B", "text": "藥物或職業暴露" },
      { "key": "C", "text": "吸菸" },
      { "key": "D", "text": "單純高血脂" }
    ],
    "answer": "D",
    "explanation": "ILD 常與自體免疫疾病、藥物/職業暴露、吸菸相關；高血脂非典型病因。"
  },
  {
    "id": "MED3_V1_ORIG_ILD_Q0017",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜丁 間質性肺病｜治療" },
    "stem": "關於 ILD 的治療原則，下列何者正確？",
    "options": [
      { "key": "A", "text": "需依病因分類，並非所有 ILD 都適合類固醇" },
      { "key": "B", "text": "所有 ILD 一律長期高劑量類固醇" },
      { "key": "C", "text": "抗生素為長期治療基石" },
      { "key": "D", "text": "支氣管擴張劑即可治癒" }
    ],
    "answer": "A",
    "explanation": "ILD 治療須依病因與型態（如 IPF vs 發炎性 ILD）決定；IPF 有抗纖維化藥物，並非一律類固醇。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_PE_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺栓塞｜臨床表現" },
    "stem": "下列哪一組最符合急性肺栓塞（PE）的典型臨床表現？",
    "options": [
      { "key": "A", "text": "突發呼吸困難、胸膜性胸痛、心搏過速" },
      { "key": "B", "text": "慢性咳痰、清晨喘鳴" },
      { "key": "C", "text": "高燒合併大量膿痰" },
      { "key": "D", "text": "長期體重減輕、夜間盜汗" }
    ],
    "answer": "A",
    "explanation": "急性 PE 常見突發呼吸困難、胸膜性胸痛與心搏過速；其餘選項較符合其他肺部疾病。"
  },
  {
    "id": "MED3_V1_ORIG_PE_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺栓塞｜危險因子" },
    "stem": "下列何者不是肺栓塞的典型危險因子？",
    "options": [
      { "key": "A", "text": "近期手術或長期臥床" },
      { "key": "B", "text": "惡性腫瘤" },
      { "key": "C", "text": "口服避孕藥或妊娠" },
      { "key": "D", "text": "單純高血脂" }
    ],
    "answer": "D",
    "explanation": "PE 危險因子包含 Virchow triad 相關因素；單純高血脂並非典型 PE 危險因子。"
  },
  {
    "id": "MED3_V1_ORIG_PE_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺栓塞｜診斷流程" },
    "stem": "疑似肺栓塞病人的診斷策略，下列何者最合理？",
    "options": [
      { "key": "A", "text": "先評估臨床前測機率，必要時再做 D-dimer 或影像" },
      { "key": "B", "text": "所有病人一律直接做溶栓治療" },
      { "key": "C", "text": "僅靠胸部 X 光即可確診或排除" },
      { "key": "D", "text": "D-dimer 陽性即可確診 PE" }
    ],
    "answer": "A",
    "explanation": "PE 診斷需先評估臨床前測機率（如 Wells），再依風險選擇 D-dimer 或影像檢查。"
  },
  {
    "id": "MED3_V1_ORIG_PE_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺栓塞｜影像" },
    "stem": "血流動力學穩定的疑似 PE 病人，最常用以確認診斷的影像為何？",
    "options": [
      { "key": "A", "text": "CT pulmonary angiography（CTPA）" },
      { "key": "B", "text": "胸部 X 光" },
      { "key": "C", "text": "腹部 CT" },
      { "key": "D", "text": "肺功能檢查" }
    ],
    "answer": "A",
    "explanation": "在腎功能許可與無顯著禁忌時，CTPA 為確認 PE 的主要影像工具。"
  },
  {
    "id": "MED3_V1_ORIG_PE_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺栓塞｜心電圖" },
    "stem": "關於肺栓塞的心電圖表現，下列何者最常見？",
    "options": [
      { "key": "A", "text": "竇性心搏過速" },
      { "key": "B", "text": "ST elevation 於多導程" },
      { "key": "C", "text": "完全性房室傳導阻滯" },
      { "key": "D", "text": "持續性心房顫動為必然" }
    ],
    "answer": "A",
    "explanation": "PE 最常見 ECG 表現為竇性心搏過速；S1Q3T3 為經典但非高敏感度。"
  },
  {
    "id": "MED3_V1_ORIG_PE_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺栓塞｜治療" },
    "stem": "血流動力學穩定的肺栓塞病人，治療的基石為何？",
    "options": [
      { "key": "A", "text": "抗凝治療" },
      { "key": "B", "text": "立即全數接受溶栓" },
      { "key": "C", "text": "僅給氧即可" },
      { "key": "D", "text": "長期類固醇" }
    ],
    "answer": "A",
    "explanation": "多數穩定 PE 病人以抗凝為治療基石；溶栓保留給高風險（massive）PE。"
  },
  {
    "id": "MED3_V1_ORIG_PH_Q0016",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺高壓｜診斷" },
    "stem": "確立肺高壓（PH）診斷的金標準為何？",
    "options": [
      { "key": "A", "text": "右心導管檢查" },
      { "key": "B", "text": "心臟超音波" },
      { "key": "C", "text": "胸部 X 光" },
      { "key": "D", "text": "肺功能檢查" }
    ],
    "answer": "A",
    "explanation": "心臟超音波可做篩檢，但 PH 的確診與血流動力學分型需右心導管。"
  },
  {
    "id": "MED3_V1_ORIG_PH_Q0017",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜戊 肺高壓｜臨床" },
    "stem": "下列何者為肺高壓常見的臨床表現？",
    "options": [
      { "key": "A", "text": "漸進性運動喘、暈厥或右心衰徵象" },
      { "key": "B", "text": "急性高燒與膿痰" },
      { "key": "C", "text": "單側胸膜性胸痛" },
      { "key": "D", "text": "僅夜間咳嗽" }
    ],
    "answer": "A",
    "explanation": "PH 典型表現為漸進性運動喘，嚴重時可暈厥，晚期出現右心衰竭徵象。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_PNA_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜定義" },
    "stem": "下列何者最符合社區型肺炎（CAP）的定義？",
    "options": [
      { "key": "A", "text": "入院 48 小時後才發生的肺炎" },
      { "key": "B", "text": "長期插管後出現的肺炎" },
      { "key": "C", "text": "在社區獲得或入院早期即存在的肺炎" },
      { "key": "D", "text": "只要是病毒感染即為 CAP" }
    ],
    "answer": "C",
    "explanation": "CAP 指在醫療機構外獲得，或入院早期即存在的肺炎；入院 ≥48 小時後新發者較符合 HAP/VAP。"
  },
  {
    "id": "MED3_V1_ORIG_PNA_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜病原" },
    "stem": "社區型肺炎（CAP）最常見的致病菌為何？",
    "options": [
      { "key": "A", "text": "Streptococcus pneumoniae" },
      { "key": "B", "text": "Pseudomonas aeruginosa" },
      { "key": "C", "text": "Mycobacterium tuberculosis" },
      { "key": "D", "text": "Candida albicans" }
    ],
    "answer": "A",
    "explanation": "肺炎鏈球菌是 CAP 最常見的典型致病菌；Pseudomonas 多見於 HAP/VAP 或特定高風險族群。"
  },
  {
    "id": "MED3_V1_ORIG_PNA_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜嚴重度" },
    "stem": "評估 CAP 是否需要住院治療時，常用的臨床評分工具為何？",
    "options": [
      { "key": "A", "text": "CURB-65 或 PSI" },
      { "key": "B", "text": "Wells score" },
      { "key": "C", "text": "APGAR score" },
      { "key": "D", "text": "CHADS2 score" }
    ],
    "answer": "A",
    "explanation": "CURB-65 與 PSI 為 CAP 常用的嚴重度評估工具，用以協助門診或住院決策。"
  },
  {
    "id": "MED3_V1_ORIG_PNA_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜治療" },
    "stem": "免疫正常、無重大共病的 CAP 病人，門診經驗性抗生素治療何者最合適？",
    "options": [
      { "key": "A", "text": "Amoxicillin 或 doxycycline（依抗藥性調整）" },
      { "key": "B", "text": "Vancomycin + anti-pseudomonal β-lactam" },
      { "key": "C", "text": "僅給吸入型支氣管擴張劑" },
      { "key": "D", "text": "預防性抗生素長期使用" }
    ],
    "answer": "A",
    "explanation": "低風險 CAP 門診治療以窄譜為主；廣譜（含 MRSA/綠膿桿菌）需有特定風險因子。"
  },
  {
    "id": "MED3_V1_ORIG_PNA_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜住院治療" },
    "stem": "一般病房住院 CAP 的經驗性治療，下列何者較合理？",
    "options": [
      { "key": "A", "text": "β-lactam + macrolide，或 respiratory fluoroquinolone 單用" },
      { "key": "B", "text": "只用 penicillin G" },
      { "key": "C", "text": "固定加 vancomycin 不論風險" },
      { "key": "D", "text": "完全不需抗生素" }
    ],
    "answer": "A",
    "explanation": "住院 CAP 常需涵蓋典型與非典型病原；β-lactam 合併 macrolide 或 respiratory FQ 為常見策略。"
  },
  {
    "id": "MED3_V1_ORIG_PNA_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜HAP/VAP" },
    "stem": "關於 HAP/VAP 的敘述，下列何者正確？",
    "options": [
      { "key": "A", "text": "較 CAP 更需考慮抗藥性菌（如 MRSA、Pseudomonas）" },
      { "key": "B", "text": "致病菌與 CAP 完全相同" },
      { "key": "C", "text": "不需要取得培養" },
      { "key": "D", "text": "抗生素選擇不需依當地 antibiogram" }
    ],
    "answer": "A",
    "explanation": "HAP/VAP 抗藥性風險較高，需依 MDR 風險與院內 antibiogram 選擇經驗性抗生素。"
  },
  {
    "id": "MED3_V1_ORIG_PNA_Q0016",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜己 肺部感染｜Aspiration" },
    "stem": "下列關於吸入性肺炎（aspiration pneumonia）的敘述，何者正確？",
    "options": [
      { "key": "A", "text": "常需涵蓋口腔厭氧菌的抗生素" },
      { "key": "B", "text": "一定由病毒造成" },
      { "key": "C", "text": "只發生在年輕健康者" },
      { "key": "D", "text": "影像分佈與體位無關" }
    ],
    "answer": "A",
    "explanation": "吸入性肺炎常與口腔菌叢相關，需涵蓋厭氧菌；影像分佈常與體位相關。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_TB_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜庚 肺結核｜臨床表現" },
    "stem": "下列何者最典型為活動性肺結核的臨床表現？",
    "options": [
      { "key": "A", "text": "慢性咳嗽、夜間盜汗、體重減輕" },
      { "key": "B", "text": "突發高燒合併膿痰，數日內痊癒" },
      { "key": "C", "text": "反覆喘鳴且完全可逆" },
      { "key": "D", "text": "僅鼻塞流鼻水" }
    ],
    "answer": "A",
    "explanation": "活動性 TB 為慢性消耗性疾病，典型症狀包含慢性咳嗽、低度發燒、夜間盜汗與體重減輕。"
  },
  {
    "id": "MED3_V1_ORIG_TB_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜庚 肺結核｜影像" },
    "stem": "免疫正常成人再活化型肺結核最常見的影像分佈為何？",
    "options": [
      { "key": "A", "text": "上肺葉或肺尖為主，可能合併空洞" },
      { "key": "B", "text": "僅右下肺葉" },
      { "key": "C", "text": "單純肺門淋巴結腫大" },
      { "key": "D", "text": "廣泛實變伴氣支氣管徵" }
    ],
    "answer": "A",
    "explanation": "再活化 TB 偏好高氧分壓區域，典型位於上肺葉或肺尖，常見空洞形成。"
  },
  {
    "id": "MED3_V1_ORIG_TB_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜庚 肺結核｜檢驗" },
    "stem": "下列何者屬於結核感染的免疫學檢驗？",
    "options": [
      { "key": "A", "text": "痰抗酸菌塗片" },
      { "key": "B", "text": "痰培養" },
      { "key": "C", "text": "IGRA 或 TST" },
      { "key": "D", "text": "核酸放大檢驗（NAAT）" }
    ],
    "answer": "C",
    "explanation": "IGRA/TST 反映宿主對結核菌的免疫反應；塗片、培養與 NAAT 為病原學檢驗。"
  },
  {
    "id": "MED3_V1_ORIG_TB_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜庚 肺結核｜治療" },
    "stem": "藥物敏感性肺結核的標準治療為何？",
    "options": [
      { "key": "A", "text": "2 個月 HRZE + 4 個月 HR" },
      { "key": "B", "text": "單用 isoniazid 9 個月" },
      { "key": "C", "text": "2 週廣效抗生素即可" },
      { "key": "D", "text": "終身治療" }
    ],
    "answer": "A",
    "explanation": "標準療程為 2HRZE/4HR，共 6 個月，可有效降低復發與抗藥性。"
  },
  {
    "id": "MED3_V1_ORIG_TB_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜庚 肺結核｜感染管制" },
    "stem": "疑似或確診活動性肺結核病人，最適當的感染管制措施為何？",
    "options": [
      { "key": "A", "text": "負壓隔離與空氣傳染防護" },
      { "key": "B", "text": "僅需一般外科口罩" },
      { "key": "C", "text": "不需任何隔離" },
      { "key": "D", "text": "只要塗片陰性即可立即解除隔離" }
    ],
    "answer": "A",
    "explanation": "活動性 TB 需空氣傳染防護；解除隔離須依臨床改善與微生物學結果綜合判斷。"
  },
  {
    "id": "MED3_V1_ORIG_TB_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜庚 肺結核｜抗藥性" },
    "stem": "MDR-TB 的定義為何？",
    "options": [
      { "key": "A", "text": "對 isoniazid 與 rifampin 皆具抗藥性" },
      { "key": "B", "text": "只對 ethambutol 抗藥" },
      { "key": "C", "text": "治療超過 6 個月即為 MDR-TB" },
      { "key": "D", "text": "僅發生於 HIV 病人" }
    ],
    "answer": "A",
    "explanation": "MDR-TB 定義為至少對 INH 與 rifampin 抗藥，治療需第二線藥物並由專家管理。"
  }

,
  
  {
    "id": "MED3_V1_ORIG_LCA_Q0010",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜分型" },
    "stem": "肺癌在臨床決策上最重要的兩大分型為何？",
    "options": [
      { "key": "A", "text": "非小細胞肺癌（NSCLC）與小細胞肺癌（SCLC）" },
      { "key": "B", "text": "腺癌與鱗狀細胞癌" },
      { "key": "C", "text": "原位癌與轉移癌" },
      { "key": "D", "text": "良性與惡性" }
    ],
    "answer": "A",
    "explanation": "NSCLC 與 SCLC 的生物行為與治療策略差異最大，為臨床決策的首要分型。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0011",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜流行病學" },
    "stem": "下列何者最符合肺腺癌（adenocarcinoma）的典型特徵？",
    "options": [
      { "key": "A", "text": "最常見的肺癌型態，常位於周邊肺野" },
      { "key": "B", "text": "幾乎只發生在中央氣道" },
      { "key": "C", "text": "極少發生遠端轉移" },
      { "key": "D", "text": "僅見於重度吸菸男性" }
    ],
    "answer": "A",
    "explanation": "肺腺癌為最常見型態，常位於周邊，與非吸菸者亦相關。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0012",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜影像與分期" },
    "stem": "肺癌完整分期最重要的影像檢查組合為何？",
    "options": [
      { "key": "A", "text": "胸部 CT（含對比）± PET-CT，必要時加腦部 MRI" },
      { "key": "B", "text": "單純胸部 X 光" },
      { "key": "C", "text": "腹部超音波即可" },
      { "key": "D", "text": "心電圖" }
    ],
    "answer": "A",
    "explanation": "CT 為基礎，PET-CT 評估遠端轉移；疑似腦轉移需腦部 MRI。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0013",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜TNM" },
    "stem": "TNM 分期中的 T 主要代表何者？",
    "options": [
      { "key": "A", "text": "腫瘤大小與局部侵犯程度" },
      { "key": "B", "text": "淋巴結轉移" },
      { "key": "C", "text": "遠端轉移" },
      { "key": "D", "text": "病人年齡" }
    ],
    "answer": "A",
    "explanation": "T 為原發腫瘤大小與侵犯；N 為淋巴結；M 為遠端轉移。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0014",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜SCLC" },
    "stem": "下列何者最符合小細胞肺癌（SCLC）的特性？",
    "options": [
      { "key": "A", "text": "生長快速、早期轉移、對化療與放療敏感" },
      { "key": "B", "text": "多為周邊型、以手術為主" },
      { "key": "C", "text": "極少與吸菸相關" },
      { "key": "D", "text": "幾乎不會有副腫瘤症候群" }
    ],
    "answer": "A",
    "explanation": "SCLC 侵襲性高、早期轉移，治療以化療/放療為主，且常見副腫瘤症候群。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0015",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜副腫瘤症候群" },
    "stem": "下列哪一項最常與小細胞肺癌相關？",
    "options": [
      { "key": "A", "text": "SIADH" },
      { "key": "B", "text": "高血鈣（PTHrP）" },
      { "key": "C", "text": "紅血球增多" },
      { "key": "D", "text": "血小板減少" }
    ],
    "answer": "A",
    "explanation": "SCLC 常見 SIADH 或異位 ACTH；高血鈣較常見於鱗狀細胞癌。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0016",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜分子檢測" },
    "stem": "對於 NSCLC（特別是腺癌），下列何者最重要以決定標靶治療？",
    "options": [
      { "key": "A", "text": "Driver mutation（如 EGFR、ALK）檢測" },
      { "key": "B", "text": "單次胸部 X 光" },
      { "key": "C", "text": "血清電解質" },
      { "key": "D", "text": "肺功能檢查" }
    ],
    "answer": "A",
    "explanation": "分子檢測可指引標靶治療選擇，對腺癌尤其重要。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0017",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜治療策略" },
    "stem": "早期（I–II 期）NSCLC 且病人可耐受手術時，首選治療為何？",
    "options": [
      { "key": "A", "text": "手術切除 ± 輔助治療" },
      { "key": "B", "text": "直接全身化療" },
      { "key": "C", "text": "只給支持性治療" },
      { "key": "D", "text": "長期抗生素" }
    ],
    "answer": "A",
    "explanation": "早期 NSCLC 若可手術，手術切除為首選，視分期與病理加輔助治療。"
  },
  {
    "id": "MED3_V1_ORIG_LCA_Q0018",
    "source_type": "original",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "第二篇 胸腔內科｜辛 肺癌｜特殊型態" },
    "stem": "Pancoast tumor 最典型的臨床表現為何？",
    "options": [
      { "key": "A", "text": "肩痛、上肢神經症狀、Horner syndrome" },
      { "key": "B", "text": "腹瀉與低鈉血症" },
      { "key": "C", "text": "急性高燒與膿痰" },
      { "key": "D", "text": "僅乾咳" }
    ],
    "answer": "A",
    "explanation": "肺尖腫瘤侵犯臂叢與交感神經鏈，造成肩臂痛與 Horner syndrome。"
  },


  {
    "id": "MED3_V1_DER_ACS_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜初始處置" },
    "stem": "58 歲男性胸痛 40 分鐘，出汗、噁心，心電圖顯示下壁 ST elevation。血壓 86/54，頸靜脈怒張，肺音清。此時最不應該立即給予的藥物是？",
    "options": [
      { "key": "A", "text": "Aspirin" },
      { "key": "B", "text": "Heparin（或其他抗凝）" },
      { "key": "C", "text": "Nitroglycerin" },
      { "key": "D", "text": "儘速安排緊急 PCI（同時給予 P2Y12 抑制劑）" }
    ],
    "answer": "C",
    "explanation": "下壁 STEMI 合併低血壓、頸靜脈怒張、肺音清要高度懷疑右心室梗塞（RVI）。RVI 依賴前負荷，硝酸甘油會降低前負荷導致休克惡化，應避免；優先補液、維持灌流並緊急再灌流。Aspirin/抗凝與緊急 PCI 仍為核心處置。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜鑑別" },
    "stem": "45 歲男性突發撕裂樣胸背痛，血壓右手 180/90、左手 140/80，胸部 X 光縱膈增寬。最應優先安排的檢查是？",
    "options": [
      { "key": "A", "text": "運動心電圖" },
      { "key": "B", "text": "冠狀動脈 CT" },
      { "key": "C", "text": "胸部 CTA（含主動脈）" },
      { "key": "D", "text": "心肌灌注掃描" }
    ],
    "answer": "C",
    "explanation": "臨床高度懷疑主動脈剝離（撕裂痛、雙側血壓差、縱膈增寬）。首選影像為胸部 CTA（主動脈 CTA），用以確認診斷與分型並決定外科/內科處置。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜胸痛｜致命鑑別" },
    "stem": "胸痛病人到急診，若要快速排除最致命的胸痛原因，以下哪一組「優先鑑別」最恰當？",
    "options": [
      { "key": "A", "text": "GERD、肋軟骨炎、焦慮" },
      { "key": "B", "text": "急性冠心症、主動脈剝離、肺栓塞、張力性氣胸" },
      { "key": "C", "text": "肺炎、氣喘、支氣管炎" },
      { "key": "D", "text": "膽結石、胰臟炎、胃潰瘍" }
    ],
    "answer": "B",
    "explanation": "急診胸痛要先排除立即致命疾病（ACS、主動脈剝離、肺栓塞、張力性氣胸等），再考慮常見良性原因。"
  },

  {
    "id": "MED3_V1_DER_HF_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心衰竭｜急性肺水腫" },
    "stem": "72 歲女性急性呼吸困難、粉紅泡沫痰、雙肺濕囉音，血壓 190/110。最符合的初始治療組合為何？",
    "options": [
      { "key": "A", "text": "大量輸液 + 升壓劑" },
      { "key": "B", "text": "利尿劑 + 血管擴張（如 nitrate）+ 正壓通氣（NIPPV）" },
      { "key": "C", "text": "只給抗生素" },
      { "key": "D", "text": "立即使用高劑量 β 阻斷劑" }
    ],
    "answer": "B",
    "explanation": "高血壓型急性心衰竭/肺水腫重點是降低前後負荷與改善氧合：NIPPV（CPAP/BiPAP）＋血管擴張（nitrate，若無禁忌）＋利尿劑。大量輸液會惡化肺水腫；急性期不會以高劑量 β 阻斷劑作為立即穩定手段。"
  },
  {
    "id": "MED3_V1_DER_HF_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心衰竭｜HFpEF vs HFrEF" },
    "stem": "65 歲女性有高血壓與肥胖，運動喘，超音波 LVEF 60%，左心房擴大、E/e' 上升。最符合下列何種心衰竭類型與主要病理？",
    "options": [
      { "key": "A", "text": "HFrEF；主要為收縮功能障礙" },
      { "key": "B", "text": "HFpEF；主要為舒張功能障礙/充盈壓上升" },
      { "key": "C", "text": "心包填塞；主要為心包積液" },
      { "key": "D", "text": "肺動脈高壓；主要為右心衰竭" }
    ],
    "answer": "B",
    "explanation": "HFpEF 常見於高血壓、肥胖、老年；LVEF 保留但舒張功能差、左房壓/充盈壓上升（E/e' 上升、左房擴大）。"
  },

  {
    "id": "MED3_V1_DER_AF_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜急診處置" },
    "stem": "78 歲男性心房顫動（AF）心室率 160，血壓 78/40、意識改變、肺水腫。最適當的下一步是？",
    "options": [
      { "key": "A", "text": "先口服 β 阻斷劑慢慢降速" },
      { "key": "B", "text": "先給 digoxin 等待數小時起效" },
      { "key": "C", "text": "立即同步電擊（synchronized cardioversion）" },
      { "key": "D", "text": "只要抗凝即可，節律/心率可觀察" }
    ],
    "answer": "C",
    "explanation": "AF 合併血流動力學不穩（低血壓、意識改變、缺血、肺水腫）→ 立即同步電擊。藥物控速起效較慢且可能惡化灌流。"
  },
  {
    "id": "MED3_V1_DER_AF_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜抗凝決策" },
    "stem": "70 歲女性 AF，病史：高血壓、糖尿病、曾中風。腎功能可。最符合抗凝建議的是？",
    "options": [
      { "key": "A", "text": "CHADS2/CHA2DS2-VASc 分數低，不需抗凝" },
      { "key": "B", "text": "建議長期口服抗凝（如 DOAC 或 warfarin，依狀況選擇）" },
      { "key": "C", "text": "只需 aspirin" },
      { "key": "D", "text": "只有做過電燒才需要抗凝" }
    ],
    "answer": "B",
    "explanation": "年齡 65–74（1 分）、高血壓（1）、糖尿病（1）、中風/TIA（2）→ CHA2DS2-VASc 高分，明確需要口服抗凝以降低中風風險。"
  },

  {
    "id": "MED3_V1_DER_AVBLOCK_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜緩脈處置" },
    "stem": "55 歲男性暈厥，心電圖顯示完全房室阻斷（third-degree AV block），血壓 82/50。下一步最適當處置？",
    "options": [
      { "key": "A", "text": "觀察即可" },
      { "key": "B", "text": "靜脈 adenosine" },
      { "key": "C", "text": "經皮或經靜脈暫時性心臟節律器（temporary pacing）" },
      { "key": "D", "text": "立即給予高劑量 β 阻斷劑" }
    ],
    "answer": "C",
    "explanation": "不穩定的高度傳導阻滯（低血壓/暈厥）→ 優先暫時性 pacing；adenosine 用於某些上心室性心搏過速，會惡化 AV block。"
  },

  {
    "id": "MED3_V1_DER_VALVE_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜瓣膜｜主動脈瓣狹窄" },
    "stem": "76 歲男性運動時胸痛與暈厥，聽診右上胸骨緣粗糙收縮期雜音放射到頸動脈。最符合的診斷與下一步檢查？",
    "options": [
      { "key": "A", "text": "二尖瓣狹窄；做心導管壓力測量為首選" },
      { "key": "B", "text": "主動脈瓣狹窄；心臟超音波評估瓣口面積與壓力梯度" },
      { "key": "C", "text": "肺動脈瓣狹窄；先做支氣管鏡" },
      { "key": "D", "text": "主動脈瓣逆流；先做運動心電圖" }
    ],
    "answer": "B",
    "explanation": "AS 典型三聯：胸痛、暈厥、心衰；雜音放射頸動脈。首選檢查為心臟超音波評估嚴重度（AVA、mean gradient、Vmax）。"
  },

  {
    "id": "MED3_V1_DER_PE_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜診斷策略" },
    "stem": "36 歲女性口服避孕藥，突發呼吸困難與胸痛，生命徵象穩定。臨床評估為低到中度懷疑肺栓塞。最適當的下一步檢查策略？",
    "options": [
      { "key": "A", "text": "直接做肺動脈 CTA，不需任何前測" },
      { "key": "B", "text": "先做 D-dimer，若陽性再做肺動脈 CTA" },
      { "key": "C", "text": "先做胸部 X 光即可排除" },
      { "key": "D", "text": "先做支氣管鏡" }
    ],
    "answer": "B",
    "explanation": "低/中度臨床懷疑 PE 時，常用 D-dimer 作為排除工具；若陰性可排除，陽性再進一步影像（CTPA）。高懷疑或不穩定則可直接影像/治療。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜高風險處置" },
    "stem": "肺栓塞病人出現持續性低血壓與休克表現，最符合的處置方向為何？",
    "options": [
      { "key": "A", "text": "只要口服止痛藥觀察" },
      { "key": "B", "text": "抗凝即可，溶栓永遠禁忌" },
      { "key": "C", "text": "屬高風險 PE，考慮系統性溶栓或介入取栓（依禁忌與資源）" },
      { "key": "D", "text": "先做肺功能檢查再決定" }
    ],
    "answer": "C",
    "explanation": "高風險（massive）PE 合併血流動力學不穩，除了抗凝外需考慮溶栓或介入/外科治療以快速降低阻塞與右心負荷（需評估出血禁忌）。"
  },

  {
    "id": "MED3_V1_DER_ASTHMA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣喘急性發作｜重症判斷" },
    "stem": "急性氣喘發作治療後，若出現下列何者最提示「呼吸衰竭風險上升」而非改善？",
    "options": [
      { "key": "A", "text": "喘鳴變明顯" },
      { "key": "B", "text": "呼吸音變得非常安靜（silent chest）" },
      { "key": "C", "text": "心跳略快" },
      { "key": "D", "text": "病人可完整說句子" }
    ],
    "answer": "B",
    "explanation": "重度氣喘氣流極差時反而可能聽不到喘鳴（silent chest），是危險徵象，可能即將呼吸衰竭，需要更積極治療與可能插管。"
  },

  {
    "id": "MED3_V1_DER_COPD_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜COPD 急性惡化｜氧療陷阱" },
    "stem": "COPD 急性惡化病人給氧後出現嗜睡，ABG 顯示 PaCO2 上升。下列何者最恰當的氧療原則？",
    "options": [
      { "key": "A", "text": "給到 SpO2 100% 才安全" },
      { "key": "B", "text": "目標 SpO2 約 88–92%，避免過度給氧" },
      { "key": "C", "text": "完全不給氧" },
      { "key": "D", "text": "只要 PaO2 正常就停氧，不需看臨床" }
    ],
    "answer": "B",
    "explanation": "COPD 可能因 V/Q 失衡與 Haldane effect 等機轉，過度氧療可使 CO2 滯留惡化。常用目標 SpO2 88–92%（依個案調整），並密切監測 ABG。"
  },

  {
    "id": "MED3_V1_DER_PLEURAL_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜Light’s criteria" },
    "stem": "下列哪一項最能支持胸水為滲出液（exudate）而非漏出液（transudate）？",
    "options": [
      { "key": "A", "text": "胸水蛋白/血清蛋白比值 > 0.5" },
      { "key": "B", "text": "胸水外觀清澈" },
      { "key": "C", "text": "病人有心衰竭" },
      { "key": "D", "text": "胸水量很少" }
    ],
    "answer": "A",
    "explanation": "Light’s criteria 用於判定滲出液；其中胸水蛋白/血清蛋白比值 >0.5 支持 exudate。心衰竭典型為 transudate（但利尿後可能「假性滲出」需用血清-胸水白蛋白梯度等再判讀）。"
  },

  {
    "id": "MED3_V1_DER_PTX_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣胸｜張力性氣胸" },
    "stem": "創傷後病人突發缺氧與低血壓，氣管偏移，患側呼吸音消失。最恰當的處置是？",
    "options": [
      { "key": "A", "text": "先照胸部 X 光確認再處理" },
      { "key": "B", "text": "立即針刺減壓（needle decompression），再放胸管" },
      { "key": "C", "text": "只給氧觀察" },
      { "key": "D", "text": "先給利尿劑" }
    ],
    "answer": "B",
    "explanation": "張力性氣胸是臨床診斷、立即致命，處置優先於影像確認：先針刺減壓解除張力，再放置胸管。"
  },


  {
    "id": "MED3_V1_DER_ACS_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜NSTEMI 風險分層" },
    "stem": "64 歲男性胸悶 2 小時，心電圖無 ST elevation，但有動態 ST depression，hs-troponin 上升。血壓穩定。下列哪一項最符合此類 NSTEMI 的處置策略？",
    "options": [
      { "key": "A", "text": "僅門診追蹤，因為無 ST elevation" },
      { "key": "B", "text": "屬高風險 NSTE-ACS，應住院監測並考慮早期侵入性策略（coronary angiography）" },
      { "key": "C", "text": "只需給 aspirin，其他都不需要" },
      { "key": "D", "text": "立刻給溶栓（thrombolysis）" }
    ],
    "answer": "B",
    "explanation": "NSTE-ACS 若有動態 ST-T 改變與 troponin 上升屬較高風險，通常需住院、給予抗血小板/抗凝並考慮早期侵入性評估。溶栓主要用於 STEMI；無 ST elevation 不代表低風險。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜抗血小板" },
    "stem": "STEMI 病人準備接受緊急 PCI。下列何者最符合抗血小板治療原則？",
    "options": [
      { "key": "A", "text": "只需 aspirin，不需其他藥物" },
      { "key": "B", "text": "雙抗血小板（aspirin + P2Y12 抑制劑）是核心之一" },
      { "key": "C", "text": "P2Y12 抑制劑只能在出院後開始" },
      { "key": "D", "text": "所有病人都禁用 P2Y12 抑制劑" }
    ],
    "answer": "B",
    "explanation": "STEMI 接受 PCI 通常需要 DAPT（aspirin + P2Y12 inhibitor）以降低血栓事件。實際選藥與時機依出血風險、計畫介入策略與禁忌調整。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0006",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜胸痛｜心包炎鑑別" },
    "stem": "29 歲男性胸痛，坐起前傾緩解、平躺加重，聽到心包摩擦音。心電圖廣泛性 ST elevation 合併 PR depression。最可能診斷為？",
    "options": [
      { "key": "A", "text": "STEMI" },
      { "key": "B", "text": "急性心包炎" },
      { "key": "C", "text": "主動脈剝離" },
      { "key": "D", "text": "肺栓塞" }
    ],
    "answer": "B",
    "explanation": "姿勢性胸痛（前傾緩解）、摩擦音、廣泛性 ST elevation + PR depression 典型支持急性心包炎；與局部導程 ST elevation 的 STEMI 不同。"
  },

  {
    "id": "MED3_V1_DER_HF_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心衰竭｜藥物禁忌" },
    "stem": "HFrEF 病人（LVEF 30%）規劃使用 spironolactone。下列哪一項情境最需要避免或極謹慎使用？",
    "options": [
      { "key": "A", "text": "血鉀 5.8 mmol/L" },
      { "key": "B", "text": "血壓 130/80" },
      { "key": "C", "text": "輕度下肢水腫" },
      { "key": "D", "text": "心跳 78/min" }
    ],
    "answer": "A",
    "explanation": "MRA（spironolactone/eplerenone）會增加高血鉀風險；若本來就高血鉀或腎功能差，需要避免或非常嚴密監測與調整。"
  },
  {
    "id": "MED3_V1_DER_HF_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心衰竭｜休克型態" },
    "stem": "68 歲男性急性心衰竭合併低血壓、四肢冰冷、尿量下降。若判斷為低灌流型（cold）心因性休克傾向，下列何者較符合處置方向？",
    "options": [
      { "key": "A", "text": "大量輸液為首選" },
      { "key": "B", "text": "考慮 inotrope/vasopressor 以維持灌流，並評估可逆原因" },
      { "key": "C", "text": "只需口服利尿劑即可" },
      { "key": "D", "text": "立即給高劑量硝酸甘油" }
    ],
    "answer": "B",
    "explanation": "低灌流（cold）/休克型心衰竭要先救灌流：inotrope ± vasopressor、同時找可逆原因（ACS、嚴重瓣膜病、心律不整等）。大量輸液未必適合；硝酸甘油可能惡化低血壓。"
  },

  {
    "id": "MED3_V1_DER_AF_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜Wolff-Parkinson-White" },
    "stem": "病人心房顫動合併 WPW（ECG 可見 delta wave，且 AF 時心室率極快、QRS 寬），血壓尚可。下列哪一種藥物最不適合？",
    "options": [
      { "key": "A", "text": "Procainamide（或其他適當抗心律不整藥物，依院內用藥）" },
      { "key": "B", "text": "同步電擊（若不穩定）" },
      { "key": "C", "text": "Adenosine 或 verapamil/diltiazem" },
      { "key": "D", "text": "尋求心臟科評估並考慮導管消融" }
    ],
    "answer": "C",
    "explanation": "AF + WPW 禁用純 AV node blocker（adenosine、verapamil/diltiazem、digoxin、單獨β阻斷）以免促進旁路傳導、誘發 VF。穩定者常用 procainamide；不穩定者電擊。"
  },

  {
    "id": "MED3_V1_DER_VALVE_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜瓣膜｜AS 用藥陷阱" },
    "stem": "重度主動脈瓣狹窄病人出現暈厥與心絞痛。下列何者最符合一般用藥原則？",
    "options": [
      { "key": "A", "text": "強力血管擴張與利尿，愈多愈好" },
      { "key": "B", "text": "避免過度降低前負荷/後負荷，並評估瓣膜介入（TAVI/SAVR）" },
      { "key": "C", "text": "只要給 nitrates 反覆使用即可根治" },
      { "key": "D", "text": "完全不需任何評估或介入" }
    ],
    "answer": "B",
    "explanation": "重度 AS 依賴足夠前負荷維持心輸出，過度利尿或血管擴張可能誘發低血壓/暈厥；根本治療是瓣膜介入或手術，藥物多為症狀性與橋接。"
  },

  {
    "id": "MED3_V1_DER_TAMPONADE_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心包填塞｜診斷與處置" },
    "stem": "病人低血壓、頸靜脈怒張、心音變小，呼吸困難。床邊超音波顯示大量心包積液合併右心房/右心室舒張期塌陷。下一步最適當處置？",
    "options": [
      { "key": "A", "text": "先安排運動心電圖" },
      { "key": "B", "text": "立即心包穿刺或外科引流（依資源），並同時支持性治療" },
      { "key": "C", "text": "只給利尿劑" },
      { "key": "D", "text": "等待胸部 CT 再決定" }
    ],
    "answer": "B",
    "explanation": "臨床與超音波符合心包填塞（Beck triad + 右心塌陷）是急症，需緊急引流解除壓迫；影像不應延誤。"
  },

  {
    "id": "MED3_V1_DER_CAP_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜社區型肺炎｜住院判斷" },
    "stem": "78 歲男性 CAP，意識改變，尿素氮升高，呼吸 34/min，血壓 88/52。此時最符合的處置是？",
    "options": [
      { "key": "A", "text": "門診口服抗生素即可" },
      { "key": "B", "text": "需住院，並高度考慮加護/更高層級照護與靜脈治療" },
      { "key": "C", "text": "不需抗生素，因為多為病毒" },
      { "key": "D", "text": "先做肺功能再決定" }
    ],
    "answer": "B",
    "explanation": "高齡合併低血壓、意識改變、呼吸急促等重症指標（相當於嚴重 CAP 的臨床風險分層）支持住院甚至 ICU 評估，需及早靜脈抗生素與支持治療。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜COPD 急性惡化｜NIV" },
    "stem": "COPD 急性惡化，ABG：pH 7.28、PaCO2 68、PaO2 58（已給氧），呼吸費力。下列何者最符合處置？",
    "options": [
      { "key": "A", "text": "立即拔掉氧氣" },
      { "key": "B", "text": "考慮非侵入性正壓通氣（NIV），並合併支氣管擴張與類固醇" },
      { "key": "C", "text": "只要口服止咳藥" },
      { "key": "D", "text": "不需要任何監測，回家休息" }
    ],
    "answer": "B",
    "explanation": "呼吸性酸中毒（pH 下降、PaCO2 上升）合併臨床呼吸窘迫，NIV 可改善通氣、降低插管率；同時給予短效支氣管擴張劑、系統性類固醇，必要時抗生素。"
  },

  {
    "id": "MED3_V1_DER_PE_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜中間風險" },
    "stem": "疑似肺栓塞，CTPA 證實 PE。病人血壓穩定但心臟超音波顯示右心室擴大，troponin 輕度上升。最符合處置方向？",
    "options": [
      { "key": "A", "text": "因為穩定所以不需治療" },
      { "key": "B", "text": "抗凝治療為主，密切監測，必要時升級為溶栓/介入（若惡化）" },
      { "key": "C", "text": "立刻對所有人常規溶栓，不需評估出血風險" },
      { "key": "D", "text": "只要給利尿劑即可" }
    ],
    "answer": "B",
    "explanation": "血壓穩定但有 RV strain 與心肌標記上升屬中間風險（submassive）PE：以抗凝為主並嚴密監測；若血流動力學惡化才考慮溶栓/介入，需衡量出血風險。"
  },

  {
    "id": "MED3_V1_DER_PLEURAL_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜利尿後陷阱" },
    "stem": "心衰竭病人胸水，已使用利尿劑後抽胸水符合 Light’s criteria 滲出液，但臨床仍高度懷疑為心衰所致。下列哪一項最有助於避免「假性滲出」誤判？",
    "options": [
      { "key": "A", "text": "只看胸水外觀" },
      { "key": "B", "text": "使用血清-胸水白蛋白梯度（serum-pleural albumin gradient）或整體臨床判讀" },
      { "key": "C", "text": "只要 Light’s criteria 就絕對正確" },
      { "key": "D", "text": "不需任何再評估" }
    ],
    "answer": "B",
    "explanation": "利尿後胸水蛋白濃縮可能使 transudate 變成符合 Light’s 的「假性滲出」。此時可用血清-胸水白蛋白梯度等方法輔助，並整合臨床。"
  },

  {
    "id": "MED3_V1_DER_PTX_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣胸｜處置策略" },
    "stem": "20 歲瘦高男性初發自發性氣胸，呼吸稍喘，生命徵象穩定，影像顯示小量氣胸。下列何者較符合一般處置方向？",
    "options": [
      { "key": "A", "text": "一定要立即開胸手術" },
      { "key": "B", "text": "可考慮觀察＋氧氣，並密切追蹤；若惡化再介入" },
      { "key": "C", "text": "一律不需追蹤" },
      { "key": "D", "text": "先給利尿劑" }
    ],
    "answer": "B",
    "explanation": "穩定且小量的初發自發性氣胸常可保守治療（觀察±氧氣）並追蹤影像；若症狀重、氣胸大或惡化則需抽吸/胸管等介入。"
  },


  {
    "id": "MED3_V1_DER_ACS_Q0007",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜主動脈剝離排除" },
    "stem": "60 歲男性胸痛，心電圖顯示 ST depression，醫師考慮 NSTE-ACS 並準備給 heparin。病人同時主訴「撕裂樣」背痛，雙上肢血壓差明顯。此時最適當的下一步是？",
    "options": [
      { "key": "A", "text": "立即給 heparin 並等待 troponin" },
      { "key": "B", "text": "先排除主動脈剝離（例如胸部主動脈 CTA）再決定抗凝" },
      { "key": "C", "text": "先做運動心電圖" },
      { "key": "D", "text": "直接給溶栓" }
    ],
    "answer": "B",
    "explanation": "若臨床高度懷疑主動脈剝離（撕裂痛、血壓差、縱膈疑慮），抗凝/溶栓可能造成致命出血，需先以適當影像排除剝離再決定 ACS 路徑。"
  },
  {
    "id": "MED3_V1_DER_AAD_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜主動脈剝離｜藥物順序" },
    "stem": "主動脈剝離病人收縮壓 190、心跳 120。下列哪一個治療順序最恰當？",
    "options": [
      { "key": "A", "text": "先給血管擴張劑（如 nitroprusside）再給 β 阻斷劑" },
      { "key": "B", "text": "先控制心跳（β 阻斷劑），再視需要加血管擴張劑降壓" },
      { "key": "C", "text": "只給利尿劑" },
      { "key": "D", "text": "只給抗生素" }
    ],
    "answer": "B",
    "explanation": "主動脈剝離首要降低剪力（dP/dt），先用 β 阻斷劑控制心跳與收縮力，再加血管擴張劑降壓；若先單用血管擴張可能反射性心搏過速增加剪力而惡化剝離。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0008",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜後壁心肌梗塞" },
    "stem": "胸痛病人 ECG 在 V1–V3 出現水平 ST depression，R 波變高，臨床懷疑後壁心肌梗塞。下一步最適當的檢查是？",
    "options": [
      { "key": "A", "text": "改做運動心電圖" },
      { "key": "B", "text": "加做後壁導程 V7–V9" },
      { "key": "C", "text": "只要重抽 troponin 就好，不需其他" },
      { "key": "D", "text": "支氣管鏡" }
    ],
    "answer": "B",
    "explanation": "V1–V3 的鏡像變化（ST depression、R 波高）需警覺 posterior MI；加做 V7–V9 可捕捉 ST elevation，影響再灌流決策。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0009",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜溶栓禁忌" },
    "stem": "STEMI 病人考慮溶栓，下列哪一項最屬於「絕對禁忌」？",
    "options": [
      { "key": "A", "text": "近兩週曾小手術" },
      { "key": "B", "text": "曾有顱內出血病史" },
      { "key": "C", "text": "高齡" },
      { "key": "D", "text": "曾有消化性潰瘍病史但無出血" }
    ],
    "answer": "B",
    "explanation": "顱內出血病史屬溶栓的典型絕對禁忌。其他選項多為相對禁忌或需個案評估。"
  },
  {
    "id": "MED3_V1_DER_AF_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜抗凝與出血風險" },
    "stem": "AF 病人因消化道出血住院，出血已控制。若其 CHA2DS2-VASc 很高，下列哪一項最符合「抗凝策略」的原則？",
    "options": [
      { "key": "A", "text": "永久停用抗凝，避免再出血" },
      { "key": "B", "text": "在出血源控制後，評估再出血風險並儘早恢復抗凝（個案化）" },
      { "key": "C", "text": "只用 aspirin 取代抗凝即可完全等效" },
      { "key": "D", "text": "出血事件後抗凝一定禁忌" }
    ],
    "answer": "B",
    "explanation": "高血栓風險 AF 病人，長期停抗凝會顯著增加中風；在出血原因處理後通常需個案化地恢復抗凝，並同時降低再出血風險。"
  },
  {
    "id": "MED3_V1_DER_VALVE_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜瓣膜｜二尖瓣狹窄與AF" },
    "stem": "45 歲女性二尖瓣狹窄合併心房顫動。關於中風預防的抗凝選擇，下列何者最符合一般原則？",
    "options": [
      { "key": "A", "text": "DOAC 一律優於 warfarin，任何情況都選 DOAC" },
      { "key": "B", "text": "屬瓣膜性 AF 的典型情境，通常以 warfarin 為主要選擇" },
      { "key": "C", "text": "不需要抗凝，只要控速" },
      { "key": "D", "text": "只用 aspirin 即可" }
    ],
    "answer": "B",
    "explanation": "中重度二尖瓣狹窄合併 AF 通常歸類為瓣膜性 AF 的重要情境，傳統上以 warfarin 為主；單用 aspirin 不足以預防血栓。"
  },
  {
    "id": "MED3_V1_DER_TAMPONADE_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心包填塞｜生理與陷阱" },
    "stem": "心包填塞病人處置前短暫穩定循環時，下列何者較符合生理與治療原則？",
    "options": [
      { "key": "A", "text": "避免輸液，因為會增加心臟負擔" },
      { "key": "B", "text": "可短暫補液增加前負荷以維持灌流，但根本治療仍是引流" },
      { "key": "C", "text": "利尿劑是首選" },
      { "key": "D", "text": "硝酸甘油是首選" }
    ],
    "answer": "B",
    "explanation": "填塞時心室充盈受限，短暫補液可提高前負荷支撐血壓（橋接）；但根本治療是心包引流。利尿與血管擴張會降低前負荷、可能惡化。"
  },
  {
    "id": "MED3_V1_DER_HF_Q0005",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜呼吸困難｜ARDS vs 心因性肺水腫" },
    "stem": "重症病人低氧，胸部影像雙側浸潤。下列哪一項較支持 ARDS 而非心因性肺水腫？",
    "options": [
      { "key": "A", "text": "BNP 很高且頸靜脈怒張" },
      { "key": "B", "text": "左心衰竭病史明確" },
      { "key": "C", "text": "PaO2/FiO2 明顯下降且無明顯容量超負荷證據" },
      { "key": "D", "text": "使用利尿後症狀立刻大幅改善" }
    ],
    "answer": "C",
    "explanation": "ARDS 以非心因性、通透性肺水腫造成嚴重氧合障礙為核心，常見 P/F ratio 顯著下降且缺乏心衰/容量超負荷證據；其餘選項偏向心因性肺水腫。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺炎｜胸水併發症" },
    "stem": "肺炎合併胸水，若懷疑複雜性副肺炎性胸水/膿胸，最重要的下一步是？",
    "options": [
      { "key": "A", "text": "只要加強口服抗生素" },
      { "key": "B", "text": "診斷性胸腔穿刺分析（必要時考慮引流）" },
      { "key": "C", "text": "等胸水自行吸收" },
      { "key": "D", "text": "做運動心電圖" }
    ],
    "answer": "B",
    "explanation": "肺炎合併胸水需評估是否為複雜性胸水/膿胸；胸腔穿刺可判斷性質並決定是否需胸管引流，單靠口服抗生素可能不足。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺炎｜吸入性風險" },
    "stem": "長照住民吞嚥困難，發燒、咳嗽，影像顯示右下肺葉浸潤。最合理的病因機轉與經驗性涵蓋方向是？",
    "options": [
      { "key": "A", "text": "典型 CAP；不需考慮吸入" },
      { "key": "B", "text": "吸入性肺炎可能；經驗性治療需考量口咽菌叢/厭氧菌風險（依情境選擇）" },
      { "key": "C", "text": "一定是肺結核" },
      { "key": "D", "text": "一定是肺栓塞" }
    ],
    "answer": "B",
    "explanation": "吞嚥困難與依賴照護者增加吸入風險；吸入性肺炎常影響依重力分布的肺葉（如右下葉），治療需個案化評估是否需涵蓋厭氧與口咽菌叢。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0004",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜抗凝禁忌" },
    "stem": "確診肺栓塞後計畫抗凝。下列哪一項最屬於「抗凝的強烈禁忌/需立即再評估」？",
    "options": [
      { "key": "A", "text": "輕度貧血" },
      { "key": "B", "text": "活動性顱內出血" },
      { "key": "C", "text": "輕度高血壓" },
      { "key": "D", "text": "近期上呼吸道感染" }
    ],
    "answer": "B",
    "explanation": "活動性顱內出血是抗凝的典型重大禁忌；此時需另行評估（如暫緩、下腔靜脈濾器等替代策略視情境）。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜COPD｜抗生素使用條件" },
    "stem": "COPD 急性惡化是否加用抗生素，最典型會依下列哪一組「症狀惡化」作為重要判斷依據？",
    "options": [
      { "key": "A", "text": "頭痛、噁心、腹瀉" },
      { "key": "B", "text": "呼吸困難加劇、痰量增加、痰變膿" },
      { "key": "C", "text": "胸痛、便秘、體重增加" },
      { "key": "D", "text": "只有發燒才可用抗生素" }
    ],
    "answer": "B",
    "explanation": "COPD 急性惡化常以三大症狀（呼吸困難加劇、痰量增加、痰變膿）作為是否加用抗生素的重要依據之一（臨床仍需整合嚴重度與其他資訊）。"
  },
  {
    "id": "MED3_V1_DER_PTX_Q0003",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣胸｜次發性氣胸" },
    "stem": "70 歲 COPD 病人突發呼吸困難，影像顯示中等量氣胸，生命徵象尚穩但呼吸明顯費力。最合理的處置方向是？",
    "options": [
      { "key": "A", "text": "次發性氣胸仍可一律觀察即可" },
      { "key": "B", "text": "次發性氣胸風險較高，較常需要介入（如胸管）與住院監測" },
      { "key": "C", "text": "只要給利尿劑" },
      { "key": "D", "text": "只要給抗生素" }
    ],
    "answer": "B",
    "explanation": "次發性氣胸（如 COPD）對氧合與儲備影響更大、併發症風險較高，臨床多較傾向住院與較積極介入（依大小、症狀與穩定度決定）。"
  },


  {
    "id": "MED3_V1_DER_CHESTPAIN_INT_Q0010",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜胸痛整合｜致命鑑別" },
    "stem": "55 歲男性突發胸痛合併呼吸困難，血壓 88/56、心跳 128，頸靜脈怒張，右胸呼吸音減弱，氣管稍偏左。最適當的下一步是？",
    "options": [
      { "key": "A", "text": "先安排 CTPA 排除肺栓塞" },
      { "key": "B", "text": "立即針刺減壓（needle decompression）" },
      { "key": "C", "text": "先給 aspirin 並安排心導管" },
      { "key": "D", "text": "先抽 D-dimer 再決定" }
    ],
    "answer": "B",
    "explanation": "血流動力學不穩＋單側呼吸音消失＋頸靜脈怒張＋氣管偏移高度懷疑張力性氣胸，需立即減壓，不能等影像或抽血。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0011",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜低血壓處置" },
    "stem": "下壁 STEMI 病人低血壓、肺音清、頸靜脈怒張，懷疑右心室梗塞。最合適的初始支持治療是？",
    "options": [
      { "key": "A", "text": "硝酸甘油持續點滴" },
      { "key": "B", "text": "利尿劑快速脫水" },
      { "key": "C", "text": "補液提高前負荷並儘速再灌流" },
      { "key": "D", "text": "立即給 ACEi 大劑量" }
    ],
    "answer": "C",
    "explanation": "右心室梗塞依賴前負荷，補液可改善灌流；nitrate/利尿會降低前負荷使休克惡化。根本仍需再灌流。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0012",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜心因性休克" },
    "stem": "STEMI 病人出現意識改變、四肢冰冷、尿量下降，血壓 78/46。此時最符合的處置方向為何？",
    "options": [
      { "key": "A", "text": "僅止痛與觀察" },
      { "key": "B", "text": "立即溶栓後可延後介入" },
      { "key": "C", "text": "緊急再灌流（PCI 為優先）並以升壓/強心藥維持灌流" },
      { "key": "D", "text": "大量利尿劑減少肺水腫" }
    ],
    "answer": "C",
    "explanation": "心因性休克合併 ACS 的救命關鍵是盡快再灌流並支持灌流壓（vasopressor/inotrope），利尿與延後介入會增加死亡風險。"
  },
  {
    "id": "MED3_V1_DER_ARR_SVT_Q0013",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜規則窄 QRS SVT" },
    "stem": "23 歲女性突發心悸，心跳 190，心電圖規則窄 QRS 心搏過速，血壓正常。最適當的第一線處置是？",
    "options": [
      { "key": "A", "text": "同步電擊" },
      { "key": "B", "text": "先嘗試迷走神經刺激（vagal maneuver），必要時給 adenosine" },
      { "key": "C", "text": "直接給 amiodarone 長時間點滴" },
      { "key": "D", "text": "立即給溶栓" }
    ],
    "answer": "B",
    "explanation": "穩定的規則窄 QRS SVT：先 vagal maneuver，再用 adenosine 終止；電擊保留給不穩定或藥物失敗。"
  },
  {
    "id": "MED3_V1_DER_ARR_WCT_Q0014",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜規則寬 QRS" },
    "stem": "62 歲男性有 CAD 病史，心電圖規則寬 QRS 心搏過速 170/min，血壓 92/58，冒冷汗。最適當的下一步是？",
    "options": [
      { "key": "A", "text": "先當作 SVT with aberrancy，給 adenosine 反覆嘗試" },
      { "key": "B", "text": "高度當作 VT 處理，若不穩定則同步電擊" },
      { "key": "C", "text": "觀察即可" },
      { "key": "D", "text": "先做運動心電圖" }
    ],
    "answer": "B",
    "explanation": "規則寬 QRS 在結構性心臟病病人要優先視為 VT；不穩定（低血壓/缺血/休克）立即同步電擊。"
  },
  {
    "id": "MED3_V1_DER_ARR_TDP_Q0015",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜Torsades de pointes" },
    "stem": "病人使用 QT 延長藥物後出現多形性 VT（torsades de pointes），血壓尚可。最適當的急性處置為何？",
    "options": [
      { "key": "A", "text": "立即給 magnesium sulfate" },
      { "key": "B", "text": "給 digoxin" },
      { "key": "C", "text": "給 verapamil" },
      { "key": "D", "text": "不需處置，等它自己停止" }
    ],
    "answer": "A",
    "explanation": "Torsades 的第一線急救藥物是靜脈 magnesium（不論血中 Mg 是否正常），並停用致 QT 延長藥、矯正電解質。"
  },
  {
    "id": "MED3_V1_DER_BRADY_Q0016",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜緩脈｜急救流程" },
    "stem": "病人出現症狀性緩脈（心跳 38/min）、頭暈、低血壓。第一線藥物處置通常為何？",
    "options": [
      { "key": "A", "text": "Atropine" },
      { "key": "B", "text": "Adenosine" },
      { "key": "C", "text": "Furosemide" },
      { "key": "D", "text": "Nitroglycerin" }
    ],
    "answer": "A",
    "explanation": "症狀性緩脈急救：先 atropine；若無效再考慮 pacing 或升壓/強心支持（依情境）。"
  },
  {
    "id": "MED3_V1_DER_HF_CKD_Q0017",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心衰竭｜CKD/高鉀藥物取捨" },
    "stem": "HFrEF 病人（EF 30%）合併 CKD（eGFR 25）且血鉀 5.6。下列哪一項藥物策略最合理？",
    "options": [
      { "key": "A", "text": "ACEi/ARB/MRA 不需考量鉀與腎功能，照常全上" },
      { "key": "B", "text": "避免任何心衰藥，只用利尿劑" },
      { "key": "C", "text": "需個案化：評估腎功能與高鉀風險，必要時先處理高鉀並密切監測再導入 RAASi/MRA" },
      { "key": "D", "text": "立刻給高劑量 potassium supplement" }
    ],
    "answer": "C",
    "explanation": "RAASi/MRA 可改善預後但會加重高鉀/腎功能惡化風險；eGFR 低與高鉀時需個案化調整、先控鉀並嚴密追蹤。"
  },
  {
    "id": "MED3_V1_DER_HYPERTENSIVE_EMERG_Q0018",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜高血壓急症｜目標器官傷害" },
    "stem": "病人血壓 220/130 合併急性肺水腫與缺氧。下列何者最符合高血壓急症的處置原則？",
    "options": [
      { "key": "A", "text": "門診口服藥慢慢降，數週內達標即可" },
      { "key": "B", "text": "需住院靜脈降壓，並治療目標器官傷害（如肺水腫）" },
      { "key": "C", "text": "一次把血壓降到正常值越快越好" },
      { "key": "D", "text": "不需要氧氣或呼吸支持" }
    ],
    "answer": "B",
    "explanation": "有目標器官傷害（急性肺水腫）屬高血壓急症，需靜脈降壓與器官支持；過快降壓可能造成灌流不足。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0019",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜臨床前測" },
    "stem": "低到中度懷疑肺栓塞的病人，若 D-dimer 陰性，最合理結論為？",
    "options": [
      { "key": "A", "text": "仍必須做 CTPA 才能排除" },
      { "key": "B", "text": "在合適前測機率下可有效排除 PE" },
      { "key": "C", "text": "代表一定是 PE" },
      { "key": "D", "text": "需先做支氣管鏡" }
    ],
    "answer": "B",
    "explanation": "在低/中度前測機率情境，陰性 D-dimer 具高陰性預測值，可排除 PE，避免不必要的 CTPA。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0020",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜COPD 急性惡化｜插管警訊" },
    "stem": "COPD 急性惡化使用 NIV 後，出現下列何者最提示 NIV 失敗、需考慮插管？",
    "options": [
      { "key": "A", "text": "PaCO2 逐漸下降、pH 上升" },
      { "key": "B", "text": "意識惡化且 pH 持續下降" },
      { "key": "C", "text": "呼吸費力減輕" },
      { "key": "D", "text": "心跳下降到正常" }
    ],
    "answer": "B",
    "explanation": "NIV 失敗指標包含意識惡化、分泌物無法處理、持續/惡化酸中毒與呼吸窘迫，需及時升級氣道處置。"
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0021",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣喘急性發作｜危險 ABG" },
    "stem": "重度氣喘發作病人一開始常 PaCO2 偏低；若後續 PaCO2 升高趨於正常甚至上升，臨床意義為何？",
    "options": [
      { "key": "A", "text": "代表改善" },
      { "key": "B", "text": "可能代表疲憊與通氣衰竭風險上升" },
      { "key": "C", "text": "代表過度換氣，無臨床意義" },
      { "key": "D", "text": "只要 SpO2 正常就不需理會" }
    ],
    "answer": "B",
    "explanation": "重度氣喘若 PaCO2 由低轉正常/升高，常代表通氣衰竭逼近（呼吸肌疲乏、氣流嚴重受限），需警覺插管風險。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0022",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺炎｜院內感染抗藥風險" },
    "stem": "住院第 6 天發生肺炎，近期使用過廣效抗生素。下列何者最符合經驗性治療的考量？",
    "options": [
      { "key": "A", "text": "一律只用窄效 β-lactam，不需考慮抗藥性" },
      { "key": "B", "text": "需考慮 MRSA/Pseudomonas 等抗藥致病菌風險並選擇涵蓋" },
      { "key": "C", "text": "肺炎多為病毒，不需抗生素" },
      { "key": "D", "text": "只要給抗黴菌藥即可" }
    ],
    "answer": "B",
    "explanation": "HAP/VAP 或住院後期肺炎＋近期廣效抗生素暴露提高抗藥菌風險，經驗性治療需依風險與院內 antibiogram 考量涵蓋。"
  },
  {
    "id": "MED3_V1_DER_PLEURAL_Q0023",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜膿胸處置" },
    "stem": "肺炎合併胸水，胸腔穿刺：pH 7.05、葡萄糖低、LDH 高，且影像顯示分隔（loculation）。最適當處置方向為何？",
    "options": [
      { "key": "A", "text": "門診口服抗生素即可" },
      { "key": "B", "text": "只需反覆抽胸水，不需引流" },
      { "key": "C", "text": "抗生素合併胸管引流（必要時考慮 fibrinolytics 或外科介入）" },
      { "key": "D", "text": "等待自然吸收" }
    ],
    "answer": "C",
    "explanation": "低 pH、低糖、高 LDH、分隔提示複雜性副肺炎性胸水/膿胸，常需胸管引流甚至進一步介入，單靠抗生素不足。"
  },
  {
    "id": "MED3_V1_DER_CHF_PLEURAL_Q0024",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜心衰 vs 其他" },
    "stem": "心衰竭病人出現胸水。若抽胸水為漏出液（transudate），下列哪一項最符合病因推論？",
    "options": [
      { "key": "A", "text": "多為毛細血管通透性增加（如肺炎）" },
      { "key": "B", "text": "多為靜水壓上升或膠體滲透壓下降（如心衰、肝硬化）" },
      { "key": "C", "text": "幾乎一定是惡性腫瘤" },
      { "key": "D", "text": "一定需要抗結核治療" }
    ],
    "answer": "B",
    "explanation": "漏出液主要機轉是靜水壓上升（心衰）或膠體滲透壓下降（低白蛋白、肝硬化等），與發炎造成滲出液不同。"
  },

  {
    "id": "MED3_V1_DER_CHESTPAIN_INT_Q0025",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜胸痛整合｜ACS vs PE" },
    "stem": "48 歲女性突發胸痛與喘，心電圖僅竇性心搏過速，胸部 X 光無明顯浸潤；有近期長途飛行史。最合理的下一步檢查策略是？",
    "options": [
      { "key": "A", "text": "運動心電圖" },
      { "key": "B", "text": "先評估臨床前測機率，低中度則 D-dimer，陽性再 CTPA" },
      { "key": "C", "text": "直接給溶栓" },
      { "key": "D", "text": "先做胃鏡排除 GERD" }
    ],
    "answer": "B",
    "explanation": "情境支持 PE；檢查策略取決於前測機率：低中度可用 D-dimer 排除，陽性再影像；高懷疑或不穩定則直接影像/治療。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0026",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜再灌流時間窗" },
    "stem": "STEMI 病人到院後評估可做 primary PCI。下列何者最符合再灌流策略的一般原則？",
    "options": [
      { "key": "A", "text": "只要症狀改善就不需要再灌流" },
      { "key": "B", "text": "可在可行且不延誤過久的前提下優先 primary PCI" },
      { "key": "C", "text": "任何情況都一律溶栓，不需 PCI" },
      { "key": "D", "text": "只需要抽血不需要心電圖" }
    ],
    "answer": "B",
    "explanation": "STEMI 的核心是及時再灌流；若能在合理時間完成，primary PCI 通常是優先策略；若 PCI 顯著延誤才考慮溶栓（並評估禁忌）。"
  },
  {
    "id": "MED3_V1_DER_ARR_AF_Q0027",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜新發 AF next step" },
    "stem": "60 歲男性新發 AF，心室率 140，血壓穩定但胸悶。最重要的初始處理原則為何？",
    "options": [
      { "key": "A", "text": "先判斷是否血流動力學不穩，穩定者以控速/找誘因為主" },
      { "key": "B", "text": "所有 AF 都必須立刻電擊" },
      { "key": "C", "text": "只要給 aspirin 就可解決" },
      { "key": "D", "text": "不需要評估中風風險" }
    ],
    "answer": "A",
    "explanation": "AF 急診處置先看穩定度：不穩定→電擊；穩定→控速（或節律策略視情境）並找可逆誘因，同時評估抗凝需求。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0028",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜COPD｜氧療目標" },
    "stem": "COPD 急性惡化給氧時，下列何者最合理的 SpO2 目標？",
    "options": [
      { "key": "A", "text": "100%" },
      { "key": "B", "text": "95–100%" },
      { "key": "C", "text": "88–92%（多數情境）" },
      { "key": "D", "text": "不給氧" }
    ],
    "answer": "C",
    "explanation": "COPD 可能因 V/Q 失衡等機轉出現 CO2 滯留風險，常以 SpO2 88–92% 作為保守目標並配合 ABG 監測。"
  },



  {
    "id": "MED3_V1_DER_ACS_Q0029",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜Inferior MI 併發症" },
    "stem": "下壁 STEMI 病人第 2 天突發低血壓、肺音清、頸靜脈怒張，心音出現新收縮期雜音。下列哪一項最應優先鑑別？",
    "options": [
      { "key": "A", "text": "乳突肌斷裂造成急性二尖瓣逆流" },
      { "key": "B", "text": "心室中隔破裂" },
      { "key": "C", "text": "右心室梗塞或心包填塞/心破裂相關併發症" },
      { "key": "D", "text": "單純焦慮症發作" }
    ],
    "answer": "C",
    "explanation": "下壁 MI 後低血壓＋JVD＋肺音清提示「右心前負荷依賴」或機械性併發症造成的阻塞/充盈問題（右心室梗塞、心包填塞/心破裂）。新雜音也要警覺機械性併發症；需立即床邊心超確認（RV 功能、心包積液、VSD/MR）。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0030",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜再灌流後心律" },
    "stem": "STEMI 做完 PCI 後出現加速性室性節律（AIVR），血壓穩定、無胸痛。最恰當處置為何？",
    "options": [
      { "key": "A", "text": "立即電擊" },
      { "key": "B", "text": "立即給大量 amiodarone" },
      { "key": "C", "text": "多為再灌流心律，觀察並處理電解質即可" },
      { "key": "D", "text": "立刻給 verapamil" }
    ],
    "answer": "C",
    "explanation": "AIVR 常見於再灌流後，通常短暫且血流動力學穩定時不需積極治療；重點是監測、矯正 K/Mg、處理缺血或不穩定徵象。"
  },
  {
    "id": "MED3_V1_DER_AF_Q0031",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜電擊時機" },
    "stem": "AF 已持續 4 天，病人血壓穩定但症狀明顯，想做電氣復律。下列何者最符合血栓風險控管原則？",
    "options": [
      { "key": "A", "text": "可直接電擊，不需要抗凝" },
      { "key": "B", "text": "可先做 TEE 排除左心耳血栓再電擊，並在前後給予抗凝" },
      { "key": "C", "text": "只要給 aspirin 就可電擊" },
      { "key": "D", "text": "只要心跳快就一定可以直接電擊" }
    ],
    "answer": "B",
    "explanation": "AF >48 小時或不明時間者，復律前需降低栓塞風險：常見策略為（1）足量抗凝一段時間後再電擊，或（2）TEE 排除血栓後進行電擊，且電擊後仍需持續抗凝（依中風風險與個案）。"
  },
  {
    "id": "MED3_V1_DER_AF_Q0032",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心房顫動｜節律/控速選擇" },
    "stem": "新發 AF（<24 小時）病人血壓穩定但胸悶、心室率 150。以下哪一項最符合初始策略？",
    "options": [
      { "key": "A", "text": "不需控速，直接出院" },
      { "key": "B", "text": "先控速（如 β 阻斷或非 DHP CCB，依禁忌），同時評估誘因與抗凝需求" },
      { "key": "C", "text": "一律立即同步電擊" },
      { "key": "D", "text": "只要給 digoxin，其他不用做" }
    ],
    "answer": "B",
    "explanation": "穩定 AF 初始多以控速＋找誘因（感染、缺氧、甲亢、缺血等）並評估抗凝為核心；是否採節律控制（藥物/電擊）取決於症狀、時間窗、結構性心臟病與血栓風險。"
  },
  {
    "id": "MED3_V1_DER_ARR_Q0033",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜Digoxin 中毒" },
    "stem": "老年心衰病人使用 digoxin，合併 CKD。近期噁心、視覺偏黃，心電圖出現多形性心律不整。下列哪一項最可能促成中毒？",
    "options": [
      { "key": "A", "text": "低血鉀" },
      { "key": "B", "text": "低血鈉" },
      { "key": "C", "text": "高血鈣一定會保護" },
      { "key": "D", "text": "高血壓" }
    ],
    "answer": "A",
    "explanation": "低血鉀會增加 digoxin 與 Na/K ATPase 結合，顯著提高毒性與心律不整風險；CKD 亦會降低清除率。臨床需同時檢驗 K/Mg、藥物濃度並評估解毒治療（digoxin immune Fab 依嚴重度）。"
  },
  {
    "id": "MED3_V1_DER_HF_Q0034",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性失代償心衰｜β 阻斷劑" },
    "stem": "HFrEF 病人因感染誘發急性失代償心衰，出現肺水腫但血壓穩定。平時規律使用 β 阻斷劑。下列何者最符合一般用藥原則？",
    "options": [
      { "key": "A", "text": "急性期一律加倍 β 阻斷劑劑量" },
      { "key": "B", "text": "除非有心因性休克/顯著低灌流，通常維持既有 β 阻斷劑並治療誘因與去充血" },
      { "key": "C", "text": "所有急性心衰都必須停掉 β 阻斷劑" },
      { "key": "D", "text": "β 阻斷劑可立即改善肺水腫，優先於利尿" }
    ],
    "answer": "B",
    "explanation": "急性失代償心衰處置重點是去充血（利尿/NIPPV）與治療誘因。β 阻斷劑通常在血壓穩、無休克/嚴重低灌流時可維持；若休克、需 inotrope 或顯著低灌流才考慮暫停或下修。"
  },
  {
    "id": "MED3_V1_DER_SHOCK_Q0035",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜休克鑑別｜冷/暖" },
    "stem": "病人低血壓且四肢溫暖、脈壓大、皮膚潮紅，合併高乳酸與發燒。最符合的休克型態為？",
    "options": [
      { "key": "A", "text": "心因性休克" },
      { "key": "B", "text": "阻塞性休克" },
      { "key": "C", "text": "分布性休克（如 septic shock 的早期暖休克）" },
      { "key": "D", "text": "失血性休克" }
    ],
    "answer": "C",
    "explanation": "暖、潮紅、脈壓大提示周邊血管擴張的分布性休克（常見於敗血症早期），與心因性/失血性常見四肢冰冷相對。"
  },
  {
    "id": "MED3_V1_DER_PERICARD_Q0036",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心包填塞｜理學" },
    "stem": "心包填塞的 pulsus paradoxus 指的是？",
    "options": [
      { "key": "A", "text": "吸氣時收縮壓上升 >10 mmHg" },
      { "key": "B", "text": "吸氣時收縮壓下降 >10 mmHg" },
      { "key": "C", "text": "呼氣時心跳變慢" },
      { "key": "D", "text": "收縮壓與舒張壓差縮小" }
    ],
    "answer": "B",
    "explanation": "pulsus paradoxus 是吸氣時收縮壓下降超過 10 mmHg，反映填塞時心室互相競爭與充盈受限，為重要理學提示。"
  },
  {
    "id": "MED3_V1_DER_VALVE_Q0037",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜鑑別｜HCM vs AS" },
    "stem": "病人收縮期雜音，做 Valsalva maneuver 時雜音變大。最支持下列哪一診斷？",
    "options": [
      { "key": "A", "text": "主動脈瓣狹窄（AS）" },
      { "key": "B", "text": "肥厚型心肌病變（HCM）動態性流出道阻塞" },
      { "key": "C", "text": "二尖瓣狹窄（MS）" },
      { "key": "D", "text": "心包摩擦音" }
    ],
    "answer": "B",
    "explanation": "Valsalva 降低前負荷會加重 HCM 的動態性阻塞，使雜音變大；AS 多在增加前負荷/回心血量時較明顯。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0038",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜妊娠影像" },
    "stem": "懷孕婦女疑似肺栓塞且臨床懷疑度中高。下列何者最符合「降低胎兒/母體風險並兼顧診斷」的策略概念？",
    "options": [
      { "key": "A", "text": "不做任何影像，因為孕婦不能檢查" },
      { "key": "B", "text": "以臨床前測機率結合檢驗與影像（如下肢超音波、必要時選擇合適胸部影像）做階梯式評估" },
      { "key": "C", "text": "一律直接溶栓" },
      { "key": "D", "text": "只做運動心電圖" }
    ],
    "answer": "B",
    "explanation": "孕婦 PE 評估仍以「前測機率→階梯式檢查」降低不必要輻射與漏診風險：可先找 DVT（下肢超音波），必要時選擇合適胸部影像檢查，並依個案權衡。"
  },
  {
    "id": "MED3_V1_DER_PE_Q0039",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺栓塞｜V/Q vs CTPA" },
    "stem": "疑似肺栓塞，若胸部 X 光正常且病人無顯著肺實質病變風險，下列何者可作為較合適的核醫影像選項？",
    "options": [
      { "key": "A", "text": "V/Q scan" },
      { "key": "B", "text": "腹部超音波" },
      { "key": "C", "text": "胃鏡" },
      { "key": "D", "text": "頭部 CT" }
    ],
    "answer": "A",
    "explanation": "胸部 X 光正常時，V/Q scan 的判讀價值較高，可作為 PE 影像策略之一（實務仍需結合前測機率、腎功能、對比劑禁忌等）。"
  },
  {
    "id": "MED3_V1_DER_COPD_Q0040",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜ABG｜急慢性呼吸性酸中毒" },
    "stem": "COPD 病人 ABG：pH 7.34、PaCO2 60、HCO3- 32。最合理解讀為？",
    "options": [
      { "key": "A", "text": "急性呼吸性酸中毒，無代償" },
      { "key": "B", "text": "慢性呼吸性酸中毒合併代償" },
      { "key": "C", "text": "代謝性酸中毒" },
      { "key": "D", "text": "呼吸性鹼中毒" }
    ],
    "answer": "B",
    "explanation": "PaCO2 升高伴 HCO3- 明顯上升、pH 接近正常，符合慢性 CO2 滯留並有腎臟代償（典型 COPD）。"
  },
  {
    "id": "MED3_V1_DER_ASTHMA_Q0041",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣喘急性發作｜沉默胸" },
    "stem": "急性氣喘病人原本喘鳴明顯，治療後反而喘鳴消失、呼吸音變安靜，病人仍極喘。最合理解釋是？",
    "options": [
      { "key": "A", "text": "代表完全改善" },
      { "key": "B", "text": "可能是 silent chest，提示氣流嚴重受限與呼吸衰竭風險上升" },
      { "key": "C", "text": "代表病人裝病" },
      { "key": "D", "text": "代表肺炎" }
    ],
    "answer": "B",
    "explanation": "喘鳴消失不一定是好轉；若因氣流極差導致「聽不到」喘鳴（silent chest），是危險徵象，需警覺插管與重症處置。"
  },
  {
    "id": "MED3_V1_DER_PNA_Q0042",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺炎｜抗生素升/降階" },
    "stem": "HAP 病人先以廣效涵蓋治療，48–72 小時後臨床改善，培養結果顯示單一敏感菌。最符合後續策略為？",
    "options": [
      { "key": "A", "text": "維持原廣效直到療程結束" },
      { "key": "B", "text": "依培養結果降階至窄效抗生素" },
      { "key": "C", "text": "立刻停所有抗生素" },
      { "key": "D", "text": "改用更廣效藥物避免復發" }
    ],
    "answer": "B",
    "explanation": "抗生素 stewardship 強調：在臨床改善且培養/藥敏明確時，應降階以降低抗藥性壓力與副作用，同時維持療效。"
  },
  {
    "id": "MED3_V1_DER_PLEURAL_Q0043",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜結核性胸膜炎" },
    "stem": "年輕人胸水，胸水分析：淋巴球為主、蛋白偏高、ADA 升高。最支持哪一類病因？",
    "options": [
      { "key": "A", "text": "心衰竭相關漏出液" },
      { "key": "B", "text": "結核性胸膜炎（需結合臨床與進一步檢查）" },
      { "key": "C", "text": "單純外傷血胸" },
      { "key": "D", "text": "腎病症候群相關胸水" }
    ],
    "answer": "B",
    "explanation": "淋巴球為主的滲出液胸水合併 ADA 升高常支持結核性胸膜炎（仍需整合影像、微生物/病理檢驗）。"
  },
  {
    "id": "MED3_V1_DER_PLEURAL_Q0044",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜惡性胸水" },
    "stem": "疑似惡性胸水時，下列哪一項檢查最直接用於確認「腫瘤相關」？",
    "options": [
      { "key": "A", "text": "胸水細胞學（cytology）" },
      { "key": "B", "text": "尿液分析" },
      { "key": "C", "text": "運動心電圖" },
      { "key": "D", "text": "凝血時間" }
    ],
    "answer": "A",
    "explanation": "胸水 cytology 是鑑別惡性胸水的重要檢查之一；若陰性但高度懷疑，常需重複採樣或胸膜切片/胸腔鏡取樣。"
  },
  {
    "id": "MED3_V1_DER_PTX_Q0045",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜氣胸｜機械通氣風險" },
    "stem": "插管正壓通氣中的病人突然低血壓、氧合惡化、單側呼吸音消失。最適當處置為？",
    "options": [
      { "key": "A", "text": "立刻針刺減壓/放胸管（視臨床判斷）" },
      { "key": "B", "text": "先等 CXR 才能確診" },
      { "key": "C", "text": "只要提高 FiO2" },
      { "key": "D", "text": "先做肺功能檢查" }
    ],
    "answer": "A",
    "explanation": "正壓通氣是張力性氣胸高風險情境；臨床高度懷疑時需立即減壓/胸管，不能等影像延誤。"
  },
  {
    "id": "MED3_V1_DER_HEMOPTYSIS_Q0046",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜咯血｜緊急處置" },
    "stem": "大量咯血病人血氧下降、意識不清。最優先的處置目標為何？",
    "options": [
      { "key": "A", "text": "先安排 CT 找出病灶" },
      { "key": "B", "text": "優先保護氣道與維持氧合（必要時插管），再進一步診斷止血" },
      { "key": "C", "text": "只要止咳藥" },
      { "key": "D", "text": "先做運動心電圖" }
    ],
    "answer": "B",
    "explanation": "大量咯血最致命的問題常是窒息而非失血；ABC 優先，先保護氣道與氧合，再進一步影像/支氣管鏡與介入止血。"
  },
  {
    "id": "MED3_V1_DER_CHESTPAIN_INT_Q0047",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜胸痛整合｜心肌炎" },
    "stem": "年輕人病毒感染後胸痛，troponin 升高，心電圖變化不典型，冠狀動脈風險低。下列何者最符合下一步評估方向？",
    "options": [
      { "key": "A", "text": "直接溶栓" },
      { "key": "B", "text": "考慮心肌炎/心包心肌炎，安排心臟超音波與必要時心臟 MRI" },
      { "key": "C", "text": "只要當 GERD 治療" },
      { "key": "D", "text": "一律運動心電圖" }
    ],
    "answer": "B",
    "explanation": "病毒後胸痛＋troponin 升高需考慮心肌炎或心包心肌炎；心超可評估功能與積液，心臟 MRI 對發炎/水腫與鑑別有幫助。治療與 ACS 路徑不同。"
  },
  {
    "id": "MED3_V1_DER_CAP_Q0048",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜CAP｜合併 COPD/心衰鑑別" },
    "stem": "COPD 病人發燒、咳嗽、喘，X 光可疑浸潤但同時 BNP 明顯升高、JVD、下肢水腫。最合理的臨床策略是？",
    "options": [
      { "key": "A", "text": "只當 COPD 惡化，不需要影像/檢驗整合" },
      { "key": "B", "text": "同時考慮 CAP 與心衰/容量問題，整合病史、影像、床邊超音波與反應決定治療" },
      { "key": "C", "text": "一律只給利尿，不給抗生素" },
      { "key": "D", "text": "一律只給抗生素，不處理容量" }
    ],
    "answer": "B",
    "explanation": "臨床常重疊（COPD 惡化、CAP、心衰），需整合影像、實驗室與床邊超音波（肺 B-line、IVC、心功能）以及治療反應，避免只押單一診斷造成漏治。"
  },


  {
    "id": "MED3_V1_DER_ACS_Q0049",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜STEMI 等同物" },
    "stem": "胸痛病人 ECG 於 V2–V4 出現「J point 上斜型 ST depression」合併高尖對稱 T 波（de Winter pattern）。最恰當處置是？",
    "options": [
      { "key": "A", "text": "這不是 STEMI，不需緊急再灌流" },
      { "key": "B", "text": "視為前壁梗塞等同（STEMI equivalent），啟動緊急再灌流流程" },
      { "key": "C", "text": "先安排運動心電圖" },
      { "key": "D", "text": "只要觀察並重抽 troponin" }
    ],
    "answer": "B",
    "explanation": "de Winter pattern 是近端 LAD 阻塞的 STEMI equivalent，雖無典型 ST elevation 仍需緊急再灌流評估（如 primary PCI）。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0050",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜急性冠心症｜STEMI 等同物" },
    "stem": "心電圖顯示 aVR ST elevation 合併廣泛性 ST depression，病人胸痛且血流動力學不穩。最重要的臨床意涵是？",
    "options": [
      { "key": "A", "text": "典型急性心包炎" },
      { "key": "B", "text": "高度懷疑左主幹或近端多條冠狀動脈嚴重缺血，需緊急侵入性評估" },
      { "key": "C", "text": "通常是正常變異" },
      { "key": "D", "text": "只要給止痛藥即可" }
    ],
    "answer": "B",
    "explanation": "aVR ST elevation + 廣泛 ST depression 常提示左主幹/近端 LAD 或三條血管缺血，風險高，需緊急處置與侵入性評估。"
  },

  {
    "id": "MED3_V1_DER_ACS_Q0051",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心肌梗塞併發症｜VSD" },
    "stem": "AMI 後第 3 天突發呼吸困難、低血壓，聽到新出現的粗糙全收縮期雜音（左胸骨緣）合併震顫。最可能為何種機械性併發症？",
    "options": [
      { "key": "A", "text": "心包炎" },
      { "key": "B", "text": "心室中隔破裂（post-MI VSD）" },
      { "key": "C", "text": "單純肺炎" },
      { "key": "D", "text": "主動脈瓣狹窄" }
    ],
    "answer": "B",
    "explanation": "AMI 後數天新出現粗糙全收縮期雜音與震顫、快速惡化的心衰/休克需高度懷疑 VSD；需床邊心超確認並緊急心臟科/外科處置。"
  },
  {
    "id": "MED3_V1_DER_ACS_Q0052",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心肌梗塞併發症｜乳突肌斷裂" },
    "stem": "AMI 後第 2 天突發嚴重肺水腫與休克，心尖部新出現收縮期雜音但不一定很大。最應優先鑑別的併發症是？",
    "options": [
      { "key": "A", "text": "乳突肌斷裂造成急性嚴重二尖瓣逆流" },
      { "key": "B", "text": "慢性二尖瓣狹窄" },
      { "key": "C", "text": "心包炎" },
      { "key": "D", "text": "心房中隔缺損" }
    ],
    "answer": "A",
    "explanation": "乳突肌斷裂會導致急性嚴重 MR → 急性肺水腫與休克。雜音可能不大（因左房壓迅速升高使壓差減少），因此不能因雜音小而排除。"
  },

  {
    "id": "MED3_V1_DER_PERICARD_Q0053",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心包炎｜治療" },
    "stem": "急性心包炎病人無禁忌且無高度疑慮細菌/結核/腫瘤。最典型的第一線治療組合為何？",
    "options": [
      { "key": "A", "text": "抗凝（heparin）為主" },
      { "key": "B", "text": "NSAID（或 aspirin）合併 colchicine" },
      { "key": "C", "text": "高劑量利尿劑" },
      { "key": "D", "text": "溶栓" }
    ],
    "answer": "B",
    "explanation": "多數急性心包炎第一線為 NSAID/aspirin + colchicine（降低復發），並處理病因；抗凝不是常規且在某些情境可能增加出血/填塞風險。"
  },
  {
    "id": "MED3_V1_DER_PERICARD_Q0054",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心包炎｜危險徵象" },
    "stem": "急性心包炎病人下列何者屬於「高危險特徵」，通常需要住院或進一步評估？",
    "options": [
      { "key": "A", "text": "胸痛隨前傾緩解" },
      { "key": "B", "text": "低度發燒 37.6°C" },
      { "key": "C", "text": "發燒 >38°C 或免疫低下/抗凝使用/大型心包積液" },
      { "key": "D", "text": "心電圖有 PR depression" }
    ],
    "answer": "C",
    "explanation": "高危險特徵（如高燒、免疫低下、外傷、抗凝、疑似心肌炎、對 NSAID 無反應、巨大積液/填塞）通常需要住院與找二級病因。"
  },

  {
    "id": "MED3_V1_DER_ENDOCARD_Q0055",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜感染性心內膜炎｜採血" },
    "stem": "懷疑感染性心內膜炎（IE）且血流動力學穩定時，最符合的血液培養策略是？",
    "options": [
      { "key": "A", "text": "先給抗生素，再隨便抽 1 組培養" },
      { "key": "B", "text": "不同靜脈穿刺抽取多組血液培養後再開始抗生素（不延誤必要治療）" },
      { "key": "C", "text": "只需要尿液培養" },
      { "key": "D", "text": "血液培養沒有任何意義" }
    ],
    "answer": "B",
    "explanation": "IE 診斷仰賴血培與影像。穩定者應先抽取多組血培（不同穿刺點、足量血量）再開始抗生素；不穩定者則以救命治療優先但仍應盡可能先採血。"
  },
  {
    "id": "MED3_V1_DER_ENDOCARD_Q0056",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜感染性心內膜炎｜TEE 指標" },
    "stem": "懷疑 IE，TTE 未見明顯贅生物，但臨床高度懷疑且病人有人工瓣膜。下一步最適當檢查？",
    "options": [
      { "key": "A", "text": "停止評估，因為 TTE 陰性即可排除" },
      { "key": "B", "text": "安排 TEE 以提高偵測率並評估瓣周併發症" },
      { "key": "C", "text": "只做運動心電圖" },
      { "key": "D", "text": "只做胸部 X 光" }
    ],
    "answer": "B",
    "explanation": "人工瓣膜或臨床高度懷疑時，TEE 敏感度高於 TTE，亦能評估瓣周膿瘍等併發症；TTE 陰性不能排除。"
  },

  {
    "id": "MED3_V1_DER_ARR_Q0057",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜高鉀心電圖" },
    "stem": "慢性腎病病人胸悶無力，ECG 出現高尖 T 波、P 波變小、QRS 變寬。下一步最優先的處置是？",
    "options": [
      { "key": "A", "text": "立即靜脈注射 calcium（如 calcium gluconate）穩定心肌膜電位" },
      { "key": "B", "text": "只要給利尿劑即可" },
      { "key": "C", "text": "等抽血確認再處理" },
      { "key": "D", "text": "只給 aspirin" }
    ],
    "answer": "A",
    "explanation": "有高鉀造成的心電圖變化屬急症，第一優先是給 IV calcium 穩定心肌；再配合移鉀（insulin+glucose、β2 agonist）與排鉀（diuretics、resin、透析）等。"
  },
  {
    "id": "MED3_V1_DER_ARR_Q0058",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜心律不整｜不規則寬 QRS" },
    "stem": "ECG 顯示「不規則寬 QRS 心搏過速」，病人血壓尚可但心跳極快。下列何者最重要的鑑別與用藥陷阱？",
    "options": [
      { "key": "A", "text": "多為 AF with WPW；避免純 AV node blocker（如 verapamil/diltiazem、digoxin、adenosine）" },
      { "key": "B", "text": "必為心房撲動；可放心用 verapamil" },
      { "key": "C", "text": "必為竇性心搏過速；不需處理" },
      { "key": "D", "text": "必為 torsades；只要給 magnesium 就會完全解決" }
    ],
    "answer": "A",
    "explanation": "不規則寬 QRS 需高度懷疑 AF with WPW（旁路傳導）。此時禁用純 AV node blocker 以免促進旁路傳導誘發 VF；應依情境選擇適當抗心律不整藥或電擊。"
  },

  {
    "id": "MED3_V1_DER_RESP_Q0059",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜酸鹼｜慢性高碳酸血症" },
    "stem": "COPD 病人 ABG：pH 7.36、PaCO2 55、HCO3- 30。若此病人因鎮靜藥導致急性通氣變差，最可能的 ABG 變化趨勢為？",
    "options": [
      { "key": "A", "text": "PaCO2 下降且 pH 上升" },
      { "key": "B", "text": "PaCO2 上升且 pH 下降（急性疊加）" },
      { "key": "C", "text": "HCO3- 立刻大幅下降" },
      { "key": "D", "text": "ABG 不會改變" }
    ],
    "answer": "B",
    "explanation": "慢性 CO2 滯留有腎代償；若急性通氣惡化會造成 PaCO2 進一步上升且 pH 下降（急性 on chronic 呼吸性酸中毒）。HCO3- 上升的腎代償需要時間，不會立刻完成。"
  },

  {
    "id": "MED3_V1_DER_CAP_Q0060",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺炎｜非典型與住院策略" },
    "stem": "CAP 病人高燒、低鈉、腹瀉，合併相對性緩脈，影像多葉浸潤。最應優先考慮哪類致病菌與涵蓋方向？",
    "options": [
      { "key": "A", "text": "Legionella 等非典型菌；需納入能涵蓋非典型菌的方案" },
      { "key": "B", "text": "Candida；抗黴菌為首選" },
      { "key": "C", "text": "寄生蟲；驅蟲藥為首選" },
      { "key": "D", "text": "全部是病毒；不需抗生素" }
    ],
    "answer": "A",
    "explanation": "低鈉、腸胃症狀、多葉浸潤等可提示 Legionella；經驗性治療需涵蓋非典型菌（如 macrolide/doxycycline 或呼吸道 FQ，依嚴重度與風險）。"
  },
  {
    "id": "MED3_V1_DER_HAP_Q0061",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜VAP｜診斷陷阱" },
    "stem": "插管第 7 天出現發燒、白血球上升、分泌物增多，胸部影像新浸潤。下列哪一項最符合 VAP 評估與處置概念？",
    "options": [
      { "key": "A", "text": "一定等到痰培養回來才開始治療" },
      { "key": "B", "text": "以臨床與影像判斷開始經驗性治療，同時取得適當呼吸道檢體培養並於後續降階" },
      { "key": "C", "text": "VAP 不會造成死亡，不需治療" },
      { "key": "D", "text": "只要改變鎮靜藥即可改善" }
    ],
    "answer": "B",
    "explanation": "VAP 需及時經驗性抗生素（考量抗藥風險）並同時取得檢體；之後依培養與臨床反應調整/降階，避免延誤與過度用藥。"
  },

  {
    "id": "MED3_V1_DER_TB_Q0062",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜結核｜隔離與檢體" },
    "stem": "病人咳嗽兩個月、體重減輕、夜間盜汗，X 光上葉空洞。最適當的感染管制與檢體策略是？",
    "options": [
      { "key": "A", "text": "不需隔離；先給抗生素觀察" },
      { "key": "B", "text": "空氣傳染隔離，並取得多次痰檢體做 AFB smear/culture（必要時 NAAT）" },
      { "key": "C", "text": "只做血液培養即可" },
      { "key": "D", "text": "只做 D-dimer 即可" }
    ],
    "answer": "B",
    "explanation": "臨床高度疑似肺結核需空氣傳染隔離並取得適當痰檢體（多次、足量），做 AFB smear/culture 與分子檢驗以加速診斷與公共衛生處置。"
  },

  {
    "id": "MED3_V1_DER_PLEURAL_Q0063",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜胸水｜血胸" },
    "stem": "外傷後胸水呈血性，若胸管引流初次大量且持續出血，下列何者最符合處置概念？",
    "options": [
      { "key": "A", "text": "不需理會，等自然止血" },
      { "key": "B", "text": "持續大量出血提示需要外科/介入止血評估（依出血量與生理狀態）" },
      { "key": "C", "text": "只需口服止痛藥" },
      { "key": "D", "text": "先做運動心電圖" }
    ],
    "answer": "B",
    "explanation": "血胸若初次引流量大或持續出血，代表重大血管/肺實質出血風險，需外科/介入評估止血並同時復甦。"
  },

  {
    "id": "MED3_V1_DER_PHTN_Q0064",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜肺高壓｜鑑別" },
    "stem": "病人勞動喘，心超估測肺動脈壓升高，且有左心衰竭/瓣膜病史。最合理的病因分類與下一步概念為？",
    "options": [
      { "key": "A", "text": "一定是原發性 PAH；直接給 PAH 專用藥" },
      { "key": "B", "text": "可能屬於左心疾病相關肺高壓（group 2）；優先處理左心問題並進一步評估" },
      { "key": "C", "text": "一定是肺栓塞；不需其他評估" },
      { "key": "D", "text": "一定是氣喘造成" }
    ],
    "answer": "B",
    "explanation": "左心疾病（HF、瓣膜病）常導致 group 2 PH，治療核心是處理左心病因與充盈壓；PAH 專用藥不應在未分型前貿然使用。"
  },

  {
    "id": "MED3_V1_DER_SA_Q0065",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜睡眠呼吸中止｜心血管風險" },
    "stem": "疑似阻塞型睡眠呼吸中止（OSA）病人合併難治型高血壓與白天嗜睡。下列哪一項最符合處置概念？",
    "options": [
      { "key": "A", "text": "OSA 不影響心血管風險，不需處理" },
      { "key": "B", "text": "安排睡眠檢查評估，並考慮 CPAP 與生活型態介入以降低症狀與風險" },
      { "key": "C", "text": "只要給抗生素" },
      { "key": "D", "text": "只要止咳藥" }
    ],
    "answer": "B",
    "explanation": "OSA 與高血壓、心律不整等風險相關；處置包括睡眠檢查確認、CPAP、體重控制與相關共病管理。"
  },


  {
    "id": "MED3_V1_DER_LIPID_Q0066",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜乙 高血脂｜二級預防" },
    "stem": "50 歲男性曾有心肌梗塞（ASCVD），目前 LDL-C 仍偏高。下列哪一項最符合一般二級預防降脂策略？",
    "options": [
      { "key": "A", "text": "只要生活型態即可，藥物沒有角色" },
      { "key": "B", "text": "以高強度 statin 為核心，若仍未達風險導向目標可加 ezetimibe，必要時再考慮 PCSK9 抑制劑" },
      { "key": "C", "text": "fibrate 一定優於 statin" },
      { "key": "D", "text": "只有 LDL-C >300 才需要治療" }
    ],
    "answer": "B",
    "explanation": "已確診 ASCVD 屬高風險族群，二級預防以 statin（多為高強度）為核心；若 LDL-C 仍未充分下降，可加用 ezetimibe，再視風險與反應考慮 PCSK9 抑制劑。"
  },
  {
    "id": "MED3_V1_DER_LIPID_Q0067",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜乙 高血脂｜原發性預防風險分層" },
    "stem": "48 歲女性無 ASCVD 病史，但有糖尿病且多重危險因子。下列何者最符合降脂用藥的風險導向概念？",
    "options": [
      { "key": "A", "text": "糖尿病不影響心血管風險，不需考慮 statin" },
      { "key": "B", "text": "糖尿病通常屬中高風險族群，常需要至少中等強度 statin；若危險因子多可考慮更積極策略" },
      { "key": "C", "text": "只要 TG 正常就不需治療" },
      { "key": "D", "text": "只要 HDL 高就不需治療" }
    ],
    "answer": "B",
    "explanation": "糖尿病是重要心血管危險因子，原發性預防多採風險導向：通常至少中等強度 statin；若合併多重風險因子或高風險特徵，強度可再提升並個案化。"
  },
  {
    "id": "MED3_V1_DER_LIPID_Q0068",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜乙 高血脂｜家族性高膽固醇血症" },
    "stem": "25 歲男性 LDL-C 極高，家族多人早發 CAD。下列何者最符合家族性高膽固醇血症（FH）的處置概念？",
    "options": [
      { "key": "A", "text": "年輕所以不需治療" },
      { "key": "B", "text": "早期積極降 LDL（高強度 statin ± 加成藥物），並進行家族篩檢" },
      { "key": "C", "text": "只需補充魚油即可" },
      { "key": "D", "text": "只治療 TG，不必理 LDL" }
    ],
    "answer": "B",
    "explanation": "FH 為終生高 LDL 暴露、早發 ASCVD 風險高；治療強調早期且積極的 LDL 降幅（statin 為核心，必要時加用其他藥物），並建議家族成員篩檢。"
  },
  {
    "id": "MED3_V1_DER_LIPID_Q0069",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜乙 高血脂｜高三酸甘油脂與胰臟炎" },
    "stem": "45 歲男性 TG 980 mg/dL，無腹痛但有肥胖與糖尿病控制不佳。最重要的短期處置目標是？",
    "options": [
      { "key": "A", "text": "先不處理，等三個月後複檢" },
      { "key": "B", "text": "降低 TG 以預防急性胰臟炎（控制血糖、限制酒精/精緻碳水、考慮 fibrate/omega-3 等）" },
      { "key": "C", "text": "只要降低 LDL 就可以" },
      { "key": "D", "text": "只要增加飽和脂肪攝取" }
    ],
    "answer": "B",
    "explanation": "嚴重高 TG（常以 ≥500，尤其 ≥1000 mg/dL）顯著提高胰臟炎風險；短期重點是把 TG 降下來（生活型態、血糖控制、避免酒精，必要時藥物如 fibrate/高劑量 omega-3）。"
  },
  {
    "id": "MED3_V1_DER_LIPID_Q0070",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜乙 高血脂｜statin 不良反應" },
    "stem": "病人使用 statin 後出現對稱性近端肌肉酸痛，CK 輕度上升。最合理的處置策略為何？",
    "options": [
      { "key": "A", "text": "永久停用所有降脂藥，不再處理" },
      { "key": "B", "text": "評估其他原因與嚴重度，必要時暫停/調整劑量或換另一種 statin，再逐步挑戰並監測" },
      { "key": "C", "text": "立刻加倍 statin 劑量" },
      { "key": "D", "text": "不需管 CK 與症狀" }
    ],
    "answer": "B",
    "explanation": "statin 相關肌症狀需排除甲狀腺低下、藥物交互作用等；多數可透過暫停後再挑戰、換藥或調整強度/頻率達到可耐受的降脂策略；嚴重 CK 大幅上升或疑似橫紋肌溶解需立即停藥與處置。"
  },
  {
    "id": "MED3_V1_DER_LIPID_Q0071",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜乙 高血脂｜禁忌" },
    "stem": "下列哪一情境最不適合使用 statin？",
    "options": [
      { "key": "A", "text": "懷孕或計畫懷孕" },
      { "key": "B", "text": "高血壓" },
      { "key": "C", "text": "輕度脂肪肝但肝功能正常" },
      { "key": "D", "text": "曾經吸菸" }
    ],
    "answer": "A",
    "explanation": "懷孕（及通常含哺乳期）是 statin 的重要禁忌/避免使用情境；其他選項多非絕對禁忌，仍需個案化。"
  },

  {
    "id": "MED3_V1_DER_CMP_DCM_Q0072",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜庚 心肌症｜擴張型心肌病" },
    "stem": "擴張型心肌病（DCM）病人的重要可逆或需排除病因，下列何者最典型？",
    "options": [
      { "key": "A", "text": "酒精/毒性暴露、病毒性心肌炎、甲狀腺疾病" },
      { "key": "B", "text": "只有先天性心臟病，其他不用查" },
      { "key": "C", "text": "只要 BNP 高就是 DCM，無需找原因" },
      { "key": "D", "text": "所有 DCM 都是細菌感染造成" }
    ],
    "answer": "A",
    "explanation": "DCM 病因多元，需系統性排除可逆原因（毒性/酒精、心肌炎、代謝/內分泌、缺血性心臟病等），因為治療與預後會受影響。"
  },
  {
    "id": "MED3_V1_DER_CMP_HCM_Q0073",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜庚 心肌症｜HCM 治療陷阱" },
    "stem": "肥厚型心肌病（HCM）合併動態性左心室流出道阻塞，病人運動時暈厥。下列哪一項藥物方向最合理？",
    "options": [
      { "key": "A", "text": "首選擴血管（如 nitrates）以降低後負荷" },
      { "key": "B", "text": "β 阻斷劑（或非 DHP CCB）以降低心跳與收縮力" },
      { "key": "C", "text": "高劑量利尿以降低前負荷" },
      { "key": "D", "text": "一律溶栓" }
    ],
    "answer": "B",
    "explanation": "HCM 的動態性阻塞會因前負荷下降、收縮力上升而加重；β 阻斷劑或非 DHP CCB 可降低心跳與收縮力、改善症狀。過度利尿或強力血管擴張可能惡化阻塞。"
  },
  {
    "id": "MED3_V1_DER_CMP_HCM_Q0074",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜庚 心肌症｜猝死風險" },
    "stem": "HCM 病人的猝死風險評估，下列哪一項屬於重要高風險線索之一？",
    "options": [
      { "key": "A", "text": "家族猝死史或不明原因暈厥" },
      { "key": "B", "text": "單純高 LDL" },
      { "key": "C", "text": "輕微鼻塞" },
      { "key": "D", "text": "偶發性胃痛" }
    ],
    "answer": "A",
    "explanation": "HCM 猝死風險與家族猝死史、不明原因暈厥、非持續性 VT、極端壁厚等相關；風險高者可能需 ICD 評估。"
  },
  {
    "id": "MED3_V1_DER_CMP_RCM_Q0075",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜庚 心肌症｜限制型心肌病" },
    "stem": "限制型心肌病（RCM）常呈現以舒張功能障礙為主的心衰竭。下列何者最典型的病因之一？",
    "options": [
      { "key": "A", "text": "心肌類澱粉沉積（amyloidosis）" },
      { "key": "B", "text": "單純高血脂" },
      { "key": "C", "text": "急性闌尾炎" },
      { "key": "D", "text": "單純貧血" }
    ],
    "answer": "A",
    "explanation": "RCM 的典型病因包含 infiltrative disease（如 amyloidosis）等；臨床表現常像右心衰（水腫、肝鬱血）且心室不易擴張。"
  },
  {
    "id": "MED3_V1_DER_CMP_STRESS_Q0076",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜庚 心肌症｜Takotsubo" },
    "stem": "更年期女性重大情緒壓力後胸痛，troponin 輕度上升，冠狀動脈攝影無明顯阻塞，但心超顯示左心室局部運動異常不符合單一冠脈分布。最可能診斷？",
    "options": [
      { "key": "A", "text": "Takotsubo（壓力性心肌病）" },
      { "key": "B", "text": "肺栓塞" },
      { "key": "C", "text": "結核性胸膜炎" },
      { "key": "D", "text": "主動脈瓣狹窄" }
    ],
    "answer": "A",
    "explanation": "Takotsubo 常在壓力事件後出現類 ACS 表現，但冠脈無阻塞，且壁運動異常常超出單一冠脈灌流區；治療多以支持性與心衰處置為主並監測併發症。"
  },
  {
    "id": "MED3_V1_DER_MYOCARDITIS_Q0077",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "心內｜庚 心肌症｜心肌炎評估" },
    "stem": "疑似心肌炎（病毒後胸痛、troponin 上升、心律不整），下列哪一項檢查最能提供「心肌發炎/水腫」的組織層級線索？",
    "options": [
      { "key": "A", "text": "心臟 MRI" },
      { "key": "B", "text": "單純胸部 X 光" },
      { "key": "C", "text": "運動心電圖" },
      { "key": "D", "text": "腹部超音波" }
    ],
    "answer": "A",
    "explanation": "心臟 MRI 可提供心肌水腫、延遲增強等資訊，對心肌炎的非侵入性評估很有價值；是否需心肌切片則視病情嚴重度與治療決策而定。"
  },

  {
    "id": "MED3_V1_DER_VENT_ARDS_Q0078",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜庚 呼吸器｜ARDS 通氣策略" },
    "stem": "ARDS 侵入性通氣的核心策略，下列何者最符合？",
    "options": [
      { "key": "A", "text": "高 tidal volume 以洗掉 CO2，越高越好" },
      { "key": "B", "text": "低 tidal volume（以預測體重計）並限制 plateau pressure" },
      { "key": "C", "text": "完全不需要 PEEP" },
      { "key": "D", "text": "PaCO2 一旦上升就一定立刻停止低潮氣量" }
    ],
    "answer": "B",
    "explanation": "ARDS 採肺保護通氣：低潮氣量（常約 6 mL/kg PBW）與限制 plateau pressure（常以 <30 cmH2O 為目標概念），可降低 VILI。必要時允許一定程度 permissive hypercapnia（視禁忌）。"
  },
  {
    "id": "MED3_V1_DER_VENT_ARDS_Q0079",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜庚 呼吸器｜PEEP 與氧合" },
    "stem": "ARDS 病人氧合差，增加 PEEP 最主要的生理目的為何？",
    "options": [
      { "key": "A", "text": "增加肺泡塌陷" },
      { "key": "B", "text": "促進肺泡招募、減少反覆張合造成的肺傷" },
      { "key": "C", "text": "降低功能性殘氣量（FRC）" },
      { "key": "D", "text": "一定會降低肺順應性" }
    ],
    "answer": "B",
    "explanation": "適當 PEEP 可招募塌陷肺泡、改善 V/Q 與氧合，並降低 atelectrauma；但過高 PEEP 也可能導致過度膨脹與血流動力學影響，需要權衡。"
  },
  {
    "id": "MED3_V1_DER_VENT_Q0080",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜庚 呼吸器｜Barotrauma" },
    "stem": "插管通氣病人突然低血壓、氧合惡化、單側呼吸音消失。最合理的鑑別與處置是？",
    "options": [
      { "key": "A", "text": "張力性氣胸；立即減壓/胸管（依臨床判斷）" },
      { "key": "B", "text": "單純焦慮；給鎮靜即可" },
      { "key": "C", "text": "肺炎；改抗生素即可" },
      { "key": "D", "text": "只要提高 FiO2 就會解決" }
    ],
    "answer": "A",
    "explanation": "正壓通氣是 barotrauma 高風險；臨床符合張力性氣胸時需立即處置，不能等影像。"
  },
  {
    "id": "MED3_V1_DER_VENT_Q0081",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜庚 呼吸器｜Auto-PEEP" },
    "stem": "COPD 病人機械通氣後出現血壓下降、呼氣末仍有流速未回到 0（flow-time curve 未歸零）。最可能問題是？",
    "options": [
      { "key": "A", "text": "Auto-PEEP（動態過度充氣）" },
      { "key": "B", "text": "低氧造成的癲癇" },
      { "key": "C", "text": "肺水腫必然惡化" },
      { "key": "D", "text": "主動脈剝離" }
    ],
    "answer": "A",
    "explanation": "氣道阻塞病人若呼氣時間不足會造成 air trapping → auto-PEEP，影響回心血量導致低血壓；處置多包含降低 RR、延長呼氣、調整潮氣量與支氣管擴張等。"
  },
  {
    "id": "MED3_V1_DER_VENT_WEAN_Q0082",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜庚 呼吸器｜撤機評估" },
    "stem": "拔管/撤機前最重要的評估要點之一是？",
    "options": [
      { "key": "A", "text": "只看胸部 X 光" },
      { "key": "B", "text": "病人是否能保護氣道、意識與咳嗽/分泌物處理能力、氧合/通氣穩定" },
      { "key": "C", "text": "只要心跳正常就一定能拔管" },
      { "key": "D", "text": "只要 PaCO2 偏高就一定不能拔管" }
    ],
    "answer": "B",
    "explanation": "撤機不只看數值，還要看能否保護氣道（意識、咳嗽、分泌物）、呼吸功耗、氧合/通氣穩定與血流動力學，避免拔管失敗。"
  },

  {
    "id": "MED3_V1_DER_THX_BASIC_Q0083",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜甲 胸腔基本｜CXR 鑑別" },
    "stem": "胸部 X 光顯示一側下肺野均質性白影伴隨肋膈角鈍化與上緣弧形（meniscus sign）。最可能診斷為？",
    "options": [
      { "key": "A", "text": "肺葉不張" },
      { "key": "B", "text": "肋膜積液（pleural effusion）" },
      { "key": "C", "text": "氣胸" },
      { "key": "D", "text": "肺栓塞" }
    ],
    "answer": "B",
    "explanation": "meniscus sign 與肋膈角鈍化是典型胸水影像線索；肺不張則常見容積減少與縱膈牽移等。"
  },
  {
    "id": "MED3_V1_DER_THX_BASIC_Q0084",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜甲 胸腔基本｜肺不張 vs 肺炎" },
    "stem": "同為局部肺野白影，下列何者較支持肺不張（atelectasis）而非肺炎實變（consolidation）？",
    "options": [
      { "key": "A", "text": "容積減少、縱膈/裂隙朝病灶牽移" },
      { "key": "B", "text": "氣管支氣象（air bronchogram）明顯" },
      { "key": "C", "text": "高燒與膿痰一定存在" },
      { "key": "D", "text": "白影區域永遠不會改變" }
    ],
    "answer": "A",
    "explanation": "肺不張的核心是容積減少，常見縱膈牽移、裂隙位移、鄰近結構拉扯；肺炎實變多為容積保留甚至稍增，air bronchogram 常見但需綜合判讀。"
  },
  {
    "id": "MED3_V1_DER_THX_BASIC_Q0085",
    "source_type": "derived",
    "book": { "code": "MED3_V1", "title": "三(1) 心內、胸內" },
    "location": { "section": "胸內｜甲 胸腔基本｜心因性肺水腫線索" },
    "stem": "急性呼吸困難病人 CXR 顯示雙側肺門為主的蝴蝶狀浸潤合併 Kerley B lines。最支持哪一病因？",
    "options": [
      { "key": "A", "text": "心因性肺水腫" },
      { "key": "B", "text": "單純氣胸" },
      { "key": "C", "text": "肺結核" },
      { "key": "D", "text": "肺栓塞" }
    ],
    "answer": "A",
    "explanation": "Kerley B lines 與中央分布浸潤常提示間質性水腫/肺水腫，需結合臨床（JVD、S3、BNP、心超）判斷心因性可能。"
  }


]
